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Summary
There are two distinct biosynthetic pathways to the essential amino acid L-lysine 
(A). The diaminopimelate pathway to L-lysine occurs in higher plants and 
bacteria. The second pathway known is the a-aminoadipate pathway and is 
found to operate in fungi and yeasts. This thesis will deal with only the 
diaminopimelate pathway to L-lysine and in particular with the first step, which 
involves the condensation of L-aspartic acid (3 -semialdehyde (ASA) (B) with 
pyruvate (C) to form L-dihydrodipicolinate (DHDP) (D). The mechanism of 
formation of L-DHDP (D) was studied using electrospray mass spectrometry. 
The synthesis and testing of potential inhibitors of dihydrodipicolinate synthase 
(DHDPS) was also studied.
O co2O
H H3
(B)
c o 2h
h o 2c
(C) (D)
l-ASA is a substrate of the first enzyme of the diaminopimelate pathway to L- 
lysine. A former co-worker in the group, Dr D. Tudor had developed a route to 
l-ASA as the trifluoroacetate salt. This route was low yielding, approximately 
14% for four steps, thus a higher yielding route was developed utilising the 
para-methoxybenzyl (PMB) ester protecting group. This material was not 
suitable for use in the biochemical assay as an impurity from the deprotection 
stage was found to absorb strongly at the wavelength used for the our enzyme 
assay system. An improved procedure for the synthesis of l-ASA was 
developed increasing the overall yield of the procedure to approximately 48% 
for the same four steps.
The synthesis of l -ASA as its trifluoroacetate salt allowed a number of 
analogues of l -ASA to be prepared with some synthetic modification of the 
original route. The compounds prepared this way were alkylated derivatives of 
l-ASA. The a-methyl ASA (E) was prepared by the reaction of methyl iodide 
with the anion generated from treating diprotected allylglycine with lithium
iv
diisopropylamide (LDA). It proved to be a poor inhibitor but initial studies 
suggest that it may be a reasonably good substrate for DHDPS. A number of 
other derivatives were prepared including p-methyl ASA (F) which again was a 
poor inhibitor but was found to be a good substrate for DHDPS (p-methyl ASA 
is utilised at approximately 20% of the rate that l-ASA is consumed). A number 
of other derivatives and analogues of l -ASA were prepared.
(E) (F)
A number of heterocyclic compounds were prepared as analogues of DHDP 
and were tested for inhibitory effects with DHDPS. These compounds were 
prepared by a 1,3-dipolar cycloaddition of a nitrile oxide onto an alkene or 
alkyne. The isoxazolines produced had a general structure (G). These 
compounds were found to be poor inhibitors of DHDPS with none showing 
inhibition below 1 mM. The ring opened isoxazolines (H) were prepared as 
analogues of pyruvate but again they proved to be poor inhibitors of DHDPS.
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An attempt to synthesise glutamic acid y-semialdehyde (I) starting from glutamic 
acid was undertaken. The compound isolated from the series of reactions was 
found to have cyclised and was stable as the carbinolamine (J). This route was 
abandoned due to the cyclisation of the product.
A number of pyridinedicarboxylic acid derivatives and analogues were prepared 
to test for inhibitory activity. The pyridine-2,6 -dicarboxylic acid /V-oxide (K) and 
the pyridine-2,6 -dinitrile (L) showed very good inhibitory activity. These 
compounds were studied in detail to determine the type of inhibition they 
showed. The two compounds (K) and (L) were found to be non-competitive 
inhibitors of DHDPS. A number of other saturated and unsaturated analogues 
of L-DHDP were prepared and tested for inhibitory action.
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A study of the mechanism of DHDPS was undertaken using electrospray mass 
spectrometry to detect enzyme bound intermediates. The electrospray mass 
spectrometer was able to provide evidence for a number of pyruvate analogues 
bound to the enzyme as Schiff's bases. No evidence for L-ASA bound to 
DHDPS could be found. Further to these studies was the need to preserve 
stocks of DHDPS used for inhibitor testing and biotransformations. A study of 
the immobilisation of DHDPS on Eupergit resins was undertaken to determine 
the feasibility of this technique as a method of obtaining reusable DHDPS. The 
studies found that only up to 18% of the initial sample of DHDPS was bound to 
the beads. This suggests that this may not be a suitable method for the 
immobilisation of DHDPS, however DHDPS bound to the beads was found to 
have long term stability.
vi
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Chapter One: Amino Acids and L-Lysine
1.1 Introduction
a-Amino acids are found in all living organisms in both their free form and 
joined together by amide linkages to form highly complex polymers called 
proteins. Over the last 100 years techniques have improved to the extent that it 
is known now that upwards of 1000 different amino acids occur naturally. This 
increase in the number of naturally occurring amino acids has led to an 
increase of activity within pharmaceutical companies. They often make use of 
amino acids as chirons for the synthesis of novel drug substances in optically 
active form.
With the blossoming use of amino acids as building blocks for many new drug 
substances has arisen the interest in utilising the polymeric form of amino 
acids, namely proteins, to catalyse transformations. These enzymic 
transformations are usually achieved with very high enantiomeric or 
diastereomeric excess, which is often a very difficult problem using modern 
synthetic chemical techniques.
There are only 21 of the 1000 or so amino acids that are genetically encoded 
and incorporated into proteins. The first proteinogenic amino acid to be 
discovered was glycine, quickly followed by leucine and then by 1920, 2 0  of the 
21 proteinogenic amino acids had been discovered. 1'3 All of the amino acids 
except glycine are chiral and are mainly found in the L-form at the a-carbon. 
Only the L-forms are incorporated into proteins. The general structure of amino 
acids is shown in figure 1.
Figure 1: General structure of L-a-amino acids.
The R groups vary widely, and figure 2 shows the R groups for the 21 
genetically encoded amino acids. The R group functionality allows subdivision 
into families of hydrophobic, acidic, basic and hydrophilic amino acids. A given 
amino acid may be found in more than one category e.g. aspartic acid is both 
acidic and hydrophilic. Lysine (1) is itself basic and the biosynthesis of it and all
1
the amino acids will be discussed in the following section. The biosynthesis of 
lysine (1) will be discussed in greater detail in chapter two.
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Figure 2: R groups for the 21 genetically encoded a-amino acids.
1.2 Amino acid biosynthesis
Many metabolic differences exist between the plant and animal kingdoms. 
Plants, unlike animals, are self sufficient, that is they obtain energy by 
harvesting light via the process of photosynthesis. This enables plants to 
obtain all the energy that is required for the biosynthesis of the wide diversity of 
compounds they require. Plants can synthesise all of the required a-amino 
acids and vitamins whereas animals need to obtain a large number of the a- 
amino acids and vitamins from their diet. Figure 3 shows the pathways by
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which plants derive the a-amino acids. Common intermediates define families 
of biosynthetically related a-amino acids. Amino acids essential for the 
mammalian diet are underlined. Pathways below the dashed line do not occur 
in mammals but are found in plants and bacteria.
It can be seen from figure 3 that all 21 of the genetically encoded a-amino 
acids can be generated from 6  biochemical pathways. All of the building blocks 
for the biosynthesis of the amino acids are generated by the processes of 
glycolysis, the pentose phosphate pathway and the citric acid cycle.
A number of herbicides are known to act by inhibiting essential amino acid 
biosynthesis. The biosynthetic pathways which each herbicide inhibits are 
marked by a cross in figure 3. Glyphosate (GP) (2 ) is a non-selective herbicide 
which inhibits general aromatic amino acid biosynthesis. 4,5 Aminotriazole (AT)
(3) was patented as a broad spectrum herbicide by the American Paint 
Company. It was found to act by antagonising histidine biosynthesis by 
blocking the activity of imidazole glycerol phosphate dehydratase .6 The 
sulfonylurea herbicides, chlorosulfuron (CS) (4) and sulfometuron methyl (SM) 
(5) are notable for their high potency and low mammalian toxicity. 7 While 
sulfometuron methyl (5) is a broad spectrum non-selective herbicide, 
chlorosulfuron (4) is selective and can be used to prevent the growth of weeds 
without harming commercially important crops. Both of these compounds 
inhibit the biochemical pathways to branched chain amino acids.
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The biosynthesis of essential amino acids has been an area of active research 
for many years. The ability to design selective herbicides and antibacterial 
agents is the driving force for continued research in this area. As biochemical 
and genetic techniques have advanced, more information about the 
biochemical pathways has emerged. We are now at the point where rational 
design can take place to obtain the next generation of compounds which will 
tackle the growing threat of resistance to current agents.
The biochemical pathway to L-lysine (1) has not received much attention until 
recently. It is a good pathway from which new herbicides and anti-bacterial 
agents could be generated. Our research at Glasgow has been looking at the 
early stages of the biosynthetic pathway as found in plants and bacteria. An 
account of the biosynthetic pathway to lysine can be found in section 1.5 of this 
thesis, along with the design and synthesis of potential inhibitors of the first step 
in the pathway.
1.3 The importance of lysine
Lysine is an economically important amino acid. Mammals cannot 
biosynthesise lysine and must therefore consume it as part of their diet. Lysine 
is therefore an essential amino acid for animals and mammalian nutrition. The 
nutritive value of a protein depends on the quantity and balance of its 
constituent amino acids. Figures for the estimated daily requirement for the 
essential mammalian amino acids are given in table 1.
Amino acid Required daily amount (mg/kg)
Isoleucine 10
Leucine 14
Lysine 12
Methionine 13
Phenylalanine 14
Threonine 7
Tryptophan 4
Valine 10
Table 1: Dietary requirements for the essential amino acids
The consumption of the essential amino acids must meet the daily minimum or 
the whole protein synthesis system is affected. The level of amino acid usage 
is lowered, in mammals, to the level of the limiting amino acid. Under such 
conditions protein is broken down to provide an extra source of the limiting
amino acid. Lysine (1) is often the limiting amino acid in food crops, especially 
cereal protein. It has been necessary, in the past, to supplement the lysine 
content of feed stock by the addition of the required daily minimum amount. 
Commercially the largest producers of lysine (1 ) are the bacteria 
Corynebacterium glutamicum, Brevibacterium flavum and B. lactofermentum.8 
The developments in the production of lysine (1) will be discussed in section 
1.4.
The biosynthesis of lysine in plants and bacteria is not fully understood. It has 
been shown by labelling studies that the pathway in bacteria proceeds through 
the intermediate meso-2 ,6 -diaminopimelic acid (6 ) .9 meso-2,6-Diaminopimelic 
acid (6 ) is known to be utilised in the peptidoglycan cell wall of many Gram 
positive and negative bacteria. The meso-2 ,6 -diaminopimelic acid (6 ) is found 
as part of the cross-linking material of the cell walls, lending mechanical 
strength to the wall.10 Figure 4 shows how meso-2,6-diaminopimelic acid (6 ) is 
utilised, where a pendant penta-peptide is branched off a polymer of N- 
acetylmuramic acid (NAM) and A/-acetylglucosamine (NAG).
NAM NAG
T  
L-Ala
D-GIn
DAP -  Gly — Gly —  Gly — Gly — Gly 
D-Ala 
D-Ala
NAM NAG
L-Ala
D-GIn
D A P-G ly  — Gly —  Gly — Gly — Gly 
D-Ala 
D-Ala
D-Ala
T ranspeptidase
HNAM NAG NAM NAG H
L-Ala L-Ala
D-GIn D-GIn
DAP -  Gly — Gly —  Gly — Gly — Gly — D-Ala- DAP - G ly - Gly —  Gly — Gly — Gly 
D-Ala 
D-Ala
Diaminopimelic Acid (DAP): ^
Figure 4: Utilisation of /neso-2,6-diaminopimelic acid in bacterial cell walls
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Inhibitors of peptidoglycan biosynthesis can possess powerful antibiotic 
properties; and one such drug is Vancomycin. 10,11 The utilisation of an 
important intermediate of lysine (1) biosynthesis in cell wall strengthening 
makes the enzymes of lysine biosynthesis an important area to study. An 
understanding of the pathway could lead to better inhibitors and better 
therapies for bacterial infections. These compounds would be of further 
importance as the biosynthetic pathway to lysine (1 ) is not present in mammals. 
The drugs might therefore possess an excellent mammalian safety profile.
The conversion of lysine (1) into alkaloids is an important biological process 
which has been widely studied for many years. Alkaloids are a diverse group of 
natural products containing a nitrogen heterocycle. They are found mainly, but 
not exclusively, in plants. They are known for their wide range of biological 
activities, e.g. quinine (antimalarial); colchicine (gout suppressant); 
rescinnamine (anti-hypertensive); and morphine (analgesic). The isolation of 
large numbers of alkaloids has been accompanied by an increase in the 
understanding of their biological properties and their pharmacological, 
toxicological and ecological significance in nature. The use of isotopically 
labelled precursors in feeding experiments has helped to understand the 
complex nature by which alkaloids are biosynthesised. Alkaloids are 
biosynthesised in plants from a small subset of a-amino acids (lysine, ornithine, 
phenylalanine, tryptophan and tyrosine) along with mevalonate and acetate. 
Alkaloids have found importance in many fields such as medicine, industry and 
chemistry.
There are two main classes of alkaloid which utilise lysine (1) as a precursor, 
namely the piperidine alkaloids and the quinolizidine alkaloids. Both of these 
types of alkaloid occur in a limited number of plant species.
Many higher plants possess the necessary machinery to synthesise piperidine 
alkaloids. In each case these alkaloids possess one or more piperidine rings. 
Figure 5 shows the biosynthetic pathway taken from lysine in the production of 
a piperidine alkaloid, anabasine (8 ). Robins and co-workers12 studied the 
biosynthesis of anabasine (8 ) in transformed root cultures of Nicotians rustica 
and N. tabacum using cadaverine (7) precursors labelled with deuterium. 
These labelling studies indicated that the pro-R  hydrogen of cadaverine is 
retained at the position that becomes C-2 ' of anabasine.
Quinolizidine alkaloids are of importance because they exhibit toxicity to 
humans and livestock as constituents of poisonous plants, and also have a
7
range of useful pharmacological properties. These alkaloids are normally found 
in species of the genius Lupinus from the plant family Fabaceae. The 
biosynthesis of quinolizidine alkaloids starts with a decarboxylation of lysine (1 ) 
to give cadaverine (7), in an analogous fashion to that described for the 
piperidine alkaloids. The initial step is analogous to the first step in the 
formation of pyrrolizidine alkaloids; namely the decarboxylation of ornithine to 
putrescine. 13
n h 2
c o o h
Decarboxylase
,COOH
N
NH2 
Cadaverine (7)
Diamine oxidase 
or transaminase
‘CHO
.NH2
Anabasine (8)
Figure 5: Biosynthesis of anabasine (8), a piperidine alkaloid from
L-lysine (1)
From this point on the two biosynthetic pathways differ. The route to the 
pyrrolizidine alkaloids involves a symmetrical intermediate (C4 -N-C4 ), whereas 
the biosynthetic pathway to quinolizidine alkaloids does not involve an 
analogous (C5 -N-C5 ) symmetrical intermediate. The most common 
quinolizidine alkaloid is sparteine (9). It has been isolated from many plant 
species including Spartium scoparium,u Sarothamnus scoparius,15 Lupinus 
iindeniancus16 and Lupinus laxus Rydb.u Careful labelling studies by the 
groups of Robins18 and Spenser19 showed that there were equal levels of 13C 
enrichment for six carbon atoms in sparteine after feeding [ 13C-15N]-1,5- 
diaminopentane (cadaverine (7)), and that there were two 13C-15N doublets in 
the 13C NMR spectrum. This confirmed that two molecules of cadaverine (7) 
are incorporated into the two outer rings of sparteine (9) in a specific manner as 
shown in figure 6. The biosynthesis of quinolizidine alkaloids has been 
reviewed recently. 20
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Figure 6: labelling pattern of sparteine (9) after feeding with [13C-15N]-1,5-
diaminopentane
Lysine (1) and arginine (10) play an important role in molecular interactions in 
biological systems because of their basic groups. It is well known that lysine (1) 
and arginine (1 0 ) are indispensable for the growth of microbes, 21'24 plants25'27 
and animals.28'30 Furthermore an antagonistic role between these two amino 
acids has also been observed in living organisms.31,32 Antagonism between 
lysine (1 ) and arginine (1 0 ) has been clearly demonstrated by their effect on 
animal tissues. Either oral or peritoneal administration of a large dosage of 
lysine (1 ) or arginine (10 ) has been found to produce a highly significant change 
in the growth of transplantable tumours in mice.33,34 L-Lysine (1) strongly 
inhibited tumour growth while L-arginine (10) promoted the growth of the 
tumour. Administration of the enantiomer D-lysine promoted the growth of the 
tumour while D-arginine retarded its growth.
From the description above it is easy to see that L-lysine (1) plays a crucial role 
in nature. Hence, L-lysine (1) biosynthesis in both plants and micro-organisms 
is of considerable practical importance. There are two main pathways to L- 
lysine (1). These are the a-aminopimelate (AAA) and the diaminopimelate 
(DAP) pathways which will be discussed in section 1.5.
1.4 Production of L-lysine
The amino acid industry has been growing steadily since monosodium 
glutamate was marketed as a flavouring material in 1909. All of the 
proteinogenic amino acids are now produced industrially by at least one 
method. a-Amino acids can be produced by extraction of protein hydrosylates; 
after fermentation with the aid of micro-organisms; by enzymic processes with
0coov
L-Arginine (10)
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genetically engineered bacteria; and by chemical syntheses. L-Lysine (1) is 
prepared industrially by direct fermentation methods and by biotransformation 
utilising both chemical and microbial techniques.
With the development of modern genetic techniques, it is possible to produce 
most proteinogenic amino acids by fermentation methods. The bacteria are 
engineered to stockpile L-lysine (1) by specific mutation of the wild type 
bacteria. Monosodium glutamate and L-lysine (1) are produced in the largest 
amounts industrially with annual production of 370,000 and 40,000 tons 
respectively. 35
Two types of genetically engineered bacteria are used to stockpile the desired 
amino acid; auxotrophic and regulatory mutants. Auxotrophic mutants are 
engineered so that they lack the enzymes necessary for the production of a 
certain compound and thus they must be supplied with that compound in the 
growth medium to enable the growth of the organism. For the production of 
large quantities of L-lysine (1), it is desirable to knock out the pathway to L- 
methionine, L-threonine and L-isoleucine to concentrate all of the L-aspartic 
semialdehyde down the lysine biosynthetic pathway. This is achieved by using 
mutants without homoserine dehydrogenase (usually E. coli or C. glutamicum) 
and leads to an accumulation of L-lysine (1) as shown in figure 7.36
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v
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X  =Blocked by mutation
Methionine 
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Figure 7: Accumulation of L-lysine by a mutant lacking homoserine
dehydrogenase
Regulatory mutants are genetically modified in a different manner. The 
organism loses its ability to stop or slow down production of a required material. 
This is usually in the form of a mutation of one protein in the biosynthetic
10
pathway so that the organism does not respond to the information telling it to 
slow down its turnover of intermediates in the pathway. L-Lysine is produced in 
this manner by the mutated bacterium B. flavum.37
A biotransformation approach to the industrial production of L-lysine is achieved 
using DL-aminocaprolactam (11), synthesised from cyclohexene.38 Addition of 
L-aminocaprolactam hydrolase (Cryptococcus laurentii) and aminocaprolactam 
racemase (Achromobacter obae) results in the complete enzymic conversion 
into L-lysine (1), shown in figure 8 .
HON
NOCI n h 3
L-Lysine (1)
L-Aminocaprolactam Hydrolase HN
(11)
D-a-Aminocaprolactam
a-Aminocaprolactam Racemase 
Figure 8: Biotransformation approach to production of L-lysine
1.5 Biosynthesis of L-lysine
L-Lysine (1) is biosynthesised via two pathways found in different organisms: 
the AAA pathway and the DAP pathway. The AAA pathway, figure 9, is found 
in Euglenids, some Phycomycetes (Chytridiales, Blastocladiales and 
Mucorales), yeasts and higher fungi (Ascomycetes and Basidiomycetes). It 
starts with the reaction of 2 -oxoglutaric acid (12), a product of the Krebs cycle, 
with acetyl-CoA and involves the synthesis of aminoadipic acid (18) and 
saccharopine (20) as intermediates on the way to L-lysine (1). The DAP 
pathway, figure 12, occurs in bacteria and higher plants and presents a totally 
different approach to the synthesis of L-lysine (1). The initial reaction involves 
the condensation of pyruvic acid (32) with aspartic acid p-semialdehyde (ASA) 
(23) to form dihydrodipicolinic acid (27). Several unique enzyme-catalysed
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steps then transform this condensed product, via meso-diaminopimelate (6 ), 
into L-lysine (1).
The oc-aminoadipate pathway to L-lysine.
Labelling studies utilising radioactive 1 4 C-acetate have shown that, in 
Saccharomyces cerevisiae, the carbon skeleton of lysine (1 ) is built up of 
acetate units via the Krebs cycle.39 The proposed pathway for the formation of 
lysine (1) in yeast, figure 9, involves the condensation of acetate with 2- 
oxoglutarate (1 2 ) to yield homocitrate (13) followed by a set of reactions which 
are analogous to those found in the citric acid cycle.40
Lysine biosynthesis has been investigated in detail in S. cerevisiae 41 The 
enzymes of a-aminoadipate biosynthesis, namely homocitrate synthase, 
homoaconitate hydratase, homoisocitrate dehydrogenase and aminoadipate 
aminotransferase, are all localised in the mitochondria. A second aminoadipate 
aminotransferase has been identified free in the cell. The rest of the enzymes 
of the pathway are also non-mitochondrial. 42 It is therefore important that 
transport of the precursors, a-aminoadipate and a-ketoadipate, to the cytosol is 
efficient. The story in plants is somewhat different with none of the enzymes 
free in the cell.
The first intermediate of the AAA pathway is formed by the condensation of 2- 
oxoglutaric acid (12) with acetyl-CoA to produce homocitrate (13). The reaction 
requires both ATP and acetyl-CoA and is catalysed by the enzyme homocitrate 
synthase. A dehydration reaction then converts homocitrate (13) into 
homoaconitate (14), catalysed by the enzyme homocitrate dehydratase. 
Homoaconitate hydratase then converts homoaconitate (14) into homoisocitrate 
(15). Action of homoisocitrate dehydrogenase converts homoisocitrate (15) into 
oxaloglutarate (16). This enzyme is dependent on NAD and Mg2+ for its 
action.43 Oxaloglutarate is an enzyme-bound intermediate and after a 
spontaneous decarboxylation the product, a-ketoadipate (17), is released from 
the enzyme.
Aminoadipate aminotransferase then converts a-ketoadipate (17) into a- 
aminoadipate (18), via a pyridoxal phosphate dependent transamination 
reaction with glutamate as the amino donor. 42 Conversion of a-aminoadipate 
(18) into a-aminoadipate semialdehyde (19) using the enzyme aminoadipate 
dehydrogenase is the next step. This enzyme catalyses the reaction via a 
multi-step pathway utilising ATP, NADPH and Mg2+ .44
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Figure 9: The a-aminoadipate pathway to L-lysine.
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The reduction of a-aminoadipate (18) to a-aminoadipate semialdehyde (19) in 
Saccharomyces has been shown to be a three stage process. The amino acid 
first reacts with ATP to form an adenyl-a-aminoadipate derivative, releasing 
orthophosphate. This derivative is then reduced in the presence of NADPH. 
The reduced adenyl derivative is then cleaved to form aminoadipate 
semialdehyde (19), as shown in figure 10.
Two steps remain in the pathway to lysine (1). The first step is the 
condensation of a-aminoadipate semialdehyde (19) with glutamate to give 
saccharopine (20), catalysed by saccharopine dehydrogenase (glutamate 
forming). This enzyme requires glutamate and NADPH to facilitate the 
conversion. The final stage is the conversion of saccharopine (20) into lysine 
(1) by the enzyme saccharopine dehydrogenase (lysine forming). This enzyme 
cleaves saccharopine into lysine (1) and 2-oxoglutarate (12).45
ATP, Mg
COOH
o2c
oc-Aminoadipate (18)
NADPH, Mg'Ad=Adenosine
OH
0 2C0 2C
©
a-Aminoadipate semialdehyde (19)
Figure 10: Reduction of a-aminoadipate by aminoadipate semialdehyde
dehydrogenase
The diaminopimelate pathway to L-lysine
As mentioned previously lysine (1), threonine (24), isoleucine (25) and 
methionine (26) belong to the aspartate family of amino acids. In E. coli, they 
each derive part or all of their carbon skeletons from aspartate (21) and share a 
common biosynthetic pathway, shown in figure 11.
Aspartate (21) is phosphorylated to asparty! phosphate (22) and is then 
reduced to give aspartic acid p-semialdehyde (ASA) (23). The pathway to
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Figure 11: The aspartate family of amino acids
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lysine branches at this point with the condensation with pyruvate to form 
dihydrodipicolinic acid (27). The pathway to the other amino acids in the family 
continues with the conversion of ASA (23) into homoserine and then O- 
phosphohomoserine. The path to methionine (26) branches at this point with 
the reaction of O-phosphonohomoserine with cysteine. The pathway to 
threonine (24) and isoleucine (25) involves the reduction of O- 
phosphonohomoserine to give threonine (24) and then from threonine (24) 
isoleucine (25) is produced.
In plants and bacteria, lysine (1) is produced via the diaminopimelate pathway46 
from ASA (23) and pyruvate (32). The pathway requires seven unique steps to 
transform the initial reactants into lysine (1), shown in figure 12. Most of the 
enzymes of the pathway have been isolated and characterised in E. coli and 
other bacteria. A different story exists in plants where Only the enzymes 
responsible for the first and last transformations have been isolated. Evidence 
now suggests that the enzymes for the production of lysine (1) are wholly 
located in the chloroplasts.47 This is in accord with current theories of plant 
evolution which state that the organelles such as the chloroplast are of 
microbial origin.48
The first step in the transformation of ASA (23) into lysine involves the 
condensation of ASA (23) with pyruvic acid (32). Dihydrodipicolinate synthase 
catalyses the formation of the new carbon-carbon and carbon-nitrogen bonds to 
generate the heterocycle 2,3-dihydrodipicolinate (DHDP). The heterocyclic 
product 2,3-DHDP (27) is reduced to 2,3,4,5-tetrahydrodipicolinate (THDP) (28) 
by the enzyme dihydrodipicolinate reductase, in an NADH/NADPH dependent 
fashion. At this point the pathway splits, and two routes exist to lysine (1) in 
different bacterial species.49 The longer pathway proceeds via acylation of 
THDP (28) using succinyl-CoA. This produces acyl-blocked a-amino-e- 
ketopimelic acid (29). The e-keto group once free is transaminated by the 
pyridoxal phosphate dependent transam inase, A/-succinyl-L,L-DAP 
aminotransferase. This reaction uses glutamate as the amino donor. The 
product from this reaction is A/-succinyldiaminopimelate (30). Removal of the 
blocking group by the enzyme A/-succinyl-L,L-DAP desuccinylase, affords L,L- 
DAP (31) which is subsequently epimerised by meso-DAP epimerase to yield 
meso-DAP (6). This is then decarboxylated at the D-centre using DAP 
decarboxylase to generate L-lysine (1).
The shorter of the two routes is found in some species of bacteria and plants. 
meso-DAP (6) is produced directly from THDP (28) by means of the enzyme
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meso-DAP dehydrogenase. This enzyme requires both ammonia and NADPH 
for the reaction to take place. The last step of +he shorter pathway is exactly 
the same as for the longer route, namely the decarboxylation of meso-DAP (6) 
by DAP decarboxylase to produce L-lysine (1).
It is known that both routes to L-lysine (1) operate in some species of bacteria 
including Corynebacterium glutamicum,50 which is an industrially important 
producer of L-lysine (1).
The diaminopimelate pathway to lysine (1) will be discussed more fully in 
chapter two.
1.6: Design of inhibitors of the DAP pathway to L-lysine
Based on the fact that meso-diaminopimelic acid (6) is present in and crucial to 
bacterial cell walls it was natural to assume that inhibitors of the enzymes of the 
DAP pathway could be powerful anti-bacterial agents.
There are many compounds available which block or interfere with the 
biosynthesis of bacterial cell walls. These compounds include the p-lactams, 
which mimic the D-ala-D-ala end of the cross-linking peptide found before the 
wall is completed. The p-lactams form covalent enzyme-bound products which 
can take no further part in the biosynthesis of the cell wall peptidoglycan.
Vancomycin is a macrocyclic aminoglycopeptide, found in strains of 
Streptomyces orientalis. It is a broad spectrum antibiotic and is used to treat 
bacterial infections that have become immune to front line medicines. Its mode 
of action was discovered to be at the site of cell wall assembly. Vancomycin 
blocks the later stages of the process by preventing the final attachment of the 
cell wall to the extracellular acceptors.
Cycloserine is another antibacterial agent which acts at the level of the 
peptidoglycan cell wall assembly. Cycloserine inhibits the racemisation of L- 
alanine to generate the D-alanine required for cell wall assembly. The energy 
required for the cross-linking of the cell wall in the extracellular cavity is 
provided by the D-ala-D-ala bond cleavage.
There are other reasons why the cell wall synthesis of bacteria has been 
targeted for research. These include the absence of the pathways in humans 
and the low toxicity profile this should engender.
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Figure 12: The diaminopimelate pathway to L-lysine
The research in Glasgow has not only concentrated on the design and 
synthesis of inhibitors but also on the production of substrates. Dr. D. Tudor 
first synthesised the substrate aspartic acid (3-semialdehyde (23) and this will 
be briefly discussed in chapter 3, along with improvements to the proceedure 
and some derivatives of the ASA skeleton. Dr S. Connell and Dr. L. Couper 
made a number of analogues of the substrates and products of DHDPS, which
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were tested for inhibitory action. Other product analogues including isoxazoles, 
pyruvates and product-based compounds will be discussed in chapters 4 and 6. 
Finally the higher homologue of ASA, glutamic semialdehyde, was required to 
attempt some biotransformations and to find out if it was a substrate for 
DHDPS. Studies towards this synthesis and the problems it entails will be 
discussed in chapter 5.
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Chapter Two: The Diaminopimelate Pathway to 
L-Lysine
2.1 Introduction
As discussed in section 1.5 the diaminopimelate pathway (figure 12) to L-lysine 
(1) is found in bacteria and higher plants. In these systems L-lysine (1) is 
produced by a series of seven enzyme catalysed reactions from l-ASA (23) 
and pyruvic acid (32). This chapter details the reactions of this pathway and 
presents a review of the current state of understanding of the reaction 
mechanisms. To that end, each enzyme will be discussed separately at some 
length detailing isolation, purification, mechanism and any other relevant 
information. The research at Glasgow has been focused on the first enzyme of 
the pathway, namely dihydrodipicolinate synthase and it is with this enzyme 
that the review below will start. The biosynthesis of L-lysine (1) via the DAP 
pathway has recently been reviewed.51
2.2 Dihydrodipicolinate synthase (DHDPS) (EC 4.2.1.52, dapA)
This enzyme catalyses the formation of dihydrodipicolinate (27) from l-ASA 
(23) and pyruvic acid (32) via what is thought to be a multi-step process, see 
figure 13. This condensation marks the first step unique to the biosynthesis of 
L-lysine (1), and the branch point from the aspartate family of amino acids 
(figure 11).
h o 2c  o
(32)
O
DHDPS
h 3 n  ^ c o 2
h o 2c
(23) (27)
Figure 13: The reaction catalysed by DHDPS.
DHDPS has been characterised from bacteria and a wide range of higher 
plants including spinach (Spinacia oleracea), wheat germ (Triticium aestivum 
L ), and maize seedlings (Zea mays L ), and has been highly purified from 
wheat cell suspension cultures and tobacco leaves (Nicotiana sylvestris). The 
complete amino acid sequences of DHDPS from E. coli, Corynebacterium  
glutamicum, wheat and maize have been reported.52,53 These enzymes have 
been shown to exist as homotetramers, composed of four identical subunits.
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The first preparation of E. coli DHDPS to achieve a high degree of purification 
was carried out by Shedlarski and Gilvarg.54 They achieved a purification of 
over 5000 fold from crude cellular extracts of E. coli W. The were able to study 
the enzyme and found that it was indeed a homotetramer comprising of four 
identical subunits. They determined the molecular weight of the protein 
monomer to be 33,000 by SDS polyacrylamide gel electrophoresis.55 The 
amino acid sequence was determined by degradation experiments it was 
discovered that the amino acid methionine was absent from the protein. They 
demonstrated that the protein was homogeneous by gel electrophoresis and 
that it bore a negative charge in the pH range 6.0-9.2. The nucleotide 
sequence of the dapA gene locus52 predicts that the molecular weight of the 
protein produced from that gene sequence should be in the region of 31,372. 
The molecular mass of the native protein was estimated by the more gentle 
technique of gel permeation chromatography. The molecular weight obtained 
by this technique was 134,000 giving good evidence for the existence of 
DHDPS as a tetramer in its native form.54'56
In 1975, Cheshire and Miflin reported a partial purification of DHDPS from 
maize (Z  mays L ) .57 Mazelis and co-workers reported the detection of DHDPS 
activity in a range of monocotyledonous and dicotyledonous species including 
corn, beansprout, cabbage, spinach leaf, potato tuber and squash fruit. They 
further succeeded in partially purifying DHDPS form wheat germ.58 Wallsgrove 
and Mazelis obtained partially purified DHDPS from spinach leaves (S. 
oleracea L.) by chromatography and gel filtration.59 They determined the 
molecular weight to be 115,000. The DHDPS of spinach leaves was found to 
be localised in the chloroplast where the pH optimum of the enzyme was 
discovered to be 8.2. This is close to the actual pH found inside the 
chloroplast.60 DHDPS was purified 5100 fold from suspension cultured cells of 
wheat ( Triticum aestivum var. Chinese spring) by Kumpaisal and co-workers in 
1987.61 An average molecular weight of the native wheat enzyme was found to 
be 123,000 by gel filtration experiments. A subunit molecular weight of 32,000 
was determined. The enzyme exhibited maximum activity close to pH 8.0.
Ghislain and co-workers62 isolated and characterised DHDPS from N. 
sylvestris. The synthase was found to be located in the chloroplasts but they 
also identified a soluble stroma enzyme by enzymatic and immunological 
methods. The molecular weight of the DHDPS they isolated was found to be
164,000. They carried out a series of experiments with isotopically labelled 
14C-pyruvate and were able to determine that the enzyme was composed of 
four identical subunits with a molecular weight of 38,500.
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A more recent isolation of the enzyme was reported by Frisch and co­
workers.63 They isolated DHDPS from maize leaves (Z  mays L.) and obtained 
a 30,000 fold purification. They determined the molecular weight of the maize 
enzyme homotetramer to be 130,000. By SDS-PAGE they found that the 
subunit molecular weight was 38,000.
DHDPS which may be of a different origin was reported by Schar and co­
workers.64 They purified DHDPS to homogeneity from pea (Pisum sativum), 
and found that the pea DHDPS was a homotrimer of native molecular weight
127,000. The subunit molecular weight was found to be 43,000. The evidence 
for the different origin of this enzyme was that it contained 22 moles of 
methionine per mole of native protein. The E. coli enzyme contains no 
methionine in its amino acid content. The initial stage of the mechanism, 
however, was found to be the same, namely the formation of the Schiff’s base 
between pyruvic acid (32) and the enzyme.
2.3 Purification of DHDPS
Protein purifications generally involve the use of chromatography. The crude 
protein mixture is loaded onto a material which is designed to bind proteins to 
different degrees. This allows the mobile phase to separate the various 
proteins by virtue of the different relative retention times in each phase. These 
materials are generally polymeric materials with a group attached designed to 
attract or repulse proteins.
Many materials are available making use of the wide-ranging properties of 
proteins. The simplest are gel filtration, where the holes in the material are of a 
fixed size and proteins larger than the holes flow through the column quickly. 
Proteins smaller than the holes are retarded and their progress through the 
column is slowed. Ion exchange chromatography is based on the attraction of 
opposite charges. Proteins contain many positive and negative charges on 
their surface and the net charge is either positive or negative. Two types of gel 
are available, namely anion and cation exchangers. The proteins are removed 
from the column by increasing the ionic concentration of the eluant. Many 
materials are marketed; two of these are diethylaminoethyl (DEAE) sephacel 
which is an anion exchanger and carboxymethyl (CM) sephacel.
Other types of purification techniques used are based on affinity and 
hydrophobic interactions. All proteins contain hydrophobic and hydrophilic
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groups on the surface, and it is usual for the hydrophilic groups to dominate 
over hydrophobic for cytosolic proteins. The balance that exists between the 
two is exploited by hydrophobic interaction columns. A more powerful 
technique is that of affinity chromatography. A group is attached that is bound 
strongly by a specific protein and this is used to bind the protein tightly onto the 
column while the rest of the undesired proteins are washed away. The protein 
is removed by an increasing concentration of the ligand it specifically binds free 
in the eluant, or simply by increasing the salt concentration. Examples of these 
techniques are outlined in figure 14.
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Figure 14: Protein chromatographic techniques.
The various purifications of DHDPS have utilised all of these techniques to 
purify the enzyme to homogeneity. Schar and co-workers64 utilised 2- 
aminoethyl-L-cysteine bound to Eupergit resin as an affinity column in their 
procedure to purify pea DHDPS. Gengenbach and co-workers63 used a phenyl 
sepharose chromatographic step to purify the DHDPS from maize cell 
suspensions. Ghislain efa/.62 utilised a DEAE sephacel chromatographic step 
to aid the purification of DHDPS from N. sylvestris by a factor of 163 fold.
At Glasgow, Borthwick55 developed a purification for DHDPS from E. coli cells. 
The initial purification was developed from wild type E. coli cells and then from
(Addition of 
D
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an overproducing strain of E. coli (MV1190/pDA2). The purification involved a 
total of three chromatographic steps and gave a purification of 49 fold. The 
chromatographic steps were DEAE sephacel followed by a phenyl sepharose 
step and finally after concentration a Mono-Q FPLC column.
2.4 Characterisation of DHDPS
There have been three assays developed to detect the presence of DHDPS 
activity. The first is based on the absorbance of an unidentified adduct of L- 
DHDP (27) with o-aminobenzaldehyde. The reaction is monitored 
spectrophotomerically at 540 nm. A second assay is based on the first and 
second steps of the pathway and is a coupled assay. This relies on both 
DHDPS and DHDPR. The product of this process will be L-THDP (27), itself 
unstable under the conditions used. The process is monitored by following the 
reduction in absorbance due to NAD(P)H being utilised. The most useful assay 
for the reaction catalysed by DHDPS is to monitor the increase in absorbance 
due to dipicolinic acid (33) formed by a spontaneous oxidation of l-DHDP (27) 
under the assay conditions (figure 15).
Figure 15: The basis for the DHDPS activity assay at 270 nm.
Utilising one or more of these assay methods has enabled groups to study 
DHDPS from many sources and gather a large amount of detail on the 
behaviour of the enzyme. As was stated earlier (section 2.2) the pH optimum 
for the reaction is about 8. A great deal of work was undertaken to determine 
the Km for the two natural substrates of DHDPS. The Km for ASA (23) varies
between 0.4 mM and 3.1 mM whereas the Km for pyruvic acid (32) is higher, 
about 0.5 mM to 11.8 mM. Kinetic analysis of the reactions catalysed by E. 
coli,65 wheat61 and maize (Z  mays)63 suggests that in the enzymic reaction 
pyruvate (31) is bound with the loss of water, followed by binding and reaction 
of ASA (23). It has been shown that the E. coli DHDPS diplays Ping Pong BiBi
DHDP (27) Dipicolinic acid (33)
kinetics.54,56,61
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2.5 Determination of the molecular weight of DHDPS from E. coli
The purification procedure developed by Borthwick55 was used to obtain 
samples of E. coli DHDPS for electrospray mass spectrometry. This is a 
gentle, but highly accurate technique for the measurement of the molecular 
mass of DHDPS.
Electrospray mass spectrometry makes use of the polycharged nature of 
proteins. The protein must first be made wholly positive or negative for the 
technique to work. This is achieved by adding 0.2% formic acid or 0.2% 
ammonia to a solution of the protein. This is then injected into the mass 
spectrometer and is carried into the probe by a carrier gas, usually heated 
nitrogen. Upon spontaneous evaporation of solvent, the polycharged species 
are then accelerated by a potential difference and crash into the detector. The 
detector measures a mass/charge ratio for each species and from the peaks 
detected can calculate the mass of the protein. A diagram of the electrospray 
mass spectrometer is shown in figure 16.
It was found by Borthwick et a/.66 that the E. coli enzyme they were studying 
had a molecular weight of 31,272 per subunit as shown in figure 17. This 
however was found to be 100 daltons higher than the DNA sequence from the 
dapA gene would suggest. It was discovered by doing a series of tryptic digest 
experiments that there was an error in the protein sequence. It was made 
known to Coggins by Laber (personal communication) that one of the three 
glutamic acid residues in the digest containing residues 220-230 in the protein 
was in fact a glycine. This lowered the mass discrepancy to 28 daltons. It was 
noted by Coggins that the electrospray mass spectrometry showed no sign of 
impurities and that there must be a second error in the sequence of the E. coli 
DHDPS protein.
Electrostatic
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Figure 16: An electrospray mass spectrometer
25
31000 31200 31400
Figure 17: Electrospray measurement of the mass for DHDPS from E. coli.
2.6 The mechanism of DHDPS
The sequence of steps that converts L-ASA (23) and pyruvic acid (32) into L- 
2,3-dihydrodpicolinate (27) has not been fully investigated and elucidated, It is 
however known that pyruvic acid (32) binds to the enzyme via the 8-amino 
group of a lysine residue (Lys 161).54,56,61 There are two theoretically possible 
pathways by which the reaction can proceed. One pathway involves the 
formation of the new C-C bond between the aldehyde group of L-ASA (23) and 
the bound pyruvic acid (32) to produce an enzyme-bound intermediate (34). 
Ring closure of the enzyme-bound intermediate requires release from the 
enzyme to liberate the 4-hydroxy-L-2,3-dihydrodipicolinate (35), see figure 18, 
The loss of a mole of water, probably while within the enzymes active site, then 
completes the synthesis of l-DHDP (27).
The evidence to support the first enzyme-bound/activated pyruvate adduct is 
quite substantial. The enzyme is known to be inactivated when pyruvate 
incubation is followed by addition of sodium borohydride.54 We have taken this 
a stage further and have direct evidence for the Schiff’s base and for the 
reduced imine, formed by sodium borohydride reduction of the Schiff’s base, 
covalently bound to the then inactivated enzyme. Figure 19 shows the ESMS 
for one mole of pyruvate bound to DHDPS. The ESMS work will be discussed 
further in chapter 7.
The second mechanism, and the less likely is that shown in figure 20. This 
involves imine formation as the first step of the reaction with the ring closure 
happening free from the enzyme or whilst still bound to the enzyme.
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Figure 18: Formation of DHDP (27) via an enzyme bound intermediate
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Figure 19: ESMS for pyruvate bound to DHDPS via a Schiff’s base
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Figure 20: Formation of DHDP (27) via an enzyme free ring closure.
Intermediate (36) is free from the enzyme, although it may still be in the active 
site of the enzyme when ring closure occurs. Loss of the elements of water will 
again give L-DHDP (27) as the product.
This reaction catalysed by DHDPS is similar to that carried out by a number of 
aldolases. It is very common for aldolase reactions to proceed via a Schiff’s 
base intermediate bound to the 8-group of a lysine residue.67
2.7 Crystal structure of E. coli DHDPS
The E. coli enzyme has been crystallised and a crystal structure at 2.5 A 
resolution was obtained.68 It was discovered that the active site lysine (Lys 
161) is at the bottom of a cavity 10 A deep by 30 A long. It is possible for the 
pyruvate substrate to approach the lysine residue through an entrance formed 
by adjacent aspartate residues (Asp 187 and 188). These two residues are 
conserved in all known DHDPS enzymes, and this is taken as an indication that 
these two residues are important. It is possible that they have a mechanistic
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roie; presumably this would be general acid/base catalysis. Figure 21 shows 
part of the crystal structure showing the active site buried below the opening.
Figure 21: The active site of E. coli DHDPS 
2.8 Inhibition and regulation of DHDPS
Numerous studies of substrate analogues and inhibitors have been carried out. 
The enzyme displays high specificity for its substrates. For the E. coli enzyme 
pyruvate (32) analogues such as phosphoenolpyruvate, phenylpyruvate, oc- 
ketobutyrate, oxaloacetate and fluoropyruvate are not recognised as 
substrates. Analogues of ASA (23) such as A/-acetyl-ASA and succinate 
semialdehyde are also not substrates.69 It was found by Robins and co­
workers70 that d-ASA was not a substrate of the E. coli enzyme and that it did 
not show any inhibition. Bromopyruvate was found to alkylate DHDPS and 
caused inhibition (Kj 1.6 mM for E. coli and 1.8 mM for wheat).71 Alkylation may 
be near or at the active site for the wheat enzyme, as it was found that high 
concentrations of pyruvic acid (32) would protect the enzyme. For the E. coli 
enzyme alkylation is not at the active site. Studies by Coggins and co­
workers66 showed that the E. coli enzyme was monoalkylated when four 
equivalents of bromopyruvic acid were added, see figure 22. Peaks 
corresponding to imine formation with Lys 161 were not detected by 
electrospray mass spectrometry. It was also found that the monoalkylated 
enzyme retained 72% of its activity. This suggests that the alkylation is near 
but not at the active site of the enzyme. Significant inhibition was seen on 
polyalkylation with a large excess of bromopyruvate.
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Figure 22: ESMS of DHDPS treated with four equivalents of bromopyruvic
acid
Acetopyruvate (37), figure 23, was found to be an effective slow binding 
inhibitor for E. coli DHDPS with a Kj of 5 j jM 72 A drop in the effectiveness of 
this inhibitor was discovered when the pH was raised above 8. It is unclear 
which of the possible tautomers is the active compound. It may be the diketone 
(37) or the structures shown as (38a) or (38b) may act as inhibitors because 
they mimic elements of both substrates, and the proposed reaction 
intermediate.
0  0  OH o  O OH
o(37) OO(38a) (38b)
Figure 23: Acetopyruvate (37) and its tautomers (38a and b)
For plants and some bacterial enzymes the final product of the DAP pathway, 
lysine (1), is regulatory. In E. coli and wheat DHDPS, the enzymes are 
inhibited weakly by lysine (1). L-Lysine (1) is a non-competitive inhibitor with 
respect to pyruvate (32), and inhibits competitively with ASA (23) for these 
enzymes. In E. coli and Bacillus sphaericus, L-lysine (1) inhibition is weak73 
(IC50 E. coli 1 mM and B. sphaericus 0.6 M). Such inhibition by L-lysine (1) has 
not been observed in other bacterial strains.74 Plant DHDP synthases show 
potent allosteric inhibition by L-lysine (1) with IC50 values as shown in table 2.
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Plant IC50 for inhibition by lysine ( jllM )
wheat germ58 11
tobacco62 15
spinach50 20
maize63 23
wheat61 51
Table 2: I C 5 0  values for allosteric inhibition of DHDPS by lysine
Analogues of L-lysine (1) show similar patterns of activity, but these are 
somewhat less effective; for wheat, f/7reo-p-hydroxy-L-lysine (39) is inhibitory 
with an IC50 of 141 |iM, as is (2-aminoethyl)-L-cysteine (AEC) (40) with an IC50 
of 288 jiM .61 Other plant DHDPS enzymes show similar patterns of inhibition 
for instance AEC (40) inhibits DHDPS from tobacco75 with an IC50 of 120 j iM , 
and the enzyme from spinach with an IC50 of 400 j iM .50
Dipicolinic acid (34) inhibits the E. coli DHDPS with an IC50 of 1.2 mM.56 This 
prompted a systematic investigation of numerous heterocyclic analogues of 
both dipicolinic acid (34) and DHDP (27) by our group in Glasgow.76 
Substituted pyridine and piperidine derivatives were found to be moderate 
inhibitors with IC50 values of less than 1 mM. The best of the inhibitors were a 
ditetrazole (41), diimidate (42), dinitrile (43) and the A/-oxide of pyridine-2,6- 
dicarboxylic acid (44). Detailed kinetic studies were carried out (see chapter 7) 
and it was found that compounds (43) and (44) were non-competitive inhibitors 
with respect to either substrate. Out of the systematic study it was discovered 
that esters were stronger inhibitors than their acid congeners and that a planar 
distribution of the substituents was preferred around the nitrogen atom.
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2.9 Dihydrodipicolinate reductase (DHDPR) (EC 1.3.1.26, dapB)
Dihydrodipicolinate reductase catalyses the pyridine nucleotide dependent 
reduction of dihydrodipicolinate (DHDP) (27) to tetrahydrodipicolinate (THDP) 
(28), see scheme 24.
h o 2c
DHDPR
NAD(P)H
h o 2c
DHDP (27) THDP (28)
Scheme 24: The reaction catalysed by DHDPR
2.10 Isolation of DHDPR
DHDPR was first isolated from E. coli by Farkas and Gilvarg.77 Tamir and 
Gilvarg78 succeeded in purifying the protein to homogeneity. A molecular 
weight of 110,000 was calculated for the enzyme. Also reported was the Km for 
L-DHDP (27), 9.0 jllM , and the pH optimum which was found to be 7.0. The 
enzyme, somewhat unusually, can utilise both NADH and NADPH as a 
cofactor.
DHDPR has also been isolated from Bacillus cereus and B. megaterium,79 The 
enzyme was purified 100 fold from crude extracts of these organisms. The 
proteins isolated proved to be homotetramers with molecular weights of 
155,000 and 150,000, respectively. The reductases were inhibited non­
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competitively with respect to L-dihydrodipicolinic acid (27) by dipicolinic acid 
(33), with Kj values of 85 jiM  and 140 |iM, respectively.
The reductase enzyme has also been isolated from maize kernels by Tyagi et 
al.30 Both the crude extracts and the partially purified extracts were assayed for 
DHDPR activity and for their ability to restore the reductase capability to crude 
extracts of mutant E. coli (defective in DHDPR). The restoration was monitored 
by following the production of meso-2,6-diaminopimelic acid (6). The enzyme 
was studied in detail and was found to have a molecular weight of 80,000. The 
Km value for l-DHDP was found to be 0.43 mM and for NADPH the Km value 
was 46 p.M. The pH optimum of the enzyme was close to 7.0 but the enzyme 
was found to be more temperature labile than the E. coli reductase.
DHDPR activity has also been detected in Chlamydomonas, corn, soybean and 
tobacco.81
2.11 Assay systems for DHDPR activity
Two assays have been described utilising synthetic DHDP (27). This material 
is stable only if stored under basic conditions at pH>10. The two methods of 
preparing DHDP (27), one enzymic and the other chemical, were reported by 
Shedlarski and Gilvarg54 and by Tyagi etal.80
Shedlarski and Gilvarg suggested that l_-2,5-DHDP (45) could be the product of 
the pyruvate/ASA condensing enzyme and that this product could be in 
equilibrium with L-DHDP (27) and L-4-hydroxy-3,4,5,6-tetrahydrodipicolinic acid 
(46), see figure 25. It is not clear which of these compounds is the immediate 
product of the enzymatic condensation.
Tyagi etal.80 described a chemical synthesis of l-DHDP from the condensation 
of L-ASA (23) and oxaloacetic acid (47) in alkaline solution, see figure 26. L- 
DHDP was precipitated as its barium salt. The compound was unstable and 
was stored at -80 °C. Only freshly prepared samples were used in assays.
The third assay procedure described makes use of the decrease in 
absorbance, at 340 nm, as NAD(P)H is used up during the course of the 
reaction.54
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2.12 Mechanism of DHDPR
A detailed study of the mechanism of DHDPR was carried out by Reddy e ta l.82 
They produced an overexpressing strain of E. coli which they used to isolate 
the dapB gene, enabling them to generate large quantities of enzyme required 
for the mechanistic study.
h o 2C
L-2,5-dihydro- 
dipicolinate (45)
L-DHDP (27)
DHDPR
L-4-hyd roxy-3,4,5,6- 
tetrahydrodipicolinate 
(46)
H 0 2C
L-THDP (28)
Figure 25: Enzymic production of L-DHDP for use in an assay system
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Figure 26: Chemical synthesis of L-DHDP for assay systems
Reddy et a l82 found that the cofactor duality was indeed present and that 
NADH was the better cofactor with a Km (1.6 j iM ) approximately four times 
lower than that obtained for NADPH (5.6 j iM ). This is remarkable because it 
was discovered that when NADPH was used the rate of reaction was more than 
twice that observed when NADH was used (Vrei 100 for NADPH and 62 for 
NADH).
Reddy et al.82 had previously proved that NAD(P)H donates its pro-R hydrogen 
to DHDP (27) by means of tritium labelling studies. They then chose to 
investigate the position of hydride addition to DHDP (27). They used deuterium 
labelled NADH for the reduction and then carried the reaction product through
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to meso-DAP (6), using meso-DAP dehydrogenase, see figure 27. They used 
[2-D]malate (48) as part of a regeneration system for NADPD for both 
reactions. The enzyme malic enzyme regenerates NADPD and converts 
malate into pyruvate and carbon dioxide. It is known that meso-DAP 
dehydrogenase transfers its pro-S hydrogen to the substrate to form the D- 
stereocenter. This generated a dideuterated meso-DAP (49). The 500 MHz 1H 
NMR spectrum confirmed the donation of the pro-R hydrogen of NADPD to the 
4-position of DHDP (27), see figure 28.
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H° C  \ q D 
[2-D]malate (48) 
C 0 2
Malic enzyme
©
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meso-DAP
Dehydrogenase
+ /-H 20
C O ?
Malic enzyme
. NH4+
NADPD NADP
A / '  i
[2-D]malate Pyravate 
+ C 0 2
Figure 27: Investigation of the mechanism of DHDPR
Figure 28 shows the the 1H NMR spectrum (A) of the unlabelled meso-DAP 
(49a) and the 1H NMR spectrum (B) of the dideuterated meso-DAP (49b). The 
changes are that the signal at 5 1.83 disappears. This is due to the action of 
DHDPR on L-DHDP (27) and the signal is reduced at 5 4.35 from integrating for 
two protons to integrating for one proton. No attempt was made to distinguish 
the two C-4 proton signals to determine the face of the deuterium delivery onto 
l-DHDP (27). Thus the mechanism for DHDPR can be illustrated as seen in 
figure 29. The 4-R hydride is transferred from the cofactor to the p-position of 
the ap-unsaturated immonium ion (nothing is known about the face of delivery),
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generating the enamine. Enzyme assisted protonation then completes the 
reduction and THDP (28) is released from the enzyme.
NH
(49b)
u. jj
41 .3
NH
(49a)
AA_
Figure 28: 500 MHz NMR spectrum of the isolated products from DHDPR
mechanistic studies82
s/'U'l/X/'
NADPH
H
N
He
Figure 29: Proposed mechanism for DHDPR
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2.13 Crystal structure of DHDPR
A crystal structure at 2.2 A resolution was reported by Scapin et a /.83 This 
structure was able to provide direct evidence of the nucleotide binding site (a 
crystal structure was obtained with NADPH bound to the enzyme). It also 
explained why NADH is bound more tightly in the active site. Some evidence 
was presented that a group of positively charged residues (His159, His160, 
Arg161, His162 and Lys163) formed the substrate binding site. Theoretical 
studies with DHDP showed that these residues form a good complex with the 
substrate. It was found that the protein would have to undergo a 30° rotation in 
order to bring the substrate and cofactor close enough to react.
2.14 Inhibition of DHDPR
The E. coli enzyme was found to be inhibited by dipicolinic acid (33). Dipicolinic 
acid (33) is a linear competitive inhibitor with respect to DHDP (27) with a Kj of 
26 pM, and inhibits non-competitively with respect to NAD(P)H with a Kj of 330 
jiM. The inhibition of the enzyme by dipicolinic acid is taken as evidence that it 
is the cyclic form, and not any ring opened form, of DHDP (27) that is the 
substrate of the enzyme. On this basis analogues of dipicolinic acid (33) were 
tested as inhibitors. /so-Phthalic acid (50) showed moderate inhibition with an 
IC50  of 2 mM, but compounds with only one carboxylate group such as 
pipecolinic acid (51) and picolinic acid (52) were much less effective with IC50 
values of greater than 20 mM. Pyridinedicarboxylic acids [e.g. (53)] were found 
not to be inhibitory.
h o 2C
x x
(50)
XNX  /
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Tyagi etal.80 found that DHDPR isolated from maize was inhibited by dipicolinic 
acid (33) with a Kj value of 0.9 mM, indicating that, as with E. coli the wheat 
DHDPR binds the product in its cyclic form. They found that a number of other
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compounds with similar structures to DHDP (27) also inhibited the enzyme, see 
table 3.
Inhibitor % inhibition
20 mM 10 mM 5 mM 1 mM
Picolinic acid (52) 24 4 8 0
Pipecolinic acid (51) 23 30 0 0
/so-phthalic acid (50) 44 20 0 0
Isocinchomeronic acid (53) - - 50 0
Dipicolinic acid (33) - - - 100
Table 3: Inhibitors of wheat DHDPR
2.15 Succinyl CoA: L-tetrahydrodipicolinate /V-succinyltransferase 
(THDP succinylase) (dapD)
Succinyl CoA: L-tetrahydrodipicolinate A/-succinyltransferase catalyses the ring 
opening reaction of L-THDP (28). The succinyl group also acts as a protecting 
group for the transamination reaction that follows. The enzyme requires 
succinyl CoA as a second substrate for the reaction. The reaction catalysed is 
shown in Figure 30 below.
h o 2c
Succinyl CoA:L-tetrahydro- 
dipicolinate A/-succinyltransferase H 0 2C
SuccinylCoA
c o 2h
o  c o 2h
(29)
Figure 30: The reaction catalysed by THDP succinylase
2.16: Isolation and characterisation of THDP succinylase
The purification and characterisation of THDP succinylase was not fully 
investigated until recently. This was due to the unavailability of the enzyme 
substrate, THDP (28) which has only recently been synthesised, see section 
2.17. Simms et a/.84 purified THDP succinylase from E. coli. They achieved a 
purification factor of 1900 fold from crude E. coli extracts. The standard assay 
needs samples of THDP (28) which were prepared enzymically by the oxidative 
deamination of meso-DAP (6) in the presence of NADPH and meso-DAP
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dehydrogenase. The protein was found to be homogeneous by polyacrylamide 
gel electrophoresis and consists of two subunits of molecular weight 31,000. 
The pH optimum for the reaction is 8.0 and the equilibrium lies to the product 
side. The equilibrium can be perturbed towards l -THDP (28) by careful choice 
of conditions. The forward reaction proceeds 380 times as fast as the reverse 
reaction under standard conditions.85
It was noted that the enzyme lost 80% of its activity within four days if 
mercaptoethanol was left out of the buffer in which the enzyme was stored. 
This was taken as evidence for the presence of an active site sulfhydryl group. 
No loss of activity was noted if the enzyme was stored in buffer containing 
0.01% mercaptoethanol. Furthermore, known inhibitors of sulfhydryl-containing 
enzymes were found to be effective inhibitors of THDP succinylase.
Richaud et al.8S were able to determine Km values for the substrates of the 
reaction. The Km for THDP (28) was determined to be 22 p.M and for succinyl 
CoA the Km was 15 jiM.
2.17 Synthesis of L-THDP
The synthesis of L-THDP (28) by chemical means was recently reported by 
Couper et a l This was not the first reported synthesis for L-THDP (28). 
Shapshak87 claimed to have prepared l-THDP (28) by treating DL-2,6-DAP with 
L-amino acid oxidase from Neurospora crassa, but there was no supporting 
chemical or spectroscopic evidence provided.
Cyclisation of a a ’-dioxopimelic acid (54) with ammonia was attempted by 
Kimura and Sasakawa,88 see figure 31. They reported that they had formed 
both dipicolinic acid (33) and dl-THDP (28) by a disproportionation reaction 
from the initial product, 1,4-dihydrodipicolinate (55). They presented as 
evidence the UV absorption spectrum of dipicolinic acid and colour changes on 
reaction with ninhydrin and o-aminobenzaldehyde (for THDP (28)).
A recent report, by Couper et al.,56 described the preparation of the dipotassium 
salt of l-2,3,4,5-THDP (59). The compound was prepared by the elimination of 
p-toluenesulfinic acid from the AMosyl derivative (58) of dimethyl c/'s-piperidine- 
2,6-dicarboxylate (57), see figure 32.
Dimethyl dipicolinate (56) was prepared from dipicolinic acid (33) by heating at 
reflux in methanol and concentrated sulfuric acid. Hydrogenation of the diester
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(56), using platinum (IV) oxide gave dimethyl c/s-piperidine-2,6-dicarboxylate
(57). Tosylation of the nitrogen atom using toluenesulfonyl chloride and 
pyridine gave (58), set up for the elimination.
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(33)
©
N
H2
(55)
'co P
Figure 31: Kimura and Sasakawa synthesis of dl-THDP
The elim ination was carried out using potassium terf-butoxide in 
dichloromethane at room temperature. This procedure also cleaved the ester 
groups. Purification of the dipotassium salt of L-2,3,4,5-tetrahydrodipicolinic 
acid (59) was achieved by means of Amberlite resin. The 1 H and 13C NMR 
data quoted suggest that the dipotassium salt of L-2,3,4,5-THDP (59) exists in 
equilibrium in solution. There were signals visible for both the open chain form 
(61) and the enamine (60). The dipotassium salt of L-2,3,4,5-THDP (59) was 
shown to be a substrate of meso-DAP dehydrogenase by monitoring the 
disappearance of NADPH when it was incubated with the enzyme.
2.18 Mechanism of THDP succinylase
A stereochemical model for the mode of action of THDP succinylase was 
proposed by Berges et al.® The model is based on the results of studies using 
cyclic and acyclic analogues of l-THDP (28) and is shown in figure 33.
From the testing of cyclic and acyclic compounds as inhibitors, Berges et al. 
were able to draw some conclusions about the active site of the enzyme. The 
proposed model involves the initial binding of l-2,3,4,5-THDP (28) to the active 
site of the enzyme. Water then adds cis to the re-face of the imine double bond
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Figure 32: Synthesis of the potassium salt of L-2,3,4,5-THDP
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Figure 33: Stereochemical model for the mode of action of THDP
succinylase
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producing a frans-piperidine-2,6-dicarboxylic acid (62). The hydrated product 
then undergoes a succinylation, and finally ring opens to give A/-succinyl-e-keto- 
a-aminopimelic acid (29).
An important piece of evidence which lends credence to this proposed 
stereochemical model is that 2-hydroxytetrahydropyran-2,6-dicarboxylate (63) 
was found to be a very potent inhibitor. The proposed model of the mechanism 
suggests that (63) should be a very close match to the transition state of the 
enzymic reaction. 2-Hydroxytetrahydropyran-2,6-dicarboxylate (63) bears a 
very close resemblance to the proposed hydrated intermediate (62). The Kj 
was found to be 58 nM, supporting the proposed similarity to the transition 
state.
2.19: Inhibitors of THDP succinylase
The development of inhibitors of THDP succinylase has been split between the 
search for acyclic compounds that fold up to mimic the active site conformation 
and cyclic compounds where the geometrical requirements of the active site 
have been designed into the molecule.
Berges et a l*9 found that D-2-aminopimelate (64) was a reasonable inhibitor of 
THDP succinylase with a Kj value of 0.76 mM. The presence of the two 
carboxylate groups was shown to be important for good binding to the enzyme. 
D- and L-aminoadipic acid and DL-aminosuberic acid were very poor inhibitors 
of the enzyme. They were thought to be too small and too large respectively to 
adopt the correct conformation in the active site of the enzyme. Berges et al,® 
also attempted replacement of a methylene group with a sulfur atom. This had 
little effect as DL-2-amino-5-thiapimelic acid was found to have a Kj value of 1.1 
mM.
(63)
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The presence of an a-hydroxy moiety is preferred slightly over an a-amino for 
binding. Thus LL-a-amino-e-hydroxypimelate (66a) is succinylated at 43% of 
the rate of L-a-aminopimelate (65). It was discovered that L-a-amino-D-e- 
hydroxypimelate (66b) was succinylated faster than (65). A conformationally 
restricted compound, 2E,5E-y-ketoheptadienedioic acid (67), was a good 
inhibitor with a Kj of 0.53 mM.
The search for cyclic inhibitors produced mainly poor inhibitors. The most 
notable inhibitor found (64) was acyclic. One compound was found to be a 
substrate of THDP succinylase, namely 3,4-dihydro-2H-1,4-thiazine-3,5- 
dicarboxylic acid (DHT) (68). This compound exists mainly as an enamine, as 
shown by a 1 H NMR spectrum of the disodium salt recorded in aqueous 
solution, see figure 34. DHT (68) has a Km value of 2 mM and this can be 
explained by the fact that only a very small proportion of the DHT (68) is at any 
time in the imine form (69).
S s
(69) (68)
Figure 34: DHT Tautomerisation
Other cyclic compounds prepared as potential inhibitors include those shown in 
figure 35. Most of these exhibited poor Kj values.
//,,’c o 2h h o 2c  x/ / ^ ^ c o 2h h o 2c  > C ^ C 0 2H
X=NH, Kj 2.0 mM X=NH, Kj 63 mM X=N,Ki12.8mM
X=0, K| 0.68 mM X=0, K| 3.9 mM X=CH, K( 8.5 mM
X=CH 2, K1144 mM X=CH 2, K j 265 mM
X=S, K| 1.1 mM X=S, Kj 4.4 mM
Figure 35: Cyclic inhibitors of THDP succinylase
2 .2 0  A /-Succinyl-LL-diam inopim elate a m in o tra n s fe ra s e  (EC  
2.6.1.17, dapC)
/V-Succinyl-LL-diaminopimelate aminotransferase catalyses the conversion of 
/V-succinyl-a-amino-e-ketopimelate (29) into A/-succinyl-L-diaminopimelate (30), 
see Figure 36. The succinylated intermediate is aminated at the s-position with 
glutamate (69) providing the amino group.
h o 2c .  c o 2h ® o 2c ^  c o 2h
Succinyl diaminopimelate 
II 1  aminotransferase : 1
O NHSuc © N H 3  NHSuc
Suc= Succinyl @0)
Figure 36: The reaction catalysed by A/-succinyl-LL-diaminopimelate
aminotransferase
2.21: Isolation and characterisation of succinyl-LL-diaminopimelate
aminotransferase
The aminotransferase has been purified to homogeneity from E. coli and its 
activity has been detected in both Gram positive and negative bacteria.90 The 
E. coli enzyme was found to be a homodimer of subunit molecular weight 
39,900.91 The enzyme is pyridoxal phosphate (PLP) dependent and requires 
glutamate (69) as its sole source of the transferable amino group. Michaelis 
constants for the natural substrates have been measured. L-Glutamate (69) 
was found to have a Km of 1.2 mM and L-A/-succinyl-a-amino-e-ketopimelic acid 
(30) had a Km of 0.18 mM. The standard assay for measurement of the activity 
of the aminotransferase involves the spectrophotometric observation of the 
disappearance of NADPH when a coupled assay with glutamate 
dehydrogenase is used. Under physiological conditions the reaction is freely 
reversible.
44
2.22: Mechanism of A/-succinyl-LL-diaminopimelate
aminotransferase
Kinetic studies suggest that the reaction mechanism is sequential with 
glutamate (69) binding and reacting before A/-succinyl-a-amino-e-ketopimelic 
acid (30) binds and reacts. Glutamate (69) binds and reacts with PLP to form 
the active transferase enzyme, see figure 37. The reaction proceeds through 
aldimine, quinonoid and ketimine intermediates.
©o2c.
Glutamate (69)
r = c h 2 c h 2 c o 2h
Enz— N
Enz— NH2
Aldimine
N 
H
Quinonoid
Enz— NH2  NH
'©Enz— NH2
Ketimine
Figure 37: Initial steps in the mechanism of A/-succinyl diaminopimelate
aminotransferase
The placement of the amino group onto A/-succinyl-a-amino-e-ketopimelic acid 
(29) occurs next by reversing the steps shown for the transfer of the amino 
group to the cofactor, see figure 38. The enzyme behaves as expected for an
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aminotransferase and obeys the characteristics of the model system, aspartate 
aminotransferase.92
h o 2c
Enz— NH2
A/-succinyl-a-amino-8 - 
ketopimelic acid (29)
/V-succinyl H0 2 C>s^ x R 
diaminopimelate (30) =
Enz— N ^ H2
Figure 38: Transfer of the amino group to AJ-succinyl-a-amino-e-
ketopimelic acid
2.23: Inhibition of A/-succinyl-LL-diaminopimelate aminotransferase
As is common with aminotransferases, A/-succinyl-LL-diaminopimelate 
aminotransferase is inhibited by hydrazine, hydroxylamine and their substituted 
derivatives. These compounds react with pyridoxal phosphate at the active site 
to produce stable nitrones93 and hydrazones94 which cannot take any further 
part in the reaction catalysed, see figure 39. These compounds have proven 
resistant to hydrolysis. This was seen as a good way to develop novel 
inhibitors. By utilising the hydrazine/hydroxylamine moiety to inactivate the 
enzyme and constructing a framework round it that was strongly recognised by 
the enzyme, potent inhibitors could be developed. It was discovered that the 
two acid groups were required by the enzyme as was the ll-configuration at the 
two chiral centres. Using this information two compounds were developed 
utilising the ll-D AP skeleton with a succinyl group (70) and with a CBZ group 
(71). These compounds were found to be potent, slow binding inhibitors of the 
enzyme with Kj values of 22 nM and 54 nM, respectively.91
RHN,
Enz— N
n h 2
NHR
I
Enz— NH2
H
Figure 39: Inhibition of A^succinyl-LL-diaminopimelate aminotransferase
by hydrazine derivatives
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2.24: M-Succiny I-LL-diaminopimelate desuccinylase (EC 3.5.1.18, 
dapE)
A/-Succinyl-LL-diaminopimelate desuccinylase catalyses the deacylation of N- 
succinyl-LL-diaminopimelate (30) to LL-diaminopimelate (31) as shown in figure 
40.
0o2c c o 2h co0
A/-Succinvl diamino- ^
7 A pimelate desuccinylase ? 1
© N H 3  NHSuc © N H 3  © N H 3
Suc= c o c h 2 c h 2 c o 2h  
Figure 40: The reaction catalysed by M-succinyl-LL-diaminopimelate
desuccinylase
2.25: Isolation and characterisation of A/-succinyl-LL- 
diaminopimelate desuccinylase
The E. coli enzyme has been isolated and purified to homogeneity95 and DAP 
desuccinylase activity has been detected in a number of bacterial species.96 
The E. coli enzyme has been shown to be dimeric at low concentrations (< 1 
mg/ml) and tetrameric at higher concentrations. The subunit molecular weight 
was determined to be 40,000 which is in agreement with the figure of 41,129 
derived from the nucleotide sequence of the dapE gene.97 The DapE locus of 
C. glutamicum has also been sequenced and predicts a subunit molecular 
weight of 39,942.98
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The E. coli enzyme was shown to require a metal ion, ideally cobalt (II), but zinc 
(II), iron (III) and nickel (II) have been shown to be acceptable. The reaction 
proceeds at a lower rate (-2.2 fold turnover decrease) with these metals. The 
enzyme is functionally very similar to the many cellular carboxypeptidases, and 
shares 38% sequence homology with acetylornithine deacetylase from E. co//'.99
The Michaelis constant for the natural substrate was determined to be 410 p,M 
and a systematic study was undertaken to find substrate analogues. The E. 
coli desuccinylase will hydrolyse LL- and meso-A/-succinyl DAP compounds (the 
succinyl group must be attached to the L-centre). L-a-/V-Succinyllysine (72) 
was found to be a very poor substrate (0.016% of the rate for the natural 
substrate) as was LL-/V-acetyl DAP. A mixture of isomers of A/-succinyl-a- 
aminopimelate (73) proved also to be a poor substrate (0.036% of the rate for 
the natural substrate).
o2c
©  n h 3 c o 2hHN
O H 0 2C
HN
(73) O
2.26: meso-Diaminopimelate epimerase (EC 5.1.1.7, dapF)
meso-Diaminopimelate epimerase (meso-DAP epimerase) is responsible for 
the epimerisation of the e-amino group of ll-D A P  (31) to produce DL- or meso- 
DAP (6), see figure 41.
meso-DAP epimerase
Figure 41: The reaction catalysed by meso-DAP epimerase
2.27: Isolation and characterisation of meso-DAP epimerase
meso-DAP epimerase was first isolated over 30 years ago from E. co//100 but 
was only recently purified and characterised by Wiesman and Nichols.101
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Purification was difficult due to the presence of a free thiol residue which was 
necessary for activity. The Bacillus megaterium enzyme has also been isolated 
but only purified 20 fold.102 The E. coli enzyme has received most attention and 
the dapf locus has been cloned,103 sequenced104 and overexpressed.105 The 
epimerase was found to be monomeric, with a molecular weight of 34,000 from 
gel filtration experiments. The molecular weight was refined to 30,265 from the 
nucleotide sequence.
As mention above the enzyme interconverts ll-DAP (30) and meso-DAP (6). 
The dd-DAP compound is not a substrate for the enzyme. It is therefore the 
stereochemistry of the non-reacting centre that governs substrate recognition 
by the enzyme. The stereochemistry of the other e-centre is fully reversible 
under physiological conditions. The Michaelis constants for the substrates 
have been determined. For ll-DAP (30) the Km value of 160 jiM was found 
and for meso-DAP (6) the Km value found to be 360 pM. An equilibrium 
constant of 2.0 was derived from HPLC analysis.
There are two assay systems for the enzyme. The first monitors the release of 
tritium from a-tritiated DAP. The second is easier and involves a coupled assay 
system with meso-DAP dehydrogenase. The assay system relies on the 
turnover of NADP+ to NADPH by meso-DAP dehydrogenase and can be 
monitored spectrophotometrically at 340 nm.
2.28: Mechanism of meso-DAP epimerase
It was discovered early on that the enzyme did not require PLP as a cofactor 
and that it was not inactivated by hydrazine. No evidence for a reducible imine 
could be found and sodium borohydride did not inactivate the enzyme. Metal 
ions, flavin and nicotinamide cofactors were not utilised by the enzyme. It was 
discovered that for substrates labelled with an a-tritium, exchange with the 
solvent was rapid and reversible. The enzyme was also found to be unstable in 
solution without the presence of dithiothreitol, or similar reducing agent. A time 
dependent inactivation by iodoacetamide was discovered and one molecule of 
acetamide was bound per enzyme molecule. This evidence was enough to 
enable the proposal of a base catalysed abstraction of the a-proton as a likely 
mechanism for meso-DAP epimerase.
The abstraction of tritium has been thoroughly investigated.101 This involved 
detailed kinetic studies to determine the rates of tritium abstraction from mesch 
DAP and ll-D A P . It was found that the rates of abstraction for the two
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substrates were different and that in each turnover of the enzyme a tritium was 
exchanged for a solvent derived proton. This was taken as evidence for a 
mechanism involving two bases. A single base mechanism involving 
abstraction from one face and reprotonation from the other is not supported by 
the evidence presented, see figure 42.
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Figure 42: Two base mechanism for meso-DAP epimerase
It has been suggested that meso-DAP epimerase bears a resemblance to 
proline racemase in its mechanistic behaviour.106 meso-DAP epimerase differs 
from proline racemase because the kinetic evidence does not support the two 
bases being the same (the kinetic isotope effects are different). It is however 
known that one of the bases is in fact a thiol as shown by the removal of 
catalytic activity of meso-DAP epimerase when treated with azi-DAP (74), 
which covalently binds to Cys73 of meso-DAP epimerase,107 see figure 43.
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Figure 43: Inactivation of meso-DAP epimerase by azi-DAP
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Studies of other epimerases have been of great interest to try to understand 
how a base of pKa of about 15 can deprotonate the a-carbon of an amino acid, 
which has a pKa of >20. This apparent paradox has recently been solved with 
the experimental validation of the concept of short-strong hydrogen bonds.108, 
109 These are believed to occur between the active site residue and the 
carboxylate in the transition state. These H-bonds have been described as “low
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barrier'’ and can help stabilise transition states to a large degree. This then 
affects the pKa of the a-hydrogen, making the proton abstraction possible. This 
is the currently accepted explanation for the paradox, but it has yet to be proved 
in the case of meso-DAP epimerase.
2.29: Inhibition of meso-DAP epimerase
The proposed mechanism for the reaction catalysed by meso-DAP epimerase 
requires that a negative charge be located on the a-carbon atom. This feature 
has been exploited in an attempt to develop inhibitors of meso-DAP epimerase. 
There are two main areas that have been explored. The first is compounds that 
are unstable after proton abstraction, such as compounds set up for p- 
elimination, and secondly compounds with good leaving groups on the nitrogen 
atom. A good example of this was the development of p-chloro DAP (75) by 
Baumann et a/.110 This compound was a potent inhibitor of the epimerase with 
a Kj of 200 nM. Inhibition was found to be reversible and competitive with the 
substrate. At low concentrations the inhibition decreased with time, indicating 
that the inhibitor was acting as a poor substrate towards the enzyme. Baumann 
et a/.110 carried out experiments to determine the product of the reaction and 
found that the product reacted with meso-DAP dehydrogenase. This meant 
that the enzyme was catalysing the elimination of HCI from p-chloro-DAP (75) 
to give an enamine intermediate (76) which transformed slowly into L-THDP 
(27), see figure 44.
Cl
Q
0 2C co2© 9 d2c co2©
© n h 3 © n h 2 © n h 3 © n h 3
(75) (76)
© ©co2
(27)
Figure 44: Turnover of p-chloro-DAP by mesoDAP epimerase
51
Further to the determination that p-chloro-DAP was turned over by the enzyme, 
Gelb et a/.111 synthesised the four stereoisomers of p-fluoro-DAP (77a-d). 
These were found to be good inhibitors of the enzyme with IC50 values of 10 
mM, 25 mM, 4 mM and 8 mM for compounds, 77a-d respectively. The enzyme 
was able to eliminate HF from the p-fluoro-compounds again forming L-THDP 
(27) as the eventual product. The elimination reactions varied in their rates of 
HF elimination. The rates of epimerisation and elimination were determined 
separately. For one pair of isomers (77c, d) the elimination was slow but the 
epimerisation was fast and the two diastereoisomers are in rapid equilibrium. 
For (77a, b) the elimination was fast and was the only observable reaction. 
These results enabled Gelb et a/.111 to suggest a stereochemical course of 
reaction as shown in figure 45. The position of the charged groups and the R 
groups are fixed in the enzyme active site. As expected, when the H and F are 
syn-planar or anti-coplanar the elimination is fast. But when the H and F cannot 
adopt either of these positions the epimerisation was found to be the faster 
process.
F F
C 02 (77b)
Fast
Fast
C 0 2
Slow Slow
Fast
c° 2© f
(77c)
Figure 45: Stereochemical reaction course of p-fluoro-DAP with meso-
DAP epimerase
Many groups have reported the synthesis of both isomers of p-hydroxy-DAP 
(78a and b).110'112 Both isomers proved to be poor inhibitors, with I C 5 0  values 
of 2.5 and 4 mM, respectively. Water was not eliminated and (78b) was not 
epimerised while (78a) was epimerised at the carbon distal from the hydroxy
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group. A/-Amino-DAP (79) and A/-hydroxy-DAP (80) were prepared and 
inhibited the epimerase with Kj values of 56 pM  and 2.9 mM, respectively.
® n h 3 © n h 3
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© N H 3 © n h 3
(78b)
C 0 2
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A great deal of effort has gone into the development of heterocyclic based 
inhibitors of meso-DAP epimerase.113 These compounds have a planar 
heterocyclic region (81 )-(85) set up to mimic the transition state of the enzyme. 
None of the compounds proved to be a good inhibitor of meso-DAP epimerase.
A number of miscellaneous compounds have been tested for inhibition against 
meso-DAP epimerase. These include the y-methylene compound (86) and 
meso-lanthionine (87).114 Both were inhibitors, but with Kj values of 0.95 mM 
and 0.18 mM, respectively, they can be considered moderate at best.115
2.30: meso-Diaminopimelate dehydrogenase (EC 1.4.1.16, ddh)
The dehydrogenase enzyme catalyses the main step in an alternative pathway 
to L-lysine in some bacteria and plants. The enzyme cuts out the need for 
succinylation, transamination, desuccinylation and epimerisation by converting 
L-THDP (27) directly into meso-DAP (6) by utilising NADPH and ammonia, see 
figure 46.
meso-DAP dehydrogenase
NADPH, NH 3
Figure 46: The reaction catalysed by meso-DAP dehydrogenase
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2.31: Isolation and characterisation of meso-DAP dehydrogenase
meso-DAP dehydrogenase occurs in Bacillus sphaericus,u 6 which lacks the 
enzymes of the other pathway117 and also in many Gram positive and negative 
bacteria.118,119 Reports have stated that meso-DAP dehydrogenase has been 
found in several plant species, and indeed it has been isolated from the shoots 
of Glycine max by Wenko et a/.120
m eso-DAP dehydrogenase has been purified to homogeneity from 
Corynebacterium glutamicumu 9 and Brevibacterium spp.121 but most of the 
work on the dehydrogenase has relied on the enzyme isolated from B. 
sphaericus ,122 which has been reported as having high dehydrogenase 
activity.118
The dehydrogenase reaction is freely reversible and maximal velocity in the 
forward direction (to meso-DAP) is achieved between pH 7.0 and 8.5. The 
reverse reaction achieves maximal velocity at pH values between 9.0 and 
10.5.123 The reverse reaction can be forced to proceed at pH 7.8 by using 
NADP+ and not supplying ammonia.124 An assay system for the enzyme is 
based on the consumption or generation of NADPH and can be monitored 
spectrophotometrically at 340 nm.
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The bacterial enzymes exist as homodimers with a subunit molecular weight of 
about 39,000, and there are two active sites per dimer. The ddh gene has been 
cloned from C. glutamicum and sequenced.125 The inferred subunit molecular 
weight was 35,099.126 The Michaelis parameters for the natural substrates and 
cofactors of the B. sphaericus enzyme have been determined and are shown in 
table 4.
Substrate Km (mM)
L-THDP (27) 0.2
NADPH 0.2
n h3 12
meso-DAP (6) 2.5
NADP+ 0.00083
Table 4: Km values for the natural substrates and cofactors of meso-DAP
dehydrogenase from B. sphaericus
2.32: The mechanism of meso-DAP dehydrogenase
Detailed kinetic analysis of the dehydrogenase has revealed that the 
mechanism is very ordered.123 In the forward direction NADPH binds followed 
by L-THDP (27) and then finally ammonia. After the reaction meso-DAP (6) is 
released first followed by NADPT The sequence is reversed for the reverse 
reaction. This ordered mechanism is reminiscent of the mechanism of 
glutamate dehydrogenase.
The oxidation reaction takes place at the D-centre and substrate studies have 
shown that the other centre must have the L-configuration (DD- or LL- 
compounds were not substrates for the enzyme). The mechanism is believed 
to involve an acyclic imine (88) resulting from attack of ammonia on L-THDP 
(27), see figure 47. The imine (88) is then hydrogenated by attack of the 4-pro- 
S hydride from NADPH in what is believed to be the rate determining step.
2.33: Inhibition of meso-DAP dehydrogenase
Several analogues were tested as inhibitors by Lam et a/.115 They found that 
the enzyme was specific for the meso-geometry of its natural substrates. They 
found that meso-lanthionine (87) was a weak competitive inhibitor with a Kj of 
0.28 mM. Most other analogues were found to be substrates including N-
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hydroxy-DAP (80) and A/-amino-DAP (79), which were turned over at 22% and 
4% of the rate of the natural substrate, respectively.
h o 2c
o2c co2
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Figure 47: Mechanism of meso-DAP dehydrogenase
Abbot eta/.,113 as discussed earlier, synthesised a number of isoxazoles (81)- 
(84) and an imidazole (85) as analogues of meso-DAP (6). Of these 
compounds, (81) was found to be a very potent inhibitor with a Kj of 4.2 pM. 
Changing the stereochemistry of the side chain gave (82) which was a poor 
inhibitor with only 13% inhibition at 1 mM. Removing the side chain entirely or 
just the amino group gave rise to poorer inhibitors. Isoxazole (81) was 
discovered to be competing with L-THDP (27) for its binding site within the 
enzyme.
Other inhibitors of the B. sphaericus enzyme have included compounds that 
attack free thiol groups in enzymes. Bulky sulfhydryl reagents such as Hg2+ or 
5,5’-dithiobis(2-nitrobenzoic acid) (89) were found to inhibit the enzyme. 
Activity was restored by adding cyanide and forming an enzyme cyanide 
adduct. This was taken as an indication that the sulfhydryl group was not 
necessary for enzyme activity.127
2.34: meso-Diaminopimelate decarboxylase (EC 4.1.1.20, lysA)
The final enzyme in the seven stage pathway to L-lysine (1) via the DAP 
pathway transforms meso-DAP (6) into L-lysine (1) by means of a 
decarboxylation, see figure 48.
meso-DAP decarboxylase
Figure 48: The reaction catalysed by meso-DAP decarboxylase
2.35: Isolation and characterisation of meso-DAP decarboxylase
meso-DAP decarboxylase is widespread in both plants and bacteria. It has 
been purified from a number of sources including E. co//,128,129 B. sphaericus,130 
duckweed (Lemna perpusilla) 131 and wheat (Triticum vulgaris) .132 The 
decarboxylase was first detected by Dewey and Work133 in E. coli and then was 
isolated from B. sphaericus by Asada et a/.130 They purified the enzyme to 
homogeneity and were able to determine that the enzyme was a homodimer 
with a subunit molecular weight of 40,000. The E. coli enzyme is a 
homotetramer, with a subunit molecular weight of 46,099 determined by genetic 
analysis.134 The decarboxylase from B. sphaericus was found to have a pH 
optimum for activity between 6.8-7.8.
Assays for the reaction rely on release of 14CC>2 from labelled meso-DAP (6) or 
the determination of L-lysine (1) content in non-continuous assays.135 The 
decarboxylase is specific for meso-DAP (6) with a Km of 1.7 mM for bacterial 
enzymes and 0.16-0.35 mM for plant decarboxylases. Neither l l -  nor dd-DAP 
are substrates or inhibitors of the enzyme Thus again it is the non-reacting 
centre that must possess the L-configuration.
The lysA loci has been cloned and sequenced from a number of bacterial 
species including B. subtilis,136,137 B. m ethanoiicus ,138 Mycobacterium  
tuberculosis,139 C. glutamicum140 and Pseudomonas aeruginosa . 1 4 1  These 
genes encode for proteins of similar molecular weight (45,000-49,000) and 
have high sequence homologies.
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2.36: The mechanism of meso-DAP decarboxylase
The enzyme is PLP dependent and was found to be inhibited by hydrazine and 
hydroxylamine derivatives. The protein sequence confirms the unique nature of 
the protein as it is quite different from the structure of other decarboxylases. 
The meso-DAP decarboxylases from various organisms are closely related.141' 
144 The course of the reaction in B. sphaericus has been studied in detail.145 
The reaction as catalysed, proceeds with inversion of stereochemistry; that is 
the hydrogen is added to the opposite face from which the carbon dioxide was 
eliminated. This is again quite different from known PLP dependent 
decarboylases which catalyse the reaction with retention of stereochemistry.
Two proposals have been put forward to explain this unique feature. The first 
involves a “swinging door” hypothesis which was made by Asada et a/.130 This 
suggests that after the decarboxylation has taken place a conformational 
change occurs in the enzyme allowing a proton source to add to the opposite 
side of the newly formed double bond. It is stated that this change would have 
to be quite major in order to place the groups close enough to react. The 
second hypothesis also presented by Asada et a/.130 involves the protonation of 
a quinonoid intermediate from the opposite face, see figure 49.
As is common with other PLP reactions the plane of the bond which is to be 
broken must be aligned perpendicularly to the plane of the ^-system of the 
aromatic ring. In this case it is the carboxyl group that should adopt this 
position to enable the orbitals to line up for the movement of electrons to take 
place, see figure 50.
® o
Figure 50: stereochemical alignment for meso-DAP dehydrogenase 
2.37: Inhibition of meso-DAP decarboxylase
Many of the inhibitors of meso-DAP decarboxylase have been based on 
analogues of the starting material. Kelland et a/.146 prepared many analogues 
of meso-DAP (6). The best of these analogues were lanthionine sulfoxides (90)
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which were found to give 50%  inhibition at a concentration of 1 mM. The 
corresponding sulfones gave poorer inhibition values. Better inhibition figures 
were obtained for A/-hydroxydiaminopimelate (80) and /V-aminodiaminopimelate 
(79) (mixture of isomers) which gave Kj figures of 0.91 and 0.71 mM and 0.1 
and 0.084 mM, respectively.
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Figure 49: Mechanistic proposal for meso-DAP decarboxylase
Girodeau ef a/.147 synthesised unsaturated analogues of meso-DAP (6) and 
tested them against the dehydrogenase from E. coli. The best of the 
compounds was trans-3,4-didehydro-DAP (91) which was the most potent 
inhibitor of meso-DAP decarboxylase with a Kj of 180 jiM.
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Figure 51 shows the mode of action envisioned by Girodeau et al. for these 
compounds. A active site base was expected to attack the PLP intermediate 
and to attach the compound covalently to the active site.
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Figure 51: Mode of action of unsaturated analogues of meso-DAP
oc-Difluoromethyl-compounds are known to inhibit other PLP dependent 
dehydrogenases. These compounds can undergo a series of eliminations at 
the active site resulting in irreversible enzyme inactivation. 148 When a- 
difluoromethyl-DAP (92) was made and tested against the dehydrogenase from 
E. coli it was found that the compound was only a weak competitive inhibitor 
(IC50 -10 mM). a-Methyl-DAP (93) was also a poor inhibitor.114 These findings 
helped to reinforce the theory that meso-DAP decarboxylase shows high 
specificity for its natural substrate meso-DAP (6 ).
Chapter Three: Synthesis of Analogues of 
Aspartic Acid |3-Semialdehyde
3.1 Introduction
As discussed in chapters one and two the role played by aspartic acid (3- 
semialdehyde (ASA) (23) in the biosynthesis of several amino acids is of the 
utmost importance. ASA (23) is an intermediate in the production of threonine 
(24), isoleucine (25), methionine (26) and lysine (1).
The DAP pathway to L-lysine (1) in bacteria utilises ASA (23) as one of the 
starting materials from which L-lysine (1) is synthesised. The research of our 
group in Glasgow has focused on the condensation of ASA (23) with pyruvic 
acid (32) catalysed by DHDPS to form dihydrodipicolinate (31). This is one of 
the most interesting steps in the biosynthetic pathway to L-lysine (1).
The use of ASA (23) as a starting material for the synthesis of more complex 
and unnatural amino acids has been reported in the literature recently.149 The 
aldehyde function of the molecule is a very good handle upon which to perform 
a wide variety of synthetic modifications.
The research in Glasgow required a supply of ASA (23) which could be used in 
the testing of the potential inhibitors made within the group. The first reported 
synthesis of ASA (23) was by Black and Wright in 1975.150 They prepared ASA 
(23) by the treatment of an acidic solution of allylglycine (94) with ozone at low 
temperature. They presented little evidence for the formation of ASA (23), 
stating only that the product was reduced by homoserine dehydrogenase. The 
synthesis of Black and Wright was the basis on which Dr D. Tudor prepared 
ASA (23) as a solid of known purity. Dr D. Tudor reported the synthesis of ASA 
(23) as its trifluoroacetate salt in four steps from allylglycine (94) with an overall 
yield of 14%. In this work the synthesis has been improved and now has an 
overall yield of 48%.
This chapter will detail the improved synthesis of ASA (23) and then discuss the 
synthesis of various alkylated derivatives of ASA (23) designed to be inhibitors 
of DHDPS. The chapter will start with an overview of the synthesis of a-amino 
acids and the reactions involved, then a brief discussion of protecting groups in 
the context of amino acid synthesis will be given. The chapter will conclude 
with a discussion of the compounds prepared.
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3.2 Synthetic procedures for the production of a-amino acids
The isolation and synthesis of novel a-amino acids will continue to be one of 
the most important areas of active research. There are a vast number of 
methods by which a-amino acids have been synthesised which are described 
in the literature.151,152 There are three main areas into which the synthetic 
reactions towards amino acids fall. These are alkylation of glycine equivalents; 
condensation and substitution reactions by which the amino or carboxyl groups 
are introduced to complete the synthetic procedure; and the rearrangement of 
suitable substrates to form a-amino acids. Each of these synthetic strategies 
will be discussed separately in this section. A review by O'Donnell details the 
most recent advances in the preparation of a-amino acids.153
There has also been much effort into the synthesis of a-amino acids by 
asymmetric methodology. The result of this is that there are now a large 
number of reliable methods by which a-amino acids can be prepared in high 
enantiomeric excess.154 This discussion will only briefly touch on this subject 
as it is in itself a large area of research.
Alkylation of glycine derivatives to give a-amino acids
There are two major types of starting materials for this type of reaction. The 
first are A/-acylaminomalonates which are easily alkylated by virtue of their 
acidic hydrogens at the a-position. The second type of starting material are 
benzylidene glycine esters which are again acidic at the a-position and undergo 
facile alkylation with reasonably weak bases.
A typical procedure for the alkylation of diethyl acetamidomalonate (95) 
involves the reaction of the appropriate alkyl halide with the diester (95), see 
figure 52. In the presence of a base such as sodium ethoxide the 
acetamidomalonate is deprotonated to form (96) and then displaces the halide 
ion from the alkyl halide in an S n2 reaction. The esters are removed by 
hydrolysis of (97) using aqueous sodium hydroxide. This yields a malonic acid 
derivative (98) which is then decarboxylated by heating in water to give the 
desired amino acid (99). The side chain required must be inert to the harsh 
hydrolysis conditions at the end of the synthesis, and this can restrict the 
applicability of this route to certain types of functional groups.
The use of benzylideneglycine esters was all but abandoned due to the over- 
alkylation seen with these compounds. The remaining hydrogen was too acidic
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and the products isolated consisted of a mixture of mono- and di-alkylated 
derivatives. Alkylation under phase transfer conditions was introduced as a
NHCO CH 3
Na in EtOH
E t02C CC^Et 
(95)
Xp-R
NHCO CH 3
C 0 2Et 
C 0 2Et 
(96)
RX
©
NH3
R ' '"C O p
Decarboxylation
©
NH3
R ^ \ ^ C O p
c o 2h
(98)
Hydrolysis
NHCO CH 3
R ^ \  C 0 2Et 
C 0 2Et
(99)  (97)
Figure 52: Alkylation of N-acylacetamidomalonates
method of alkylating these benzylideneglycine esters selectively to give 
exclusively the mono-alkylated product. The compound of most use is (AA 
diphenylmethylene)aminoacetonitrile, since the corresponding glycine ester 
was found to undergo a certain amount of ester hydrolysis under the reaction 
conditions. (A/-Diphenylmethylene)aminoacetonitrile (100) is an active 
methylene compound and is acidic due to the stabilisation of the negative 
charge by delocalisation into the k systems of the aromatic groups and the 
nitrile. The alkylation is carried out as in figure 53. The resulting alkylated 
compound (101) can be easily deprotected by stirring in aqueous acid to 
remove the benzylidene protecting group to give (102) and then by further 
hydrolysis of the nitrile using sodium hydroxide to produce the amino acid 
(103).
This method relies on a quaternary ammonium species acting as a phase 
transfer catalyst. In these experiments the phase transfer agent used is 
generally benzyltriethylammonium chloride (BTEAC). The catalyst forms a tight 
ion pair with the hydroxide ion and escorts it into the organic layer where the 
hydroxide ion abstracts a proton from the active methylene compound (100). 
The catalyst escorts the subsequently released halide ion back to the aqueous 
layer, where the catalyst exchanges the halide for a hydroxide and the process 
begins again. The remaining hydrogen is not sufficiently acidic to be
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appreciably deprotonated by aqueous sodium hydroxide and this explains the 
isolation of mono-alkylated compound as the major product.
NC N
R
Ph
RX
Ph
50% N a0H /E t20  
BTEAC
(100)
NaOH (aq), Reflux
NC N 
(101) P h ^ ^ P h
2M HCI
f
R
, &  ©
NC NH3  Cl
(103) (102)
Figure 53: Alkylation of (diphenylmethylene)aminoacetonitrile 
Condensation and substitution reactions to produce a-amino acids
This methodology is exemplified by the Strecker synthesis which involves the 
condensation of an aldehyde (104) with ammonia, or other amine, to give an 
imine (105) and then reaction with sodium cyanide to give an a- 
aminoalkanenitrile (106) which can be hydrolysed to the a-amino acid (103) 
using sodium hydroxide, see figure 54. The nitrile is quite easily hydrolysed to 
the acid and this makes the Strecker synthesis a versatile method for producing 
amino acids. The reaction is only limited by the production of the starting 
aldehyde which is not always an easily available starting material.
Amination of a-halo acids
The alkylation of a-halo acids (107) is one of the most general and high yielding 
of the preparations of a-amino acids available, see figure 55. The method is 
convenient and general as long as the a-halo acid can be prepared from one of 
the many methods known.
Rearrangement reactions leading to a-am ino acids
A number of the classical rearrangements of organic chemistry can be 
employed in the synthesis of a-amino acids. The Hofmann, Curtius and
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Schmidt rearrangements can all give a-amino acids by careful choice of starting
0  NH3 /NH 4 CI H0\  7n h 2 -h 2o  NH
R H R H R H
(104) (105)
Na CN
©OO C NH3  Hydrolysis NCX 7NH2
R H R H
(103) (106)
Figure 54: Strecker synthesis of a-amino acids
material, see figure 56.155 The Hofmann reaction involves the rearrangement 
of amides (108) via the isocyanate (109), formed by the migration of an R group 
from carbon to nitrogen in a 1,3-migration. The leaving group in this case is a 
bromide ion. The Schmidt rearrangement involves acyl azides (110), formed by 
reaction of an acid (111) with hydrazoic acid. The R group migration is driven 
by the loss of a molecule of nitrogen. The Curtius rearrangement proceeds 
through an analogous acyl azide to that of the Schmidt rearrangement formed 
by reaction of an acyl hydrazide (112) with nitrous acid. The isocyanate is then 
hydrolysed by treatment with aqueous acid and decarboxylated to form the 
amino acid.
n h 3
0
n h 3
R" 'C O 2 H x  is generally Cl, Br or I R" ^ C o jP
(107) (103)
Figure 55: Amination of a-halo acids
Asymmetric synthesis of a-amino acids
Numerous methods have been developed for the preparation of a-amino acids 
in high enantiomeric purity. A large number of these reactions rely on the inter­
conversion of one a-amino acid into another using the natural optical activity of 
the a-amino acid (both R-and S-forms of natural and some unnatural amino 
acids can be purchased). This makes the synthesis of one enantiomer much
6 6
easier as the chiral synthesis has already been carried out by the bug or plant 
that originally manufactured the a-amino acid.
A general method that allows construction of amino acids with very high 
enantiomeric excess is the method developed by Schollkopf.156
O
R nh2 
(108)
Hofmann
Br2
O
R NHBr
R 
(111)
OH
Schmidt
HN3
N -r -B r
R
(112)
NHNH 2
Curtius
N a N 0 2/HCI
N = ^ N = N ©  
(110)
R — N =  C = 0
(1°9) h+/h2o
v
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Figure 56: Rearrangement reactions forming a-amino acids
The method of Schollkopf involves the reaction of alkyl halide with lithiated bis - 
lactim ethers of 2,5-dioxopiperazines. The heterocycle used is based on a 
simple amino acid such as glycine or alanine and the other half of the 
heterocycle is made up of a valine molecule acting as the chiral auxiliary, see 
figure 57. The most common bis-lactim ether (113) in use is made from 
glycine and L-valine . The heterocycle is acidic and the hydrogen is easily 
removed by n-butyllithium to give (114). This is an almost planar species which 
can be alkylated from either face. The high degree of selectivity can be 
understood by noting that the face on which the valine side chain resides is 
much more sterically crowded than the other face. Hydrolysis of the resulting 
alkylated dioxopiperazine (115) under mild acidic conditions liberates the newly 
formed amino acid (116) and the chiral auxiliary (117). The main disadvantage 
of this reaction is that it can sometimes be difficult to separate the chiral 
auxiliary from the newly formed amino acid, especially if they are similar in size 
and shape.
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There are numerous other methods for the chiral syntheses of a-amino acids 
described in the literature.
MeO N'
(113)
OMe
OMe OMe
n-BuLi
MeOMeO
(114)
H
NH2
C 0 2Me
H2 N ‘
C 0 2Me
R
0.25 M HCI
• ' v  / 0 M e' / / /
MeO N' R
(117) (116) (115)
Figure 57: Schollkopf's chiral synthesis of a-amino acids
3.3: Protecting groups in a-amino acid chemistry
It is often necessary to mask the reactive amino and carboxyl groups of a- 
amino acids to allow synthetic manipulation of the side chains or to form amide 
bonds. These protecting groups are required to be stable to a large variety of 
reaction conditions. Another important feature of a protecting group is that the 
protection and deprotection steps should be high yielding and not require harsh 
conditions which may affect other groups of the amino acid.
The protecting groups that are used most for the protection of the amino group 
are the f-butoxycarbonyl (BOC) and the benzyloxycarbonyl (Cbz or Z). The 
carboxyl function also has numerous available protecting groups including f- 
butyl esters and benzyl esters. These groups fulfil all of the stated 
requirements for protecting groups.
The two most common reagents used for the formation of BOC protected amino 
acids are di-f-butyldicarbonate (118)157 and 2-f-(butoxycarbonylimino)-2- 
phenylacetonitrile (119) (BOC-ON), see figure 58.158 These groups are 
normally put on under mild basic conditions and yields are very good, generally
6 8
above 80% using both reagents. The mechanism for the formation of the BOC 
protected amino acids is shown in figure 58.
Di- f-butyldicarbonate
BuO'
N aH C 0 3
H
O + tBuOH
(118)
BOC-ON
H }BuO
H
CN
NEt3
Ph
(119) O
HO CN
N= (
Ph
Figure 58: Formation of a BOC protected a-amino acid
BOC groups are cleaved under mild acidic conditions, due to the stability of the 
f-butyl cation which is an intermediate of the deprotection. The deprotection is 
usually carried out using trifluoroacetic acid at room temperature and yields are 
generally high.159 The mechanism of removal is analogous to the A alJ  
mechanism for ester hydrolysis.
The carboxyl group can also be protected using a f-butyl group in the form of 
the f-butyl ester. This ester is formed by reacting the free acid group with 
isobutylene gas and concentrated sulfuric acid.160 This again uses the stability 
of the f-butyl cation which is attacked by the hydroxyl of the acid group. Yields 
above 85% are normal for the formation of f-butyl esters.
Cleavage of f-butyl esters occurs under the same mild acidic conditions that 
cleave the BOC group. The mechanism in this case is the AalJ  mechanism 
and involves the formation of the f-butyl cation as the alkyl oxygen bond is 
cleaved. The similar cleavage conditions for the BOC group and f-butyl ester 
have made this pairing a popular choice for many reactions involving a-amino 
acids.
The other major amino protecting group is the benzyloxycarbonyl or Cbz group 
(120). This is prepared by reacting the free amino group with benzyl
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chloroformate (121) under mildly basic conditions, see figure 59. This again is 
a good, stable protecting group for the amino group with high yields for its 
formation, usually greater than 90%.
H
I
N
(121)
N aH C 0 3
FT
Ph
O
(120)
Figure 59: Formation of a Cbz protected a-amino acid
The Cbz group is stable under mild acidic conditions. It can however be 
removed by catalytic hydrogenation with a number of catalysts and under 
numerous sets of conditions. Another method of cleavage known for the Cbz 
group is cleavage by the Lewis acid trimethylsilyl iodide, see figure 60.
H H H
MeOHOSiMe
MeCN
SiMe3
Figure 60: Removal of a Cbz group using a Lewis acid
The carboxyl group is also commonly protected as its benzyl ester which is 
usually prepared by reacting benzyl bromide with the free carboxylate. This is a 
slow reaction and the development of the p-methoxybenzyl ester (PMB) as a 
carboxyl protecting group grew out of the need to find a better substitute. The 
p-methoxybenzyl ester is formed by reacting the carboxylate with the more 
reactive p-methoxybenzyl chloride (122) under basic conditions, see figure 61. 
The PMB ester, unlike the benzyl ester, is cleaved under mild acidic conditions.
OMe
N aH C 0 3
(122)
PMB
Figure 61: formation of the PMB ester of an a-amino acid
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3.4: Synthesis of Aspartic acid p-semialdehyde
As reported earlier aspartic acid p-semialdehyde (ASA) (23) was prepared by 
Black and Wright.150 They treated allylglycine with ozone at -78 °C in acidic 
solution and obtained ASA (23) in solution, but no isolation was attempted. 
Black and Wright also did not quote any chemical or spectroscopic evidence for 
the formation of ASA (23).
This was not a satisfactory situation to begin a detailed investigation of a 
biochemical pathway. Within our group at Glasgow a former co-worker Dr D. 
Tudor repeated the Black and Wright procedure in an attempt to characterise 
the products of the ozonolysis. He found that ASA (23) was indeed produced in 
varying amounts and that aspartic acid, resulting from over-oxidation, could 
also be identified.
This was not a good method for the synthesis of large quantities of ASA (23) 
needed to carry out the biochemical studies. Dr D. Tudor therefore developed 
a controlled synthesis of ASA (23) as shown in figure 62.70 This was based on 
the ozonolysis of allylglycine that Black and Wright had used; however the 
amino acid was doubly protected to enable organic solvents to be used.
Allylglycine (123) was protected at the amino and carboxyl groups with the BOC 
group and a f-butyl ester respectively. The carboxyl protection was the first 
step and gave the f-butyl ester (124) in only 34% yield, much lower than most 
reported preparations. This was isolated as the hydrochloride salt which was 
neutralised in situ and the BOC group was introduced using di-f- 
butyldicarbonate to give doubly protected allylglycine (125). The yields from 
this step, in general greater than 90%, were in keeping with the normally high 
yields for amino protection using the BOC group. Ozonolysis proceeded well 
with no side products and after a reductive work up and removal of the 
triethylamine A/-oxide by chromatography, compound (126) was isolated as an 
oil in 90% yield. Treatment of (126) with trifluoroacetic acid (TFA) gave after 
one hour a 74% yield of a yellow solid, which by NMR spectroscopy was 
identified as the trifluoroacetate salt of ASA (23). The ASA (23) was isolated as 
a hydrate with no signal for the aldehyde proton in the 1H NMR spectrum, 
instead a triplet at 6 5.1 was found representing the C-4 proton.
The major problem with this synthesis was the low yield of the f-butyl ester from 
the initial step. This was a great problem especially as the allylglycine was a
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Figure 62: Synthesis of aspartic acid p-semialdehyde70
reasonably expensive starting material. A new method of preparing ASA (23) 
was required that removed the problem of the low yielding esterification. The 
problem was solved by using the p-methoxybenzyl ester which could be put in 
place in much higher yields and led to a more efficient synthesis, see figure 63.
HO
© © CO2 K
(B0C)2 0 , KHCO3
(123)
OH C 0 2H 
. ©
H2 0/dioxan 
Overall yield 40%
NHBOC
PMBCI, DMF, RT
As for Figure 62
(127)
n h 3  c f 3 c o ®
c o 2p m b
NHBOC
(23) (128)
Figure 63: p-Methoxybenzyl ester route to aspartic acid p-semialdehyde
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Allylglycine (123) was treated with di-f-butyldicarbonate in aqueous potassium 
bicarbonate to produce (127) in good yield. Compound (127) was treated with 
p-methoxybenzyl chloride in DMF to produce the doubly protected allylglycine 
(128) in 95% yield. The rest of the synthesis was the same as that for the f- 
butyl ester, but the overall yield was now 40%.
The material produced by the p-methoxybenzyl ester route was identical to that 
from the f-butyl ester route by NMR spectroscopy. This was not the case in the 
UV assay used for the inhibitor studies. The material produced by the p- 
methoxybenzyl ester route normally produced an assay cocktail with a 
background absorbance of about 1.7-1.8 absorbance units. This was 
compared to the cocktail made using ASA (23) prepared by the f-butyl ester 
route. This gave a much lower background absorbance of 1.4-1.5 absorbance 
units. This suggests that some impurity is present in the ASA (23) prepared by 
the p-methoxybenzyl ester route. The assay system used for studying 
reactions with DHDPS was therefore carried out with a high background 
absorbance. The lower the background absorption the more reliable the data 
obtained from the assay system should be. It was therefore preferable to use 
ASA (23) produced via the f-butyl ester route.
It was thus desirable to increase the yield of the f-butyl ester preparation to 
greater than 70%. The main problem of the reaction as it was carried out was 
the formation of an unidentified polymer of isobutylene, which used up most of 
the isobutylene in the reaction. Maintaining the temperature below -50 °C for 
seven hours resulted in improved yields of the f-butyl ester (124). The use of 
low temperatures retarded the formation of the isobutylene polymer. This 
allowed more “free” f-butyl cation in the organic layer for the carboxylate to 
attack. Using this procedure it was possible to obtain almost quantitative yields 
of the f-butyl ester (124) of allylglycine, see figure 64.
Figure 64: Improvement in the yield of the f-butyl ester preparation
1. Isobutylene/c.H^SO^ <-50 °C, 6 h
2. HCI/Et20
£>
(123) (124)
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3.5: Preparation of alkylated aspartic acid p-semialdehyde 
derivatives
There was methodology within the group for the synthesis of a-amino acids by 
the method of O’Donnell and Eckrich162 This procedure involved the alkylation 
of A/-(diphenylmethylene)aminoacetonitrile using phase transfer conditions as 
outlined in section 3.2. The plan was to construct two simple a-alkylated amino 
acids to test as inhibitors of DHDPS. They might also act as substrates and so 
might be used for biotransformation experiments. The compounds chosen 
were the a-amino acids (129) and (130). They are methyl- and ethyl- 
substituted derivatives of ASA (23).
CO2 CO2
The starting point for both of these a-amino acids was, as mentioned above, N- 
(diphenylmethylene)aminoacetonitrile (100). This was dissolved in toluene and 
50% aqueous sodium hydroxide was added as a base. To this was added 
BTEAC and the two phase system was stirred vigorously. The alkylating agent, 
allyl bromide, was added slowly over about an hour. The resulting product was 
found to be a mixture of the mono- (131) and di-alkylated product (132), see 
figure 65. The di-alkylated product was the minor component by a small 
margin. Using less allyl bromide helped to decrease the yield of di-alkylated 
product, but it was still a contaminant. This di-alkylated product is being 
investigated by Dr. P. Mallon as the precursor to possible inhibitors of DHDPS.
Ph
Ph
Ph
N: \
Ph
CN
1. 50% aq. NAOH, BTEAC
2. Allyl bromide
(132)
CN Ph
= \  N:
Ph
CN
(131)
Figure 65: Alkylation of A/-(diphenylmethylene)aminoacetonitrile
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Two methods were found to alleviate this problem, the first was to carry out the 
proposed scheme of work the other way round, see figure 66. If methylation or 
ethylation is carried out first before alkylation with allylbromide, the mono­
alkylated species (133) and (134) are not as likely to be further alkylated. This 
is due to the lower reactivity of the alkylating agent when compared to allyl 
bromide. The mono-methyl compound (133) was isolated in 90% yield and the 
mono-ethyl (134) was isolated in 75% yield. These were then alkylated with 
allylbromide to produce the protected nitriles (135) and (136).
1. 50% NaOH, BTEAC
CN CN
R=Me (133) 
R=Et (134)
1. Base
2.Allylbromide
R= methyl or ethyl
Ph
Ph
Deprotection and hydrolysis CN
R
R=Me (137) R= Mel (135)
R=Et (138) R=Et (136)
Figure 66: Scheme of work to produce the a-alkylated amino acids
The second method found to alleviate the di-alkylation problem was to use 20% 
aqueous sodium hydroxide. This allowed the preparation of the mono-alkylated 
product (132) in 91% yield.
The second alkylation was attempted by the procedure of O'Donnell and 
Eckrich162 The mono-alkylated product was to undergo a second phase 
transfer alkylation using powdered potassium hydroxide as the base. Under 
these conditions only starting material was recoverd.
The di-alkylated compounds were prepared by using lithium di-isopropylamide 
(LDA) as the base. The a-methyl nitrile (135) was prepared in 90% yield from 
the mono-alkylated compound (133). The a-ethyl nitrile (136) was prepared in 
88% from (134). The best evidence for the formation of these di-alkylated 
compounds was the disappearance of the signal for the a-proton in the 1 H
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NMR spectrum. In the starting material there was a triplet at 8 4.2 which 
corresponds to the 2-H. In both of the di-alkylated compounds this signal had 
disappeared.
Deprotection of compounds (135) and (136) involved the removal of the 
benzylidene protecting group first. This group is extremely acid sensitive and 
was removed by stirring in 2M hydrochloric acid for two hours. The yields of the 
free amino compounds were good, above 80% for both (139) and (140). The 
nitriles were hydrolysed to produce the a-amino acids (137) and (138). This 
was achieved by heating the compounds at reflux in 10% sodium hydroxide for 
eighteen hours, see figure 67. The a-amino acids were isolated together with 
an appreciable amount of sodium chloride from the hydrolysis of the nitriles. 
This was not removed and all subsequent reactions were carried out with the 
salt present.
Ph
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R= Me (135) 
R= Et (136)
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2M HCI/Et20
R= Me (139) 
R= Et (140)
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NH2
CN
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* ©
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R= Me (137) 
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Figure 67: Deprotection of the a-alkylated aminonitriles
The 1 H and 13C NMR spectra of compounds (137) and (138) were consistent 
with the a-amino acid structure of these compounds. As can be seen in 
figures 68a and b, which show the 1 H NMR spectrum of (137) and the 13C 
NMR spectrum of (138) in D2 O the compounds contain mainly the amino acid 
with a small proportion of aqueous soluble impurity.
The 1H NMR spectrum of (137) showed the a-methyl group at 5 1.45 as a 
singlet as expected. The CH2 group of the amino acid was split into a complex 
pattern and was recorded at 5 2.5. The CH2 might be expected to be split into 
an ABX system due to the fact that the two hydrogens on C-3 are
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diastereotopic. This coupling pattern is further split by a coupling to the CH2 of 
the terminal alkene. This coupling did not appear to be resolved in the 1H NMR 
spectrum. The alkene hydrogens were found at 8 4.9 and 5.7, and were split 
into a complex multiplet. The 13C NMR spectrum revealed the position of the 
a-carbon to be 5 62. The carboxyl quaternary carbon appeared at 5 172.0.
The 1 H and 13C NMR spectra of compound (138) were similar to those of (137) 
in that the chemical shifts for the alkene signals were very similar. The a- 
carbon of the amino acid was found at 8 66 in the 13C NMR spectrum, with the 
carboxyl quaternary carbon being found at 5 174.5. The 1 H NMR spectrum 
showed signals at 8 0.75 and 1.7 for the a-ethyl substituent.
The mass spectra of both (137) and (138) showed molecular ion signals at m/z 
129 and 143 respectively. Both compounds showed loss of their side-chains as 
the major pathway of fragmentation. The IR spectra showed the amino acid I 
and II bands at 1734 and 1636 cm-1 for (137) and 1705 and 1625 cm'1 for 
(138).
NH.
P P M
Figure 68a : 1H NMR spectrum for compound (137)
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Figure 68b: 13C NMR spectrum of compound (138)
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The next stage involved the protection of the amino acids (137) and (138) at the 
carboxy and amino groups in preparation for the ozonolysis. Attempts to form 
the f-butyl ester were unsuccessful with only starting material being recovered. 
Attempts were also made to form the methyl ester at the a-carboxyl. Treatment 
of the amino acid in methanol with hydrochloric acid gas gave again only 
starting material. All attempts to make the A/-BOC amino acids were also 
unsuccessful. It was initially thought that the nitrile group had not hydrolysed 
fully under the conditions used and that the compound isolated was the amide. 
This does not however explain the lack of reactivity of the amino group towards 
the BOC reagent.
An attempt to hydrolyse the amide, if indeed it was present, was made using 
barium hydroxide solution (0.5 M). Compound (137) was heated at reflux for 
six hours in barium hydroxide solution and then allowed to cool. The barium 
ions were removed by precipitation as barium carbonate using solid carbon 
dioxide. Upon removal of the water the amino acid was isolated as a pale solid. 
An attempt was made to prepare the methyl ester using methanol and 
hydrochloric acid gas. Only the starting amino acid was recovered from this 
reaction.
The failed attempt to prepare the a-methyl-ASA by this route was unexpected. 
No explanation for the low reactivity of compounds (137) and (138) towards the 
standard protecting conditions could be found.
Another route that was investigated was based on the alkylation of diprotected 
allylglycine (125), see figure 69. An initial attempt to alkylate compound (125) 
using LDA as a base and iodomethane as the alkylating agent had given a yield 
of about 10% of the alkylated material. This was promising enough to warrant 
further investigation considering the difficulties found with the other route to the 
compounds (137) and (138).
The diprotected allylglycine (125) was prepared as discussed previously. The 
alkylation of (125) was optimised by varying the reaction time and temperature 
to produce yields of the alkylated products of >70% after chromatography. 
Attempts to prepare the a-hydroxymethyl compound from paraformaldehyde 
failed to produce appreciable amounts of compound (143). Compounds (141) 
and (142) were isolated in 86% and 75% yields respectively. The a-methyl 
signal for compound (141) was found at 5 1.4 in the 1 H NMR spectrum, 
whereas the corresponding signals for the a-ethyl compound were found at 5 
1.1 and 1.5. The signal at 5 1.5 for compound (142) was attributed to the CH2
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of the a-ethyl group and was found to be a multiplet for the diastereotopic 
protons.
Ozonolysis of compounds (141) and (142) produced the diprotected ASA 
derivatives (144) and (145) in 80% and 77% yields, respectively. The 
mechanism for the ozonolysis is shown in figure 70. The aldehyde signals 
were found at 5 9.7 and 9.75 in the 1H NMR spectrum and at 5 198.1 and 201.4 
in the 13C NMR spectrum, respectively. No contamination by starting material 
was seen from the NMR spectrometry evidence, as the signals for the alkene 
group were absent from both the 1H and 13C NMR spectra.
Compounds (144) and (145) were deprotected fully in one step using 
trifluoroacetic acid in dichloromethane. Compound (144) gave a pale yellow 
solid (129) which showed no sign of an aldehyde peak by 1 H or 13C NMR
c o 2tBu
1. LDA, -78 C
2. Rl, -78 C-RT, 3h ^  \  NHBOC
or paraformaldehyde R
R= Me (141)
R=Et (142)
R=CH2OH (143)
C 0 2  Bu
NHBOC
(125)
R= Me, Et or C H 2OH
C 0 2H
©
NH3  Q  
R CF3 C 0 2
TFA, C H 2 CI2 , 1 h
R=Me (129) 
R=Et (130)
1 . 0 3, -78 C 
2. NEt3, -78 C-RT
CO^Bu
NHBOC
R
R=Me (144) 
R=Et (145)
Figure 69: Alkylation of diprotected allylglycine using LDA
spectra. The compound was isolated as a hydrate as shown by the signal in 
the 1H NMR spectrum at 5 4.9. The a-ethyl compound (130) was also isolated 
as a hydrate. Both compounds were tested with DHDPS and the results of the 
testing can be found in chapter seven.
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3.6 /V-Formyl aspartic acid p-semialdehyde
A/-Formyl ASA (146) was first prepared by Tudor from allylglycine in four steps. 
The compound was never tested for substrate or inhibitor activity against 
DHDPS and it was decided to re-synthesise it in order to obtain the biological 
data. The compound was designed to bind and react with pyruvate present on 
the enzyme, but it should be unable to cyclise to DHDP (27) and may therefore 
act as an inhibitor.
The route by which compound (146) was synthesised is shown in figure 71. 
The coupling reagent used, dicyclohexylcarbodiimide (DCC), was not the same 
as that reported by Tudor. He used 1-(3-dimethylaminopropyl)-3-ethyl 
carbodiimide which was reported to have good water solubility and would be 
easily removed after the reaction. When the coupling was carried out using the 
original coupling reagent the the yield was less than 5%, and the product 
required further purification. DCC gave no such problems with a yield of (147), 
after chromatography, of 95%. The mechanism of the coupling is outlined in 
figure 72. The A/-formyl hydrogen appeared in the 1H NMR spectrum at 8 8.2 
and the A/-formyl carbonyl appeared at 8 160.5 in the 13C NMR spectrum.
G NHBOC
C 02!Bu
(£X 0 NHBOC
Primary ozonide
Et3N
C 0 2tBu © /
NHBOC
H2C
NHBOC
Secondary ozonide
0Et3N ^
C 02tBu
O NHBOC
NHBOC © ©
Et3N O + H2C = 0
Figure 70: Mechanism for the ozonolysis of alkenes
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Ozonolysis of the protected AMormylallylglycine (147) was carried out under the 
standard conditions of reductive work-up with two equivalents of triethylamine. 
Tudor had reported that no aldehyde was formed under these conditions; the 
only product he reported isolating was the ozonide of compound (147). The 
yield obtained from the ozonolysis of compound (147) was 75%, and the 
product was recovered as a colourless oil. The 1H and 13C NMR spectra were 
consistent with the formation of the aldehyde; the C-4H was found at 5 9.7 in 
the 1H NMR spectrum and C-4 was found at 5 199.1 in the 13C NMR spectrum. 
No signals were seen at 5 91.2 in the 13C NMR spectrum, which Tudor 
attributed to the C-4 of the ozonide.
O
(124)
OH HN
O
A
H
HNDCC, formic acid, Et2 0
1 . 0 3, -78 °C 
2. NEt3, -78 °C-RT
TFA, C H 2 CI2
HO v  C 0 2H 
(146)
Figure 71: Preparation of AMormyl-ASA
(147)
C 0 2 Bu
/V-Formyl ASA was deprotected using TFA to give a 92% yield of compound 
(146). The AMormyl proton was found at 8 7.7 in the 1H NMR. The compound 
was found to exist as a hydrate after the deprotection, since no signal was 
found for the C-4 aldehyde in the 1H or 13C NMR spectra.
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Figure 72: Mechanism of DCC coupling of (108) with formic acid
3.7 Succinic Semialdehyde
Succinate semialdehyde (149) lacks the amino group of ASA (23) and so may 
act as an inhibitor of DHDPS, as again it would be incapable of ring closure. 
Succinate semialdehyde may be prepared by the ozonolysis of pent-4-enoic 
acid (150). However in the light of the problems encountered in the ozonolysis 
of allylglycine it was decided that the best course of action would be to protect 
the carboxyl group, see figure 73.
R=H (150) 
R=lBu (151) 
R=Me (152)
1 . 0 3, -78 C
2. NEt3, -78 C-RT
R=H (149) 
R=!Bu (153)
Figure 73: Formation of succinate semialdehyde
Treatment of pent-4-enoic acid (150) under the conditions used for the 
preparation of f-butyl esters led to the recovery of, after chromatography, f-butyl 
pent-4-enoate (151) in a 5% overall yield. Attempted optimisation of the 
conditions gave similar results with yields below 10% in all cases. Preparation 
of the methyl ester (152) of pent-4-enoic acid was attempted as an alternative 
to the f-butyl ester. The attempt involved treating compound (150) in methanol
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with thionyl chloride. Yields were again disappointingly low, never rising above 
10%.
Treatment of f-butyl pent-4-enoate (151) with ozone under the standard 
conditions gave (153) as a pale yellow oil in 78% yield. Pent-4-enoic acid (150) 
was also treated under the standard conditions for ozonolysis and produced a 
mixture of the aldehyde (149) and the hydrate (154) upon isolation and this was 
established by NMR spectroscopy.
The f-butyl ester (153) was deprotected using TFA and was isolated as a pale 
solid (154) in a yield of 65%, with NMR spectra closely resembling those 
recorded for the product of ozonolysis of unprotected pent-4-enoic acid.
OH
OH
HO
o
(154)
3.8 Substitution of aspartic acid {3-semiaidehyde at the 3-position
The Claisen ester-enolate rearrangement was reported by Bartlett and Barstow 
to allow substitution of allylglycine systems at the 3-position.163 They reported 
the conversion of (E)-2-butenyl-A/-(f-butoxycarbonyl)amino acetate (156) into 3- 
methyl-2-(f-butoxycarbonylamino)pent-4-enoic acid (157), see figure 74.
This reaction was reported to proceed with relatively high diastereoselectivity, 
approximately 9 to 1 in favour of the methyl trans to the A/-BOC group of the 
amino acid when written as shown in figure 74. This procedure would provide 
a good method by which to produce compounds with various combinations of 
methyl groups in the 2- and 3-positions.
The desired compounds were the 3-methyl- (157), the 2,3-dimethyl- (158), the
3,3-dimethyl- (159) and the 2,3,3-trimethyl-derivative (160) as these might be 
inhibitors of DHDPS. They might also provide information about the 
geometrical requirements for the elimination of water from 4-hydroxy-THDP 
(35) to form DHDP (27). The target compounds can be seen in figure 75.
84
c o 2h
1. LDA, -78 C
2 . TMSCI, reflux BOCHN
NHBOC
(156) (157)
Figure 74: Synthesis of 3-methyl-2-(f-butoxycarbonylamino)pent-4-enoic
acid
The initial starting materials for these compounds were the amino acids glycine 
and L-alanine. They were protected under the standard conditions for A/-BOC 
protection. The two A/-BOC amino acids (161) and (162) were isolated in 
quantitative yields as solids with melting points of 88-89 C (lit.,164 87-88 C) for 
A/-BOC glycine (161) and 79-81 C for N -BOC alanine (162) (lit.,165 80-82 C).
NHBOC
(157)
NHBOC
NHBOC
(158)
NHBOC
(159) (160)
Figure 75: Target compounds from the Ciaisen rearrangement
The four esters required for the Ciaisen rearrangement were prepared by 
coupling these two A/-protected amino acids to trans-crotyl alcohol (163) and 3- 
methyl-2-butene-1-ol (164). The couplings were achieved using DCC and 4- 
(dimethylamino)pyridine (DMAP) in ether.
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(163) (164)
(£)-2-Butenyl A/-(f-butoxycarbonyl)amino acetate (156) was prepared and was 
identical to the material prepared by Bartlett and Barstow. The 1 H NMR 
spectrum of this compound is shown in figure 76. The methyl group of the 
ester was found at 6 1.7 and is clearly split into a doublet with a further small 
coupling to give a second doublet (J6.3 Hz and 1.2 Hz) . The two CH2 groups 
were found at 5 3.9 for the ester CH2 and 4.5 for the 0C-CH2 of glycine. They 
are both doublets with 3J values of 5.7 Hz and 6.4 Hz respectively. The alkene 
protons are too highly coupled to enable J value assignment. The 13C NMR 
spectrum showed no sign of the ester formed by the coupling of A/-BOC glycine 
with the cis-crotyl alcohol present in the sample bought from Aldrich (-5%). 
The alkene carbons were found at 8 124.5 and 131.8, with the ester CH2 group 
recorded at 8 42.3.
A
Figure 76: 1H NMR spectrum of (£)-2-Butenyl Af-(t-butoxycarbonyl)amino
acetate
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The other three esters were prepared under the same conditions and were 
isolated in the following yields: (E)-2-butenyl A/-[(f-butoxycarbonyl- 
amino)propionate (165) 70%; (E)-2-(3-methyl)butenyl A/-(f-butoxycarbonyl- 
amino)acetate (166) 70%; and (E)-2-(3-methyl)butenyl A/-(f-butoxycarbonyl- 
amino)propionate (167) 62%.
All of the esters showed NMR spectra consistent with the structures assigned to 
them, and the spectra were similar to those recorded for (156). The methyl 
groups of the esters were all found between 6 1.2 and 1.5 in the 1H NMR 
spectra. Mass spectra gave ions which lacked the alkene group of the esters. 
For (156) a signal at m/z 174 was recorded and for compounds (165)-(167) the 
signals were found at m/z 188, 188 and 201 respectively.
The conditions chosen for the Claisen rearrangement were to generate the 
enolate of the esters (156), (165), (166) and (167) using LDA (2.1 equivalents 
to ensure complete removal of the a-proton). This enolate was then treated 
with trimethylsilyl chloride (TMSCI) to trap the enolate as the corresponding silyl 
enol ether. Allowing the mixture to warm to room temperature and then heating 
at reflux induced the Claisen rearrangement to give 3-methyl-2-(f- 
bu toxycarbonylam ino)pent-4-eno ic acid (157). The reported 
diastereoselectivity164 for this rearrangement was 9 to 1 and a similar value was 
recorded in this work. The minor diastereoisomer was difficult to identify by 13C 
NMR spectroscopy of the crude reaction products.
BOCHNBOCHN
BOCHN
The Claisen ester-enolate rearrangement shown in figure 77, takes place 
through a six-membered transition state. The reaction is believed to proceed 
through the more stable chair-like transition state rather than the boat-like 
transition state.166 This helps to define the regiochemistry of the various groups 
on the resulting product, and the most stable chair conformation will give rise to
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the products. This means that the groups are arranged around the pseudo­
chair in the positions that generate the least amount of steric strain. That is the 
larger groups will tend to adopt pseudo-equatorial positions.
OSiMe3 OSiMe3
O \ J Heat O
(168)
Figure 77: Claisen ester-enolate rearrangement
The rearrangement of the esters proceeds through a di-anion with the enolate 
adopting E-geometry (169), see figure 78. The lithium co-ordinates the 
nitrogen and the oxygen of the carbonyl helping to stabilise the geometry (170). 
TMSCI then traps the enolate in the conformation chelated by the lithium cation. 
The rise in temperature provides the energy required for the Claisen 
rearrangement to take place. The diagramatical representation of the transition 
state geometry (171) is shown in figure 79. The methyl and the A/-BOC groups 
adopt pseudo-equatorial positions relieving a great deal of steric strain. The 
TMS ether would also be expected to adopt a pseudo-equatorial position in 
order to minimise strain in the transition state.
BuO
(170)
BuO
LDA
(169)
Figure 78: The geometry of the enolate adopted for the rearrangement of
(156)
This arrangement of groups in the transition state would give rise to the anti-
arrangement of the/V-BOC and methyl groups found in the main product (172)
of reaction. 
lBuO
N
(171)
Heat
xBuO
MeaSiO
N., ,(X>2 SiMe3  
'*//s '
(172)
Figure 79: Diagramatical representation of the transition state
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3-Methyl-2-(f-butoxycarbonylamino)pent-4-enoic acid (157) was isolated as a 
solid from the reaction mixture in 68% yield. The 1H and 13C NMR spectra 
were recorded and showed a doublet for the methyl group at 5 1.1 with a 
coupling constant of 7 Hz. The C-2H and C-3H were found at 8 4.2-4.4 and 
2.7. A long term 13C NMR spectrum (32,000 scans for the broad band) showed 
the signals for the minor diastereoisomer, see figure 80. The most noticeable 
signal for the other diastereoisomer was the signal for C-2 at 5 58.9 (8 57.3 for 
the major diastereoisomer).
2,3-Dimethyl-A/-(f-butoxycarbonylamino)pent-4-enoic acid (158) was produced 
by the Claisen rearrangement in 80% yield from (165) and 3,3-dimethyl-A/-(f- 
butoxycarbonylamino)pent-4-enoic acid (159) was prepared in 79% yield from 
(166). The rearrangement of (167) did not produce consistent results, with at 
maximum 10% yield of the rearranged product (160) produced. Upon work-up 
of the organic layer only a small percentage of the starting material could be 
recovered, not fully accounting for the mass balance. The transition state must 
therefore be too crowded with the three methyl groups present to allow the 
efficient adoption of the correct geometry for rearrangement.
The conversion of these three compounds into the corresponding aldehydes 
was carried out for the synthesis of ASA (23), see figure 81. The compounds 
were protected at the acid group using p-methoxybenzyl chloride in basic 
solution to give the p-methoxybenzyl esters (173), (174) and (175) in yields of 
85%, 86% and 84% respectively. The PMB esters all showed the characteristic 
AA'BB1 system for the benzyl ester in the aromatic region of the 1H NMR 
spectra. The diprotected esters were now subjected to ozonolysis in 
dichloromethane to give the aldehydes (176), (177) and (178). The aldehydes 
were isolated as pale yellow oils with yields of 80%, 90% and 93% respectively.
The 1 H NMR spectra of the aldehydes showed the aldehyde proton for 
compounds (176), (177) and (178) at 8 9.6, 9.3 and 9.5, respectively. The 13C 
NMR spectrum for (178) is shown in figure 82. The spectrum showed clearly 
the two methyl groups on C-3 at 8 0.90 and 0.98. The C-2 proton was found as 
a doublet at 8 4.5, with a J value of 9.5 Hz. The proton was coupled to the NH, 
found at 8 5.2, of the amino acid; this also appears as a doublet with a J value 
of 9.5 Hz. The 13C NMR spectrum showed the methyl groups at 8 17.5 and
18.8 with the C-2 and C-3 carbons of the amino acid appearing at 8 57.2 and
49.9 respectively. The aldehyde signal was recorded at 8 201.9.
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Figure 80: 13C NMR spectrum for 3-methyl-2-(f- 
butoxycarbonylamino)pent-4-enoic acid (157)
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Figure 81: Preparation of the aldehydes (176), (177) and (178)
The three compounds were deprotected using TFA to produce (179), (180) and 
(181) as pale solids. Like the TFA salt of ASA (23) these compounds were 
isolated as hydrates. The 1H NMR spectra showed a signal about 8 5.0 for all 
of these compounds. For compound (179) the signal was a doublet, for (180) 
the signal was also a doublet, but for compound (181) the signal was a singlet. 
The testing of these compounds with DHDPS will be discussed in chapter 
seven.
3.9 Preparation of 2-amino-4-epoxypentanoate
The epoxide of diprotected allylglycine (182) was prepared as an intermediate 
in the synthesis of 2-amino-4-epoxypentanoate (183). This compound was a 
desirable target as it might prove to be a good inhibitor of DHDPS. The 
nucleophilic species, on DHDPS, near the active site might be close enough to 
react with the epoxide and therefore trap the compound at or near the active 
site.
The epoxide was prepared by reacting diprotected allylglycine (125) with m- 
chloroperbenzoic acid (MCPBA) in dichloromethane at 0 C, see figure 83.
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The epoxide was isolated after purification using silica gel chromatography in 
90% yield. The 1H NMR spectrum showed the epoxide CH at 6 3.0 and the 
CH2 appeared at 5 2.5 and 2.7. The signals for the a-CH and the C-3 H2 were 
found at 5 4.4 and 1.9 respectively. The 13C NMR spectrum showed no signals 
corresponding to the alkene carbons of the starting diprotected allylglycine 
(125) but did however have signals attributable to the CH and CH2 of the 
epoxide at 5 48.8 and 46.2, respectively. Deprotection using TFA produced a 
pale, very hygroscopic solid (183) in 65% yield. The NMR spectra showed 
signals attributable to the epoxide, indicating that the epoxide did not open 
under the acidic conditions.
OH OH
HO HO NH3  CF3 CO 2
(179) (180)OH
HO
(181)
C 0 2  Bu
MCPBA, C H 2 CI2, 0  C
NHBOC
(125)
NHBOC
(182)
NH 3  c f 3 c o 2
(183)
Figure 83: Preparation of 2-amino-4-epoxypentanoate
3.10 Attempted preparation of oc-difluoroallylglycine
The synthesis of the a-difluoro substituted ASA was desired to test the effects 
of fluorine substitution in the molecule. The methodology developed for the 
preparation of a-substituted allylglycines was used to try to alkylate the a - 
position of (125) with chlorodifluoromethane (CDFM) to produce (184).167,168
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The methodology calls for the generation of the a-anion using LDA and then 
addition of the alkylating agent. This procedure was carried out and as soon as 
the gaseous CDFM was bubbled through the solution of the anion of (125) a 
colour change from pale yellow to dark black was seen. After work-up the 1 H 
NMR spectrum showed no sign of the starting material (125) nor of the 
expected product (184). All that was isolated was an unidentifiable mixture of 
hydrocarbons. This instantaneous colour change was put down to the 
formation of the extremely reactive difluorocarbene from CDFM and the anion 
generated from (125) and LDA; this is not unknown for CDFM under basic 
conditions.168
C 0 2  Bu
1. LDA or HMDS  
NHBOC 2 . C H F2CI
C 0 2 1 Bu
NHBOC  
C H F 2
(125) (184)
The use of the base hexamethyldisilizane (HMDS) for the deprotonation was 
reported to reduce the formation of difluorocarbene.169 The product from this 
reaction was found to be a mixture of starting material and unidentifiable 
organic components.
It was not a sound strategy to prepare the a-difluoromethyl compound by this 
method as the molecule contains too many sites for carbenes to attack and 
then to react further. It would be advantageous to incorporate the 
difluoromethyl group before the ally) side chain as this would make the 
molecule less reactive towards carbenes.
3.11 Conclusions and Future work
A number of alkylated ASA derivatives were prepared in this chapter along with 
some other analogues and derivatives. These were prepared in reasonable 
yields and were deprotected using TFA to produce the trifluoroacetate salts of 
the amino acids.
From the biochemical testing, presented in chapter seven, it was found that the 
A/-formyl ASA (146) was not an inhibitor of DHDP synthase. The same result 
was obtained for succinate semialdehyde (154) and 2-amino-4- 
epoxypentanoate (183). The a- and p-alkylated ASA derivatives were also 
found to be very poor inhibitors of DHDP synthase.
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The a- and (3-alkylated ASA derivatives showed more promise as substrates for 
DHDP synthase. They appear to be turned over by the enzyme at an 
appreciable rate. The p-alkylated ASA derivatives would readily form 3- 
methyldipicolinic acid, but the product from the enzymic reaction on the a- 
methyl ASA derivative has not yet been identified. Further investigation of 
these two interesting biotransformations will be required to isolate and 
characterise the products of the enzymic reactions.
If these compounds are indeed being turned over by DHDP synthase, it would 
be the first biotransformation of analogues found for this enzyme. This 
presents a new line of research. A number of ASA analogues will be required 
to test the range of biotransformations possible. These will presumably involve 
halogenated ASA analogues and various other alkylated analogues of ASA.
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Chapter Four: Synthesis of Isoxazolines as 
Potential Inhibitors of DHDP Synthase
4.1 Heterocyclic compounds as inhibitors of DHDP synthase
Many heterocyclic compounds have been prepared as inhibitors of DHDP 
synthase and they exhibit varying degrees of inhibition. Some of the best 
inhibitors are those shown in chapter two, namely the pyridine analogues of L- 
DHDP (27). Some of the most potent inhibitors produced to date within our 
group at Glasgow were prepared by Dr. D. Tudor. These were 1,3-thiazoles 
(184), prepared by the cyclisation of L-cysteine and ethyl oxalyl chloride (185) 
and also by cyclisation of bromopyruvic acid with ethyl thioxamate (186), see 
figure 84.
h o2c
.SH
NH2
.Br
1. Et3N, CH2CI2
c r  'C 0 2Et
(185)
2 . P 4 S 1 0 . pyridine
H02C
Ethanol, A
C02Et
H02c r  O H2N C02Et
(186)
Figure 84 synthesis of 1,3-thiazoles
The 1,3-thiazoles (184) showed good inhibition as diesters. The methyl/ethyl 
ester and the diethyl ester were found to give approximately 21 and 15% 
inhibition at 0.1 mM respectively.
Following the promising results obtained from the five membered ring system 
present in the 1,3-thiazoles, it was reasoned that other five membered 
heterocycles might also be inhibitors. Therefore a number of isoxazolines were 
prepared to test against DHDP synthase.
Figure 85 shows the relationships that both ring systems (184) and (187) have 
to l-THDP (27) the product of DHDP synthase. The synthesis of isoxazolines 
is straightforward and allows the easy preparation of many substituents on the 
ring system.
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c o 2h R N
(184)
R
Figure 85: Relationship of the isoxazoline and 1,3-thiazine ring system to
L-DHDP
4.2 Synthesis of isoxazolines
Isoxazolines are synthesised by means of a 1,3-dipolar cycloaddition with a 
dipolarophile. This reaction is one example of the many types of pericyclic 
reaction known to exist. These reactions involve the cyclic movement of 
electrons from n bonds to form new a bonds. Pericyclic reactions are a very 
powerful tool for the preparation of a large number of organic compounds. 
Figure 86 shows some of the many pericyclic reactions known.
As indicated in figure 86 the 1,3-dipolar cycloaddition is an example of a 
[47t+27t] cycloaddition with 4n electrons shared between three atoms. The 
reaction is generally referred to as dipolar because the three atom component 
cannot be represented by electron paired resonance structures without invoking 
charges, see figure 87.
R
Figure 87: Resonance structures for the 1,3-dipole of a nitrile oxide
Isoxazolines are prepared by the 1,3-dipolar cycloaddition of a nitrile oxide 
(188), prepared by one of two methods (see section 4.4), with an alkene or 
alkyne, see figure 88. The 1,3-dipole of the nitrile oxide is known to react 
faster with electron rich or poor alkenes compared with alkyl-substituted 
alkenes.
R
C
(188)
Figure 88: 1,3-Dipolar cycloaddition to form a 2-isoxazoline
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Figure 86: Some Pericyclic reactions
4.3 Mechanism of the 1,3-dipolar cycloaddition
Dipolar cycloadditions involving nitrile oxides are believed to proceed through 
an unsymmetrical transition state in which the formation of one a bond is more 
advanced than the other.170 The reaction proceeds through a transition state in 
which the 4n electron system interacts with the 2tc electron system. The
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approach geometry gives rise to a two plane system as seen in figure 89. This 
process is a thermally activated process and is allowed by the Woodward- 
Hoffmann rules.171 The rates of the reactions are affected only slightly by the 
changing polarity of the solvent indicating a transition state no more polar than 
the starting materials.
Figure 89: Transition state geometry of a 1,3-dipolar cycloaddition
Frontier orbital theory provides a great deal of insight into the reactivities and 
selectivities of pericyclic reactions including the 1,3-dipolar cycloaddition.172 
The theory states that the reaction will proceed through a transition state as 
shown in figure 89 and is favoured if orbitals of the same sign overlap. This 
interaction is usually between a filled n orbital of one reactant and an empty n* 
orbital of the other. The interaction of these orbitals is stronger the closer they 
are in energy to each other. The orbitals best able to make this overlap are the 
HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied 
molecular orbital) of the dipole and dipolarophile. The relative energies of these 
frontier orbitals vary depending on the substitution of the reacting species. 
Reactions are therefore favoured if one species is strongly “nucleophilic” and 
the other species is strongly “electrophilic”. There are three cases of orbital 
overlap that can be envisioned depending on the substituents of the reacting 
species, see figure 90.
(i) (iii)
Energy
Dipole
Dipolar­
ophile Dipole
Dipolar­
ophile
Dipolar-
Dipole ophile
Figure 90: Dominant orbital overlaps for cycloadditions
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The first case arises when the dipole HOMO and dipolarophile LUMO are 
closest in energy and they provide the best overlap. These are then the pair of 
orbitals which will dominate in the reaction. This situation arises when nitrile 
oxides react with alkene species with conjugative electron withdrawing groups. 
Case (ii) arises when the dipole reacts with electron rich dipolarophiles such as 
enol ethers and enamines. The HOMO of the dipolarophile is raised in energy 
by the electron donating substituent and the energy gap to the LUMO of the 
dipole is then the smallest in energy. For nitrile oxides case (iii) arises when 
they react with unsubstituted alkene species such as ethylene where neither 
orbital interaction dominates. This slows the reaction down and leads to low 
yields as the unstable nitrile oxide prefers to react with itself rather than react 
with the alkene.
Selectivity of 1,3-dipolar cycloadditions
Like all cycloaddition reactions the possibility of regioisomeric products is 
present as is the possibility of generating stereoisomeric products, see figure 
91. However most 1,3-dipolar cycloadditions show considerable selectivity in 
that they give mainly or exclusively one product. Frontier orbital theory again 
provides an explanation for this selectivity. The strongest interactions are 
between orbitals of the same sign and so this helps to define the reacting 
orbitals. The orbital coefficients are then aligned so that the largest coefficients 
interact to give the product. This again is the most favourable interaction and is 
thus the driving force for the selectivity observed in the reaction products. A 
diagrammatic representation of this principle is shown in figure 92 for the 
reaction of diazomethane with methyl methacrylate.
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Figure 91: Possibilities for isomer formation in 1,3-dipolar cycloadditions
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Figure 92: Regioselectivity in 1,3-dipolar cycloadditions
Stereoselectivity of the dipolar cycloaddition is observed with products isolated 
having only the stereochemistry of the starting materials. This is a 
consequence of the concerted nature of the reaction mechanism and is also 
proof that there can be no di-radical or anionic intermediate as this would allow 
for stereochemical scrambling. Mono-substituted alkenes will give isoxazolines 
with the substituent in the 5-position on the ring This is a consequence of the 
frontier orbitals having coefficients as in figure 92.
4.4 Synthesis of nitrile oxides
Nitrile oxides as mentioned above are transient species that polymerise if no 
alkene is present with which to react. They are derived by one of two main 
methods. The first is the oxidation of aldoximes and the second involves the 
dehydration of nitro compounds. The first nitrile oxide produced was 
benzonitrile oxide (189) and was obtained in two stages by Werner and 
Buss.173 They treated benzaldoxime (190) with chlorine gas at -20 to -40 °C to 
obtain (191). The product they obtained was treated with aqueous sodium 
bicarbonate to generate the nitrile oxide (189) by a dehydrochlorination 
procedure, see Figure 93.
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Figure 93: Preparation of benzonitrile oxide by Werner and Buss
The reaction proceeds via a transient nitroso compound as indicated by the 
blue colour of the reaction.174 The best bases to use were sodium bicarbonate 
or sodium hydroxide although triethylamine was used in more recent 
preparations.175'177 The benzohydroximoyl chloride formed is solely the Z- 
form.177 The E-form was prepared by photo-isomerisation of the acetate and 
subsequent hydro lys is.179 The E-form was found to undergo the 
dehydrochlorination procedure 6x107 times slower than the Z-form. The main 
disadvantage of this procedure is the chlorination step. Chlorine is 
incompatible with a number of organic aldoximes including many aromatic 
species. Many procedures are now available for mild, selective chlorination 
using other popular chlorinating agents, including nitrosyl chloride180 and AA 
chlorosuccinimide in chloroform.181
The second significant method for the preparation of nitrile oxides was devised 
by Mukaiyama and Hoshino.182 This method involves the dehydration of nitro 
compounds using phenyl isocyanate. This method is not suitable for the 
isolation of a progenitor of the nitrile oxide but it does permit the insitu 
preparation and trapping of the nitrile oxide. Triethylamine was required in 
catalytic amounts for the initial proton abstraction, see figure 94. The reaction 
has recently been applied to an increasing number of primary nitro compounds 
and works well for most cases.182 It fails however with nitromethane, where 
after proton abstraction by triethylamine the phenyl isocyanate attacks the 
methyl carbon to generate an a-nitroacetanilide.
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Figure 94: Formation of a nitrile oxide from a primary nitro compound
using phenyl isocyanate
102
4.5 Synthesis of isoxazolines
Approximately ten isoxazolines were prepared by the 1,3-dipolar cycloaddition 
of various alkenes onto ethyl chlorooximidoacetate, the progenitor of the 1,3- 
dipole used in all of the reactions detailed below. Ethyl chlorooximidoacetate 
(192) was first reported by Skinner183 in 1923. An improved preparation was 
reported in 1983 by Kozikowski and Adamczyk.184
The procedure of Skinner describes the conversion of glycine ethyl ester 
hydrochloride (193) into ethyl chlorooximidoacetate (192). The reaction was 
carried out at room temperature in water. Addition of hydrochloric acid, slowly 
by dropwise addition and then followed by aqueous sodium nitrite was all that 
was required to achieve the transformation. The solution was stirred for two 
hours at 0 °C before work-up, and crystallisation afforded ethyl 
chlorooximidoacetate (192) in a 50% overall yield from the cheap starting 
material glycine ethyl ester.
The solid has a melting point of 79-80 °C, which compares well to the literature 
value of 80 °C.184 The 1H and 13C NMR spectra showed the formation of the 
oxime and the removal of the a-protons of glycine ethyl ester (193). The signal 
at 5 3.9 was absent from the 1H NMR spectrum of ethyl chlorooximidoacetate 
(192). The oxime proton appeared at 5 10.5. The only other signals were for 
the ethyl group of the ester at 5 1.4 and 4.4. The 13C NMR spectrum was more 
revealing with the ester carbonyl appearing at 5 158 and the oxime carbon- 
nitrogen double bond appearing at 5 133. Mass spectrometry confirmed the 
presence of ethyl chlorooximidoacetate (192), showing a molecular ion at m/z 
151 and a peak corresponding to the loss of the oxime proton at m/z 150.
The proposed method for formation of ethyl chlorooximidoacetate (192) from 
glycine ethyl ester (193) is shown in figure 95. It involves the formation of an 
alkyl diazonium species (194) initially. This species is then transformed into the 
C-nitroso compound (195) which tautomerises to the oxime (196). Chlorination 
and loss of nitrogen then occur in an unspecified order.
Whether this is the procedure by which the transformation was achieved was 
not proven conclusively by Skinner. It does however, seem unlikely that the 
alkyl diazonium species would form as the first stage in this reaction. Alkyl 
diazonium species are unstable and the glycine nitrogen atom will be 
protonated almost fully under the reaction conditions. It may be more plausible 
to invoke the C-nitrosation and tautomerisation as the first stage as this would
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be a more feasible reaction under the conditions Nitrosation of carbons 
adjacent to electron withdrawing species is a well known reaction with nitrosyl 
chloride. Sodium nitrate and concentrated hydrochloric acid form nitrosyl 
chloride and nitrous acid as products of reaction. Nitrosyl chloride is a long 
lived and stable form of NO+, which can react with the enol form of glycine ethyl 
ester to produce the C-nitroso compound. It is likely that chlorination will occur 
with the oxime as these compounds are known to be easily chlorinated.185 
Nitrogen will probably be lost from a diazonium species eventually, probably as 
a late stage reaction.
There are many pathways by which the transformation of glycine ethyl ester 
into ethyl chlorooximidoacetate could be achieved. The fact that the reaction 
calls for slow addition of the acid to the ester implies that a reaction of the ester 
would be a likely first step. The amine will remain protonated almost fully 
throughout the reaction due to the low pH and it is difficult to imagine it acting 
as a nucleophile at any point during the mechanism. This differs from the 
aromatic case where as the amine group is delocalised and its pKa is therefore 
higher, it can react with the nitronium species formed. It is clear that a number 
of questions remain regarding the formation of ethyl chlorooximidoacetate. 
Only further investigation of the mechanism may provide the answers.
cP h # C 0 2Et + H N 0 2
(193)
©  GLCl N =  N 
(194)
N
O ©  
Cl N = N '
(196)
,OH
C 0 2Et
C 0 2Et 
+ 2H20
h n o 2
N
© © 
Cl N = N
(195)
C 0 2Et 
+ H 20
,OH
N'
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c r  co2Et
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Figure 95: Proposed formation of ethyl chlorooximidoacetate from glycine
ethyl ester183
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The first cycloaddition attempted utilised acrylonitrile as the alkene component. 
This is a cheap and reactive alkene and was chosen because it was assumed 
that the reactivity of the olefin would prevent any unwanted dimerisation of the 
nitrile oxide from taking place. All of the nitrile oxides based on the 
dehydrohalogenation of ethyl chlorooximidoacetate (192) were prepared under 
the same reaction conditions. The base used to generate the nitrile oxide was 
aqueous sodium carbonate, which was added slowly to a mixture of the alkene 
and ethyl chlorooximidoacetate (192) in ether. The reactions were considered 
as finished after about two hours, as any nitrile oxide that had not reacted with 
the alkene would have dimerised or polymerised by then. Work-up was 
extraction of the isoxazoline into ethyl acetate and purification by column 
chromatography if this was required.
Reaction of (192) with acrylonitrile under the conditions outlined above gave a 
clear oil in 90% yield. The product was 5-cyano-3-ethoxycarbonyl-2-isoxazoline 
(197), see table 8. The production of the 5-substituted isoxazoline as the sole 
product can be predicted on the basis of frontier orbital theory as outlined 
previously for the addition of diazomethane to methyl methacrylate. The orbital 
co-efficients for acrylonitrile are shown pictorially in figure 96.
HOMO
NC
Figure 96: The HOMO and LUMO of acrylonitrile with pictorial 
representation of the orbital coefficients
The 1H and 13C NMR spectra support the production of a single regioisomer as 
no signals were visible for the 4-substituted isoxazoline ring system, but a small 
amount of dimerisation had taken place. The 1H NMR spectrum had signals at 
8 1.37 and 3.65 for the ethyl ester and an ABX system for the three remaining 
protons. The protons at the 4-position of the isoxazoline ring were found at 8 
3.65 and those in the 5-position were at 8 5.50. The 1 H NMR spectrum of 5- 
cyano-3-ethoxycarbonyl-2-isoxazoline (197) can be seen in figure 97. The
LUMO
NC
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Compound
Olefin component Product of Reaction Yield
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Table 5: Summary of isoxazolines prepared from simple alkenes
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Figure 97: 1H NMR spectrum of 5-cyano-3-ethoxycarbonyl-2-isoxazoline
ABX coupling system arises because the two protons on the 4-position are 
diastereotopic.These couple to the sole proton at the 5-position. ABX systems 
to their first order approximation should look like the set shown in figure 98.186 
This example is taken for a relatively large chemical shift separation of the AB 
protons. The X proton is split by both A and B protons and gives rise to a 
doublet of doublets, with lines of nearly equal intensity. The interpretation of 
this system is made more difficult by the fact that the coupling constants can no 
longer be reliably read from the spectrum. For the X component the separation 
of the two outer lines (1 and 4 in figure 98) is equal to Jax+bx• The separation 
of the outer and inner lines (1 and 2) is now not strictly equal to Jax or Jbx.
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Figure 98: ABX system for well separated AB protons186
The 13C NMR spectrum again showed the peaks for the ethyl ester at 5 13.3 
and 62.7. The AB CH2 was found at 5 39.7 and the X was found at 5 68.3, an 
indication that the regiochemistry is as expected for the 1,3-dipolar 
cycloaddition. The opposite regiochemistry would produce a product where the
4-CH would be expected at 8 27.1 in the 13C NMR spectrum. The nitrile was 
found at 5 116.3 and the carbonyl and C-N double bond were found at 5 158.8 
and 151.7 respectively. Mass spectrometry showed a signal at an m/z of 168 
which corresponds to the molecular ion. The isoxazole ring system, without 
any substituents was seen at m/z 69. The mass spectrum also showed the loss 
of the nitrile, the ethyl group from the ester and finally the carboxylate group at 
m/z of 142, 139 and 95. The nitrile and the C-N double bond appeared in the 
IR spectrum at 2245 and 1645 cm'1, respectively.
The other isoxazolines produced can be seen in summary in table 5. These 
were made with varying yields and the amount of the nitrile oxide dimer formed 
during the reaction varied with the alkene component used.
Treatment of ethyl chlorooximidoacetate (192) with sodium carbonate in the 
presence of methyl acrylate gave a 68% yield of 5-methoxycarbonyl-3- 
ethoxycarbonyl-2-isoxazoline (198). The 1H and 13C NMR spectra again 
showed the production of a sole regioisomer. The mass balance is presumably 
made up by the nitrile oxide dimer which was removed with other impurities by 
silica gel chromatography.
Signals in the 1H NMR spectrum corresponding to the ethyl ester were found at 
5 1.4 and 4.3. The more diagnostic signals were those for the three ring 
protons.
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These form what appeared to be a simple AX system with the CH2 at 8 3.5, 
being split into a doublet of 3J 9.9 Hz by the CH proton. The CH at 5 5.24, was 
in turn split by the CH2 into a triplet with a coupling constant of 3J 9.6 Hz. This 
system could however be a collapsed ABX system, that is one where the 
chemical shift difference between the A and B protons is not significant. The 
methyl ester was found at 5 3.81. The 13C NMR spectrum showed three 
quaternary carbons at 5 151.1, 159.6 and 169.3 which correspond to the C-N 
double bond, the ethyl ester and the methyl ester respectively. The ring 
carbons were found at 8 37.5 for C-4 and at 8 79.6 for C-5. The other peaks 
present were attributed to the ester groups. The mass spectrum of compound 
(199) again showed the molecular ion at m/z 201 with a similar pattern of 
breakdown to that recorded for compound (198). The loss of groups until the 
isoxazoline ring system was unsubstituted, was again the main method of 
fragmentation found for these compounds. IR spectroscopy showed the C-N 
double bond at 1627 cm'1.
Preparation of 5-hydroxymethyl-3-ethoxycarbonyl-2-isoxazoline (200) required 
treatment of ethyl chlorooximidioacetate (192) with ally! alcohol, in the presence 
of sodium carbonate. The compound was isolated as an oil in 64% yield. NMR 
spectroscopy confirmed the production of this compound and again only the 5- 
substituted regioisomer was formed. The 1H NMR spectrum showed the ABX 
system for the ring protons. The CH2 group, centred around 8 3.34, showed a 
total of seven lines. This is one less than expected for this part of the AB 
system. It appears that the two inner lines may have coalesced, as the central 
line was noticeably broader than the other lines. The CH proton, at 8 4.80, was 
split by the neighbouring CH2OH group and so a total of eleven lines were 
found. The CH2 OH group formed another ABX system with the hydrogen on C- 
5 of the isoxazoline ring. There were a total of eight lines for this AB portion of 
the ABX system which appeared centred around 8 3.53. The 2Jab  was 
measured as 12.0 Hz and the corresponding 3Jax  was 2.2 Hz and 3Jbx was 3.5 
Hz. The OH proton was found as a broad singlet at 8 3.49 and overlaps 
somewhat with the AB system of the CH2 OH.
The 13C NMR spectrum showed the CH2 OH group at 8 62.0 with the C-N 
double bond at 8 151.8 and the ethyl ester carbonyl at 8 160.4. The ring 
protons appeared at 8 84.0 for the CH and 8 34.6 for the CH2 . The other 
signals were due to the ethyl ester.
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The mass spectrum showed a molecular ion at m/z 173 and the pattern of 
breakdown was similar to that seen for the other isoxazoles. IR spectroscopy 
showed the C-N double bond at 1645 and the OH at 3375 cm"1.
The isoxazole produced by reacting methylvinylketone with ethyl 
chlorooximidoacetate was 5-methylcarbonyl-3-ethoxycarbonyl-2-isoxazoline 
(199). It was produced in 86% yield under standard conditions. The 5- 
substituted regioisomer was the only product produced. The 1H NMR spectrum 
was similar to that of compound (198), but the methyl ester of compound (198) 
has been replaced with a methyl ketone which was found at 8 2.13. The ABX 
system was again present for the ring protons. These were found at 8 3.26 for 
the CH2 and 8 4.96 for the CH. The 13C NMR spectrum showed the ketone 
carbonyl at 8 205.1 with the C-N double bond at 8 151.7 and the ester carbonyl 
at 8 159.8. The ring CH was found at 8 86.1 and the CH2 was present at 8 
35.8. The methyl group of the ketone was found at 8 26.4. No NMR evidence 
was recorded for the formation of the nitrile oxide dimer.
Nitrile oxide 1,3-dipoies do not react as quickly with alkyl-substituted alkenes as 
they do with electron deficient or electron rich alkenes. This can be explained 
by frontier orbital theory. The theory predicts that for nitrile oxides the 
interaction of the frontier orbitals of the 1,3-dipole will not be as strong with 
simply substituted alkenes because neither the HOMOdipole-LUMOdipolarophile 
or HOMO dipolarophile "LUMO dipole interaction are close enough in energy to 
dominate the reaction.
This principle can be seen in action in the reaction of . ethyl 
chlorooximidoacetate (192) with cyclohexene. The major product from this 
reaction was the nitrile oxide dimer (206) shown in figure 99. However it was 
possible to isolate 31% of the desired cycloaddition reaction product 4,5- 
cyclohexyl-3-ethoxycarbonyl-2-isoxazoline (203), which should have the same 
c/s-geometry as the cyclohexene starting material.
Purification was required to remove the major product from the crude isolate. 
Once the isoxazoline (203) was separated the 1H and 13C NMR spectra 
confirmed that the product was indeed the cyclohexyl-substituted isoxazoline. 
The 1H NMR spectrum showed the C-4 proton at 8 3.2 and it appeared as an 
unresolved broad quartet. This arises from the proton at C-4 coupling to the 
proton at C-5 and to the CH2 of the cyclohexyl ring to which it is bound. There 
may also be W coupling to another CH on the cyclohexyl ring complicating the 
coupling pattern. The cyclohexane ring protons formed a complex multiplet at 8
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1.5-2.1. The proton at C-5 on the isoxazoline ring was obscured by the triplet 
for the ethyl ester at 8 4.3-4.5.
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Figure 99: Reaction of cyclohexene with ethyl chlorooximidoacetate
The CH2 groups for the cyclohexane ring were found at 8 19.6, 21.2, 24.5 and
25.4. The CH and CH2 for the isoxazoline ring were found at 8 82.5 and 8 43.3 
respectively. The ester carbonyl was found at 8 160.8 and the C-N double 
bond was at 8 157.7. Mass spectrometry gave a molecular ion peak at m/z 197 
and the IR revealed a C-N double bond at 1627 cm'1.
Some previous work with DHDPS had indicated the presence of a nucleophilic 
group near the active site.66 It was decided that an isoxazole could be 
designed to be attacked by that nucleophilic group and might thus enhance any 
inhibition the compound might show against DHDPS. To that end ethyl 
chlorooximidoacetate (192) was cyclised with allyl bromide to produce 5- 
bromomethyl-3-ethoxycarbonyl-2-isoxazoline (202). The compound was 
isolated in 80% yield.
The 1 H NMR spectrum showed the expected two ABX systems for the CH2 
groups each coupling to the C-5H. The two AB parts of the ABX systems now 
overlap as can be seen in figure 100. They were found at 8 3.1-3.6. The 5- 
CH, at 8 5.0-5.2, was split into nine lines, as seen in figure 100. This was 
somewhat unexpected as the couplings to the two CH2 groups should have 
resulted in a total of sixteen lines. Some overlap of peaks must be responsible 
for the reduction in the number of lines found.
The 13C NMR spectrum showed the two CH2 groups at 8 32.5 (CH2 Br) and
38.2 (4 -CH2 ). The ring CH was found at 8 81.7 with the ester carbonyl at 8
160.2 and the C-N double bond at 8 151.3. The mass spectrum had peaks at 
m/z 235 and 237 which correspond to the molecular ions with either 79 o r81 Br.
Preparation of 5-formyl-3-ethoxycarbonyl-2-isoxazoline (200) involved reaction 
of ethyl chlorooximidoacetate (192) with acroelin. Acroelin was supplied as a 
30% solution in water and the yield from the reaction was low at 5%. The 1 H 
NMR spectrum was consistent with the 5-substituted regioisomer with the 
aldehyde signal at 5 9.7, appearing as weak due to partial hydration, and the 
hydrated aldehyde was present at 5 4.8. The ring protons appeared at 5 3.3 for 
the 4-CH2 and 5 5.2 for the 5-CH. The mass spectrum gave a peak at m/z 171 
corresponding to the molecular ion, IR placed the C-N double bond at 1635 and 
the aldehyde at 1712 cm"1.
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Figure 100: Part of the 1H NMR spectrum of 5-bromomethyl-3- 
ethoxycarbonyl-2-isoxazoline showing two overlapping ABX systems
Attempts to generate the isoxazoles formed from cycloaddition with maleic 
anhydride (204) and dimethyl acetylenedicarboxylate (205) resulted in isolation 
of only the nitrile oxide dimer in varying amounts.
Preparation of isoxazoles via the Mukaiyama-Hoshino method182
Two isoxazoles were prepared via this method which involved the treatment of 
nitroethane with phenyl isocyanate to generate the 1,3-dipole insitu. The two
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isoxazolines prepared were 5-cyano-3-methyl-2-isoxazoline (207) and 5- 
methoxycarbonyl-3-methyl-2-isoxazoline (208). These were made to test the 
effect of removal of the ester group in the 2-position when the compounds were 
challenged with DHDPS.
5-Cyano-3-methyl-2-isoxazoline (207) was prepared in 66% yield from 
nitroethane. The 1H NMR spectrum was similar to the ethyoxycarbonyl 
substituted isoxazoline (197) prepared previously. The ring 5-CH was found at 
5 5.2 and the 4 -CH2 was found at 5 3.4. The ABX system was still present for 
these protons and was further split by a, weak, long range coupling from the 
methyl group, see figure 101. For the A proton4J was 1.1 Hz and for the B 
proton 4J was 0.9 Hz. The methyl group was found at 6 2.1. The 13C NMR 
spectrum showed the CH at 5 65.8 and the CH2 at 5 44.4 along with the C-N 
double bond at 5 155.6. The nitrite was found at 5 117.6 and the methyl group 
was found at 5 12.3.
Figure 101: Long range coupling to the AB system of 5-cyano-3-methyl-2-
isoxazoline
CO2M6
(207) (208)
P  13 M
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5-Methoxycarbonyl-3-methyl-2-isoxazoline (208) was prepared by the addition 
of methyl acrylate to nitroethane in the presence of phenyl isocyanate in a yield 
of 58%. The 1H and 13C NMR spectra confirmed the identity of the compound, 
with the spectra similar to those previously recorded for the other isoxazolines. 
There was an ABX system for the 5-CH and 4 -CH2 although it did not appear to 
be split further by the methyl group in the 2-position, as was seen for compound 
(207).
Preparation of isoxazoles using dienes
Two dienes were used to test the effect of further unsaturation on inhibitory 
effectiveness against DHDPS. The dienes used were 2,3-dimethylbutadiene
(210) and methyl sorbate (209). They were expected to add to ethyl 
chlorooximidoacetate (192) regioselectivly to give one major product (in the 
case of 2,3-dimethylbutadiene this is not a problem as the diene system is 
symmetrical). Methyl sorbate (209) was expected to produce the isoxazoline 
where the most electron deficient double bond had reacted. This product is 
shown in figure 102. Frontier orbital theory predicts that this double bond will 
provide the best orbital overlap.
C 0 2 M6
(209)
(210)
Et02C
C 0 2Me
NaHC0 3 /H 2 0 /Et2 0  
EtQ2 C . Cl
(211)
OH
(212)
Figure 102: Addition of dienes to ethyl chlorooximidoacetate
Reaction of ethyl chlorooximidoacetate with 2,3-dimethylbutadiene (210) 
produced 5-(2’-propenyl)-5-methyl-3-ethoxycarbonyl-2-isoxazoline (212) in 48% 
yield.
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The 1H NMR spectrum confirmed the structure, with the CH2 group on the 
isoxazoline ring being found at 8 3.1. There was no CH peak for the other 
regioisomer. The alkene CH2 was found at 5 4.9 (this showed a fine splitting of 
about 1.4 Hz) and at 8 5.0 (a broad singlet). The methyl groups were found at 5
1.5 for the methyl group on the 5-position of the isoxazoline ring and 8 1.8 for 
the methyl group attached to the alkene. The CH2 of the isoxazoline ring 
showed an AB system with an 2Jab coupling of 17.7 Hz, as seen below in 
figure 103.
Reaction of methyl sorbate (209) with ethyl chlorooximidoacetate failed to 
produced 5-(methoxycarbonyl)-4-(prop-1-ene)-3-(ethoxycarbonyl)-2-isoxazoline
(211).
The reaction produced only the nitrile oxide dimer in varying yields. The diene, 
methyl sorbate (209) could not have been active enough to react with the nitrile 
oxide. This led to the nitrile oxide reacting with another molecule of the nitrile 
oxide to give the dimer.
P r e p a r a t i o n  of t -bu ty l  2-(A/-(f-Butoxycarbonylamino)-3-(3- 
ethoxycarbonyl)-2-(isoxazolin-4-yl)propanoate
Good recognition in an enzyme’s active site usually means keeping a similar 
structure to that of the enzyme’s natural substrates and products. All of the 
isoxazolines prepared thus far have been product mimics. An attempt was 
made to keep the structure of ASA (23) as the basis of another potential 
inhibitor of DHDPS. To this end we prepared t-butyl 2-(N-(t- 
butylcarbonylamino)-3-(3-ethyoxycarbonyl)-2-(isoxazolin-4-yl)propanoate (213) 
by reacting ethyl chlorooximidoacetate (192) with diprotected allylglycine (125), 
see figure 104. Compound (213) was isolated in an overall yield of 70%.
The 1 H NMR spectrum showed signals for the isoxazoline ring 5-CH and 4 -CH2 
at 8 4.89 and 3.0 respectively. The a-proton of the amino acid was found at 8
4.4, where it appeared as a doublet of triplets with J6.5 and 6.1 Hz. The CH2
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Figure 103:1 NMR spectrum of 5-(2’-propenyl)-5-methyl-3-ethoxycarbonyl
2-isoxazoline
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Figure 104: Reaction of ethyl chlorooximidoacetate with diprotected
allylgycine
of the alanine side chain of the isoxazoline was found at 5 2.17. The 13C NMR 
spectrum showed the signals for the isoxazoline ring at 8 38.8, 80.0, 151.1 and 
160.7. The a-carbon was found at 5 51.0 and the (3-carbon of the amino acid 
was found at 8 37.3.
Mass spectrometry gave a peak at m/z 364 for the molecular ion and showed a 
similar pattern of fragmentation as for the other isoxazoles. The IR spectra 
showed the lack of a C-C double bond and the presence of a C-N double bond 
at 1640 cm*1.
4.6 Ring opening of isoxazolines to give a-keto esters
Many methods have been reported to open the weak O-N bond of the 
isoxazoline ring system. These include hydrogenation with various metal 
catalysts, addition of electrons from sodium/ethanol and sodium amalgam 
systems.
Lithium aluminium hydride reduces 2-isoxazolines to 1,3-amino alcohols, see 
figure 105.187 This is also the product isolated by reduction with borane 
complexes.188 Hydrogenation produces either the keto-alcohol and an amino- 
alcohol depending on the conditions used for the reduction.189 Titanous salts 
are known to cleave the N-0 bond of isoxazolines. However the product from 
these reductions is often lacking the hydroxy group at the 3-position of the 
opened skeleton.190 Sodium borohydride is known to remove the C-N double 
bond from isoxazolines when the R group in the 3-position is an acid or ester.191
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Borane com plexes^, 
(hydrogenation will \  
form this in some cases) NH2
OH
Figure 105: Methods of cleavage for the N-0 bond of isoxazolines
The method we chose to reduce some of the 2-isoxazolines made was catalytic 
reduction using hydrogen and palladium on charcoal. We wanted to obtain 
some keto-esters that may act as pyruvate analogues when they are 
challenged with DHDPS. To this end we chose to reduce catalytically 5- 
hydroxymethyl-3-ethoxycarbonyl-2-isoxazoline (198), 5-methylcarbonyl-3- 
ethoxycarbonyl-2-isoxazoline (199) and 5-methoxycarbonyl-3-ethoxycarbonyl- 
2-isoxazoline (201). All were treated with palladium on carbon under an 
atmosphere of hydrogen gas for eighteen hours before being acidified and 
stirred for a further one hour. Basification followed by extraction and 
purification gave the corresponding keto-esters, see figure 106.
Eto2c
R
N
0
Pd on C, H 2, 18 h
CH2OH (201) 
R= COMe (199) 
C 0 2Me (198)
C 0 2Et
R OH
CH2OH (216) 
R= COMe (215) 
C 0 2Me (214)
O
H 0 2C 
Pyruvic acid (32)
Figure 106: Reduction of isoxazolines using Pd on carbon
The three isoxazolines were transformed into the keto-esters in low yields, none 
greater than 16%. The reason for the low yields was attributed to the formation
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of amino alcohols by the further reduction of the imine formed on intial cleavage 
of the N-0 bond. This, as mentioned above, was a known reaction and 
prevented the isolation of large quantities of these compounds.
The 1H NMR spectra of these compounds were very similar to those recorded 
for the corresponding isoxazoline ring systems. The major difference was the 
presence of a broad singlet at 8 6.9, 5.4 and 4.4 for compounds (214), (215) 
and (216), respectively, attributed to the hydroxyl proton. This was confirmed 
by the IR spectra where the presence of a hydroxyl group was quite 
pronounced. The hydroxyl of compound (214) appeared at 3415 cm"1 and for 
compound (216) it was found at 3395 cm"1.
It was initially intended that the esters would be cleaved to produce the free 
acids. These would have been more electronically and sterically like pyruvic 
acid at the end of the molecule recognised by DHDPS. Time constraints and 
the poor yields of the ring opened compounds prevented the production and 
testing of the free acids.
These three ring opened compounds and all of the other isoxazoles were tested 
with DHDPS. The results of the testing can be found in chapter eight.
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Chapter Five: Attempted Synthesis of Glutamic 
Acid y-Semialdehyde
5.1 Introduction
Glutamic acid y-semialdehyde (GSA) (217) is the higher homologue of ASA 
(23). It is itself a biologically important compound as it is a common 
intermediate in the enzymatic interconversions of glutamic acid, proline and 
ornithine.192 While testing a variety of compound types as inhibitors of DHDPS 
it was decided that GSA (217) would be an interesting compound to prepare for 
use in our inhibitor studies and also as a potential substrate for DHDPS.
O
H
(217)
There have been many reports of GSA (217) being prepared as a diprotected 
species in the literature. Bold et a/.193 prepared GSA (217) doubly protected on 
the amine and the carboxyl functionalities via the Rosenmund reduction 
reaction. The doubly protected semialdehyde was used directly in further 
transformations. Lee and Miller194 made the protected semialdehyde by 
reduction of the corresponding acid chloride (218) with a hydride agent such as 
tributyltinhydride or lithium tri-terf-butoxyaluminohydride, see figure 107. The 
protected semialdehyde (219) they prepared was not deprotected.
o o
(nBu)3SnH or Li(OtBu)3AIH
OCbz —  N Cbz —  N
(219)(218)
Figure 107: Lee and Miller preparation of diprotected GSA
A Japanese patent described a process for preparing optically active N- 
acetylglutamic semialdehyde from the oxidation of optically active N- 
acetylornithine with persulfate. The product was formed in aqueous solution 
and was not isolated.
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5.2 Synthesis of glutamic acid y-semialdehyde
We desired to synthesise GSA (217) as a solid, such as was obtained from the 
synthesis of ASA (23). We had envisaged a final step involving deprotection of 
diprotected GSA using TFA. It was decided to start the synthesis from L - 
glutamic acid (220) to take advantage of the natural optical activity of the amino 
acid. The synthetic plan is outlined in figure 108. The glutamic acid (220) 
would be fully protected and then the y-ester would be removed selectively to 
produce the free acid. This acid group would then be reduced selectively to the 
aldehyde using a dissolving metal reduction, trapping the aldehyde as the 
imine.
h o 2C.
(220)
Me020
(223)
©
,NH3 MeOH, SOCI2 , 0 °C  Me0 2 C-
CO P
NHZ Benzyl bromide, DMF M e 0 2o
C02Bn
© © 
,NH3 Cl
C02h (221)
Benzyl chloroformate, 
N a H C 0 3i Et2 0 , NaOH
NHZ
C02h (222)
NaOH/MeOH
NMe
C02Bn
Li/MeNH;
(224)
NHZ
C02Bn
Deprotection
(225)
t
(217)
Figure 108: Synthetic plan towards GSA (217)
Glutamic acid (220) was protected as its methyl ester at the y-carboxyl to 
produce (221), using thionyl chloride and methanol in 79% yield. This was then 
treated with benzyl chloroformate and sodium bicarbonate to produce the N- 
Cbz diprotected compound (222) in 77% yield. The final protecting group was 
added by stirring compound (222) in DMF with benzyl bromide for 24 hours. 
The benzyl ester (223) was prepared in 50% yield from compound (222).
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The methyl ester was selectively hydrolysed by stirring compound (223) in 
methanol and 2M sodium hydroxide solution at room temperature. The free 
acid (224) was recovered in 91% yield from (223).
Two reports indicated that the reduction of acids could be accomplished directly 
to aldehydes in the presence of lithium disolved in a liquified amine (either 
methylamine or ethylamine).195,196 The procedure involved the addition of the 
acid to be reduced into a solution of lithium and methylamine at -78 °C. The 
acid under these conditions was reduced to the aldehyde. The initial product 
was found to be an imine, which under the work-up conditions was hydrolysed 
to the aldehyde. The reaction was not thought to progress through the imine 
until a late stage as under the reaction conditions, imines would be reduced to 
amines. Bedenbaugh et a/.196 believed that the reaction involved the formation 
of a carbinolamine salt, which was converted into an imine during the isolation.
Treating compound (224) under the conditions detailed should have provided 
diprotected GSA, after hydrolysis of the imine. Work-up of the reaction, by 
extraction into ether and concentration under reduced pressure left an 
inseparable mixture of products. By NMR spectroscopy no evidence could be 
found for any reduced acid. The reduction was repeated on the f-butyl 
protected ester (228), see figure 109. The same result was obtained and no 
reduced product could be identified from the isolated product mixture.
© © © 
Isobutylene, c. H 2S 04  Cl^   ► —
(221) C 0 2H (226) C 0 2tBu
Benzyl chloroformate, 
N a H C 0 3) EfeO. NaOH
v
H° 2C \ / \ / ' NHZ « NaOH/MeOH M e 0 2C v , ^  ^  ^ N H Z
(228) C 0 2*Bu (227) C 0 2tBu
Figure 109: Preparation of f-butoxyA/-(benzylcarbonylamino)propane-1,3-
dicarboxylate (228)
These results are probably due to the conditions of the reduction and the fact 
that benzyl radicals are easily formed and “stable”. Under the conditions it was 
believed that benzyl radicals would be generated, probably causing the 
destruction of the compound. Another possibility was that the deprotected
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compound would no longer be organic miscible and would therefore not be 
isolated in the work-up.
The failure of the reduction of (224) or (228) to GSA (217) led to a change in 
direction. Glutamic acid (220) was still the precursor, but the plan now was to 
reduce the y-acid group and oxidise it to the aldehyde as seen in figure 110.
ro2c NHZ 1. Borane/THF or Borane/DMS
when R=H OR 2. UBH4 /THF when 
C 0 2Bn R=Me (229)
R=H (224) 
R=Me (223)
(177)
Deprotection
(230)
NHZ
C 0 2Bn
DCC, DMSO, TFA 
Pyridine
C 0 2Bn
Figure 110: Alternative route to GSA (230)
Starting from compound (224) the acid group was to be reduced to the 
corresponding alcohol (229). Boranes are well known to carry out this 
conversion without reducing the other functionality of the molecule.197 Attempts 
with both borane/THF and borane/dimethylsulfide failed to reduce the acid 
(224). The 1H and 13C NMR spectra still showed a signal due to the acid group 
at 8 10.1 in the 1H NMR spectrum and 8 178.1 in the 13C NMR spectrum.
A report by Brown and Narasihnman198 detailed the use of lithium borohydride 
as a reducing agent for carboxylic esters. The paper suggested that when 
lithium borohydride was heated at reflux in THF with compound (223) the 
methyl ester should be reduced about five times quicker than the benzyl ester. 
Upon reaction of (223) with lithium borohydride and isolation of the products, a 
60% yield of the alcohol (229) was achieved. The 1H NMR spectrum showed 
the alcohol CH2 at 8 3.5 and in the 13C NMR spectrum the CH2 was found at 8 
63.6. The NMR spectra also revealed that the benzyl ester had also been 
partially cleaved under the conditions used for reduction. A small amount of 
reduced 8-ester and reduced benzyl ester was also recovered from the reaction 
mixture. It was decide to use the material isolated for the oxidation in an 
attempt to produce N-benzyl GSA.
A selective oxidation method was required that would stop at the aldehyde 
oxidation level and not produce any acidic material by over-oxidation. A
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modification of the Swern oxidation was chosen.199 This method used DCC 
instead of oxalyl chloride to activate DMSO. The mechanism of this reaction 
can be seen in figure 111. DMSO attacks the DCC to form the complex shown 
as (231) in figure 111. This is then attacked by the hydroxyl group of the 
compound being oxidised to form the alkoxysulfonium species (232). Proton 
abstraction then completes the oxidation with dimethylsulfide and 
dicyclohexylurea as by-products.
DCC, DMSO.TFA and
Pyridine
(232)
Figure 111: Oxidation of alcohols to aldehydes using a Swern type
reaction
Oxidation of the isolated alcohol under the conditions outlined above gave a 
51% yield of an oil. The 1H and 13C NMR spectra suggested that the 
compound had cyclised to form a protected 5-hydroxyproline derivative (233).
HO
(233)
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No signal was seen for the expected aldehyde of (233), but a complex multiplet 
at 8 5.5 was seen for the 5-H in the 1 H NMR spectrum. This was probably due 
to the presence of diastereoisomers in the 1H NMR spectrum. The rest of the 
1H and 13C NMR spectra were complicated by the presence of both 
diastereoisomers.
It was clear that this route could not be used to produce GSA for testing with 
DHDPS. Other workers in our group had encountered the same problem of 
cyclisation whilst using various other protecting groups on the nitrogen. The N- 
acetyl protected compound also undergoes cyclisation. It may not be possible 
to produce GSA in a deprotected form to test due to its tendency to exist as the 
cyclic product. The only way may be to produce a protected aldehyde and then 
carry out the deprotection in situ. This may enable the enzyme to bind and 
react before the compound cyclises. Imines or acetals may be required as 
protecting groups for the aldehyde because they can be removed under mild 
conditions and without damaging the enzyme.
5.3 Studies towards the enzymic product of GSA and pyruvate
If GSA (217) does bind to DHDPS and condenses with pyruvic acid (32) a 
seven-membered diene (234) will be formed. This would not be detected at the 
wavelength at which we monitor the assay. The assay is designed to detect the 
formation of the aromatic species dipicolinic acid (33).
What will be described below is a route towards the diene (234) detailing the 
first few stages of the pathway. The rest of the route is suggested for the 
synthesis of the diene (234). It may be that another co-worker will take up the 
synthesis, but the priorities of the group have since moved away from GSA 
(217).
As for the condensation of ASA (23) with pyruvate (32) to form DHPD (27), 
GSA (217) may condense with pyruvate (32) as shown in figure 112. The 
product is now no longer capable of becoming aromatic and the diene (234) 
may be isolated or trapped.
A recent paper by Evans, Holmes and Russell200 detailed the synthesis of 7- 
substituted tetrahydroazepin-2-ones via a Claisen rearrangement. They 
prepared compounds with the structure shown as (235) in figure 113. Their 
starting materials were amino acids.
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c o 2h DHDPS
N = <
C 0 2H
R
O
(217) (32) (234)
Figure 112: Condensation of GSA with pyruvate
R
(235)
>
PN
SePh
V
R
h 2nX c o 2h
Figure 113: Retrosynthetic analysis of 7-substituted tetrahydroazepin-2-
ones
L-Serine (236) was chosen as the starting point for the synthesis of (234), as 
outlined in figure 114. L-Serine (236) was first protected as its N- 
benzyloxycarbonyl derivative (237) using benzyl chloroformate under basic 
conditions. The carbamate was isolated as a solid in 98% yield, and melting 
points confirmed the identity of the compound, with mp 118-119 °C (lit.200 1 17- 
119 °C). The A/-protected amino acid was then treated with thionyl chloride and 
anhydrous methanol to form the methyl ester (238), which was isolated as an 
oil in 97% yield. The diprotected amino acid ester (238) crystallised with time 
and a white solid with a melting point of 39-40 °C (lit.200 38-40 °C) was 
recovered.
Treatment of the diprotected amino acid ester (238) with 2,2-dimethoxypropane 
and PTSA as a catalyst produced an acetonide ester (239) in 81% yield. The 
2,2-dimethoxypropane acts as an acetone equivalent when treated under acidic 
conditions, see figure 115.
1 2 6
” 1H3N ^ CO ©
Benzyl chloroformate 
 ►
NaHC03(aq)/Et20
HO
X SOCI2/MeOH
(236)
ZHN" 'C 0 2h  
(237)
' " XZ H N ^ "^ C 0 2Me
(238)
PTSA/Dean-Stark) 
MeO OMe
DIBAL-H, -78 °C
CHO
(240)
(239)Vinylmagnesium Bromide 
THF, -78 °C
O TBSO
1. PTSA, MeOH
N
Z
2. Imidazole, TBDMSCI
ZHN
(241) (242)HO OH
Figure 114: Towards diene (234)
O M e
PTSA
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ZHN 'OH
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R
ZN .R
Me \
Z H N . R
O'
ZHN
©
R
^  (239)
Figure 115: Formation of the oxazolidine ring system
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The 1 H NMR spectrum of the oxazolidine (239) appeared more complex than 
the assigned structure would indicate, see figure 116. The oxazolidine exists 
at room temperature as a mixture of rotamers.201,202 The two ring methyl 
groups appeared as four separate signals at 8 1.70, 1.64, 1.56 and 1.48, two for 
each methyl group. The height of the signals is proportional to the percentage 
of molecules in that particular rotameric form. There were also two sets of 
peaks for all the signals except the benzene ring; these presumably overlap 
and are not seen as two distinctly separate resonances.
Figure 116: nH NMR spectrum of methyl (4S)-3-benzyloxycarbonyl-2,2- 
dimethyloxazolidine-4-carboxylate (198)
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The reduction of (198) to the aldehyde (240) was achieved in 97% yield using 
DIBAL-H in toluene. The temperature was kept below -78 °C for the duration of 
the reaction and chromatography was required to purify the aldehyde. The 1 H 
and 13C NMR spectra show the aldehyde at 5 9.4 and 9.6 in the 1H spectrum 
and at 6 199.0 in the 13C NMR spectrum. All other signals, except the benzene 
ring, show the effects due to the presence of rotameric isomers.
Attempts to reproduce the Grignard reaction as detailed in the paper of Holmes 
and co-workers200 led to the complete decomposition of the aldehyde (240). 
Careful dropwise addition of vinylmagnesium bromide to a stirred solution of the 
aldehyde was successful in producing compound (241) in a yield of 91%. The 
signals for the alkene hydrogens were found at 8 3.9-4.1 for the alkene CH and 
8 5.7-6.0 for the terminal CH2 group in the 1 H NMR spectrum. The terminal 
alkene CH2 was found at 5 116 and 118 in the 13C NMR spectrum with the 
alkene CH being found amongst the CH signais for the benzene ring carbons at 
5 128-130.
Ring opening of compound (241) produced the mono-protected diol (242). This 
was achieved using a two stage procedure which involved first the removal of 
the oxazolidine ring, and then the protection of the primary alcohol using tert- 
butyl(dimethyl)silyl chloride and imidazole. The reaction was achieved with a 
yield of 57% for the two steps. Time constraints prevented the further 
development of this route towards diene (234). The possible conversion of 
(242) into diene (234) is outlined in figure 117.
5.4 Future work
Compound (242) could be transformed into the tetrahydroazepin-2-one (243) by 
the Claisen rearrangement as shown in figure 113, for the retrosynthetic 
direction. Compound (244) could be prepared by reacting (242) with 
phenylselenenylacetaldehyde diethyl acetal and then oxidative syn-elimination 
to give the diene (244), which on heating should undergo a Claisen 
rearrangement to give the tetrahydroazepin-2-one (243). This could then be 
transformed into the diene (234) by means of the pathway outlined in figure 
117.
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Figure 117: Planned conversion of (242) into (234)
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Chapter Six: Synthesis of Inhibitors of DHDP 
Synthase
A series of compounds of varying structural types was synthesised as potential 
inhibitors of DHDPS. These included a couple of pyruvate analogues and 
some piperidinedicarboxylic acids. Other compounds were aromatic product 
analogues, differing only in their 2,6-substituents. Attempts were also made to 
reduce chelidonic acid to the 4-hydroxytetrahydropyran derivative. Other work 
towards morpholines will be discussed, indicating possible reasons for failure.
6.1 Pyruvate analogues
Pyruvate analogues have been extensively studied by previous co-workers at 
Glasgow. Dr D. Tudor and Dr. S. Connell prepared a large number of pyruvate 
derivatives which were tested against DHDPS. These compounds provided 
both good and poor inhibitors. The bulkier derivatives were reasonably poor 
[e.g. 2,4-DNP derivative (245) did not inhibit DHDPS] but compounds such as 
the ethyl hydrazinoacetate (246) gave 62% inhibition at a concentration of 1 
mM.
N 0 2
y y S
M e02C ^ ^  ^ ^ ^ N 0 2
(245)
In order to complete this area of work a couple of pyruvate analogues (247) and 
(248) were prepared. They were prepared by stirring methyl pyruvate in 
ethanol and then adding either methylhydrazine or 1,1-dimethylhydrazine. 
Compound (247) was isolated in 75% yield and (248) was prepared in 71% 
yield. Confirmation of the formation of these compounds was found in the 13C 
NMR spectra where the C-N double bond was found at 5 130.6 and 144.6 for 
compounds (247) and (248), respectively. Attempts to prepare the 
corresponding derivatives from bromopyruvate were unsuccessful, yielding only 
a complex mixture of organic materials.
.C 0 2Et
MeO 2C
(246)
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6.2 Saturated analogues of DHDP
The product of the condensation of ASA (23) with pyruvate (32), as catalysed 
by DHDPS is L-DHDP (27). It seemed reasonable to assume that fully 
saturated piperidine ring systems might provide potential inhibitors of DHDPS.
Cis- and frans-piperidine-2,6-diacids were prepared by the method of Couper et 
a/.76 and these were then converted into the dimethyl esters to test for activity 
with DHDPS. The cis-diester (249) was prepared by the hydrogenation of 
dimethyl dipicolinate using platinum oxide and formic acid in 94% yield, see 
figure 118. Formation of the A/-methyl dimethyl ester (250) was then carried 
out in 75% yield using formaldehyde, formic acid and sodium bicarbonate.
P t02, h c o 2h
MeO 2C N C 0 2Me MeO 2C C 0 2Me
(249)
H C 0 2H, HCHO, 
N aH C 03
MeO 2C N C 0 2Me
Me
(250)
Figure 118: Formation of cis piperidine-2,6-dicarboxylic acid derivatives
The trans-diesters were prepared from frans-piperidine-2,6-dicarboxylate and 
the corresponding A/-methyl compound. These were obtained from a former 
co-worker Dr. L. Couper. Treatment of these two compounds, see figure 119, 
with acetyl chloride and methanol gave the esters (251) and (252) in 79 and 
69% yields, respectively.
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R
Acetyl chloride/MeOH
C02H M e02C ‘ N C02Me
R=Me (251) 
R=H (252)
Figure 119: Formation of the trans-diesters
Testing of the diesters (249)-(252) along with the pyruvate analogues (247) and 
(248) will be discussed in the next chapter.
6.3 Aromatic analogues of DHDP
The aromatic compound dipicolinic acid (33) was found to be an inhibitor of E. 
coli DHDPS. This led to the synthesis of a number of aromatic species 
designed to be inhibitors of DHDPS. These included the ditetrazole (41), 
diimidate (42), dinitrile (43), A/-oxide (44) and the diamide (254), see figure 
120. These had been prepared previously by Dr. L. Couper but were never 
properly tested.
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MeO 2C N C 0 2Me H2NOC' N CONH2 NC
O©
R=H (44) 
R=Me (253)
(254)
N
(43)
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MeO
N
OMe
©
© N H 2 2CI ® N H 2 
(42)
N .  NH 
N
HN . N 
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N
(41)
Figure 120: Aromatic inhibitors of DHDPS
Dimethyl pyridine-2,6-dicarboxylate A/-oxide (253) was prepared from DPA (33) 
using m-chloroperbenzoic acid in dichloromethane,76 a procedure modified from 
that used by Dr. L. Couper for the preparation of A/-oxides. The compound was 
isolated as a white solid in 78% yield. Mass spectrometry identified the solid as 
the A/-oxide (253) with a peak at m/z 211 corresponding to the molecular ion.
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The other compounds were all prepared from the diamide of pyridine-2,6- 
dicarboxylic acid (254), see figure 121. The diamide was produced by 
quenching the acid chloride, formed on heating pyridine-2,6-dicarboxylic acid at 
reflux with thionyl chloride, with saturated ethereal ammonia. The diamide 
(254) was recovered in 66% yield from DPA (33). A molecular ion peak was 
found in the mass spectrum at m/z 165.
r ^ i
h 2n o c  n c o n h 2
(254)
POCI3 , toluene, A
NC
NaN3 /N H 4 CI/DMR
(41)
.N CN 
(43)
MeOH/HCI(g)
(42)
Figure 121: Synthetic modification of pyridine-2,6-dicarboxamide
Dehydration of the diamide was attempted to produce the dinitrile (43). The 
conditions used were heating at reflux a solution of (254) in toluene with 
phosphorus oxychloride. The reaction went a black colour and after the work­
up a brown solid was obtained. This solid was recrystallised from chloroform 
five times until a white solid was isolated. The overall yield of this procedure 
was 10%. The dinitrile showed a peak at 6 115.5 in the 13C NMR spectrum, 
diagnostic of the formation of the dinitrile. The mass spectrum gave a peak at 
m/z 129 for the molecular ion of the dinitrile.
Reaction of the dinitrile (43) with sodium azide and ammonium chloride at reflux 
produced the ditetrazole (41) in 90% yield. The ditetrazole is presumably 
formed via a 1,3-dipolar cycloaddition of azide onto the nitrile (43). Mass 
spectrometry gave a peak at m/z 215 corresponding to the molecular ion of the 
ditetrazole (41).
The final compound of the series was the diimidate (42), which was produced 
from the dinitrile (43) by reacting with dry hydrogen chloride in the presence of 
anhydrous methanol. On cooling the diimidate (42) crystallised from solution. 
The diimidate (42) was recovered in 10% yield. The 13C NMR spectrum 
showed the methoxy group at 5 54.2 and the mass spectrum showed a 
molecular ion at m/z 196. These compounds were tested with DHDPS and the 
results are presented in chapter seven.
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6.4 Attempted preparation of thiinanes
Due to the moderate inhibition results obtained with the piperidinedicarboxylic 
acids, it was decided to synthesise the corresponding six membered ring 
system with sulfur as the heteroatom. These were to be tested with DHDPS to 
ascertain their effectiveness as inhibitors.
The first attempted cyclic sulfide, or thiinane was based on the cyclisation of 
dimethyl 2,6-dibromopimelate (255) using sodium sulfide, see figure 122. The 
dimethyl 2,6-dibromopimelate (255) was prepared by reacting pimelic acid with 
thionyl chloride and bromine at reflux. The compound was isolated as an oil in 
87% yield. The C-2 and C-6 hydrogens were found as a triplet at 5 4.3 in the 
1H NMR spetrum, with a coupling constant of J 7.7 Hz in the 1H NMR 
spectrum.
1. soci2, a
2. Br2
H 0 2C ‘C 0 2H 3. MeOH M e 0 2C "  \  / ^ C 0 2Me
Br Br
(255)
Na2S, H 20/D M F
M e 0 2C C 0 2Me
(256)
Figure 122: Preparation of (213)
Treatment of (255) with sodium sulfide in DMF gave a 48% yield of the dimethyl 
thiinane-2,6-dicarboxylate (256) as an oil. The C-2 and C-6 hydrogens were 
found at 8 4.0 in the 1H NMR spectrum as a triplet with J 7.7 Hz in the 1H NMR 
spectrum. Mass spectrometry gave a molecular ion peak at m/z 218.
The same process was repeated for 4-oxopimelic acid in an attempt to 
generate the corresponding sulfide with a carbonyl in the 4-position. 4- 
Oxopimelic acid was treated with thionyl chloride, bromine and methanol in an 
attempt to produce dimethyl 2,6-dibromo-4-oxopimelate (257), see figure 123. 
The compound recovered from this reaction was shown by 1 H NMR 
spectrometry not to be compound (257).
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Figure 123: Attempted preparation of dimethyl 2,6-dibromo-4-oxopimelate
6.5 Attempted synthesis of morpholine derivatives
The presence of a hydroxyl group or indeed a heteroatom in the 4-position of 
the pyridine-2,6- or piperidine-2,6-dicarboxylic acids had been shown to 
enhance the inhibition of DHDPS (cf. chelidonic and chelidamic acids). The 
attempted synthesis of substituted morpholines was undertaken to develop 
inhibitors with an oxygen in the 4-position of the ring system.
The initial target was the morpholine with one ester group in the 2-position 
(262). This was to be prepared from L-serine methyl ester (258), see figure 
124. L-Serine methyl ester (258) was treated with terf-butyldimethylsilyl 
chloride and imidazole to produce (259) in 98.5% yield.
TBDMSCI, imidazole
H2IA  C 0 2Me
(258) (259) H20 /E tO H  
O
ZA
TsCI, pyridine
MeO 2 CMeO 2 C
Ts 
; (261)
OH
(260)
t
MeO 2 C
(262)
Figure 124: Attempted synthesis of morpholine derivatives
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Reaction of (259) with ethylene oxide at 0 °C produced varying yields of the 
mono-alkylated compound (260). The highest yield that (260) could be isolated 
in was 85%. The rest of the organic component was made up of di-alkylated 
compounds such as (263) and (264). These could be isolated after 
chromatography in yields of up to 25%. Compound (263) was formed by the 
reaction of the hydroxyl with the methyl ester group to form the lactone. 
Compound (264) was the result of the amine attacking two molecules of 
ethylene oxide.
T B S O ^  OH  T B S O ^
O v  / S .  ✓
N M e 0 2C
(263) (264)
Tosylation of the hydroxyl and nitrogen of compound (260) was carried out 
using tosyl chloride and pyridine. The material isolated from this reaction 
showed no sign of the expected product by NMR analysis. It may be that the 
tosylated nitrogen was still nucleophilic enough to attack the tosylated oxygen 
to give an aziridine which might react further under the reaction conditions. 
Protection of the nitrogen before tosylation of the hydroxyl group may allow the 
isolation of the desired product, this however was not attempted.
6.6 Reduction of Chelidonic acid
Chelidonic (261) and chelidamic acids (as for structure (261) except that the O 
is replaced with NH) had proved to be very good inhibitors of DHDPS. A fellow 
co-worker had undertaken some modifications of chelidamic acid, starting off 
with reduction to the fully saturated compound. These modifications were 
repeated on chelidonic acid.
The reduction of chelidamic acid had been carried out using 5%- 
rhodium/alumina catalyst at a pressure of 10 Bar under an atmosphere of 
hydrogen gas. The reaction took eight hours at 80 °C to reach completion. 
The isolated compound was a 1:1 mixture of the piperidine compound and the 
4-hydroxypiperidine.
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Treatment of chelidonic acid (261) with palladium on carbon under a hydrogen 
atmosphere, reduced the compound to afford a tacky white solid in 50% yield, 
see figure 125. Upon analysis of this solid it was discovered by 13C NMR 
spectroscopy that there was a mixture of compounds. The two compounds 
present differed only in their substitution at the 4-position. Compound (262) 
had a methine signal at 5 66.8 in the 13C NMR spectrum, indicating a hydroxy 
substituent and compound (263) had a methylene signal for C-4 at 8 23.2 in the 
13C NMR spectrum.
Pd/C, H2 or P t0 2/H C 0 2H
H02C ^  O ^ c o 2h 
(263) OH
(261) ho2c ^  o  ^ co 2h 
(262)
Figure 125: Reduction of chelidonic acid
Reduction using platinum oxide with formic acid as the “hydrogen” source also 
led to reduction of chelidonic acid. Again, by NMR spectroscopy, the product 
was identified as a mixture of the 4-hydroxy compound (262) and the 
tetrahydropyran-2,6-dicarboxylate (263). The ratio of (262) to (263) appeared 
to be 1:1 by the 13C NMR spectra for both reduction methods.
To aid the separation of the two compounds, the dimethyl esters were made by 
dissolving compounds (262) and (263) in anhydrous methanol and slowly 
adding thionyl chloride. The diesters were prepared in 84% yield based on the 
1:1 mixture of compounds (262) and (263). Silica gel chromatography enabled 
the separation of (264) and (265), see figure 126.
Compound (264) showed signals at 5 22.7 and 36.9 for the ring CH2 groups in 
the 13C NMR spectrum. Mass spectrometry gave a molecular ion for (264) at 
m/z 202. The corresponding 4-hydroxy compound, after esterification, only 
made up 15% of the isolated mass. The C-4 signal for (264) was found at 5
66.5 in the 13C NMR spectrumO. The CH2 group was found at 5 36.9. Mass 
spectrometry gave a peak at m/z 218, which corresponds to the molecular ion 
of (265).
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Test results for the isolated dimethyl esters will be given in the following 
chapter.
HO2C1
(263)
'O
OH
c o 2h
SOCI2, MeOH
MeO 2C 
^  (264)
Chromatography
O
OH
Figure 126: Esterification of reduced chelidonic acid
C02Me
139
Chapter Seven: Studies with DHDPS and 
Biological Results
7.1 Introduction
DHDPS has been extensively studied by many groups over a number of years. 
A great deal is known about the enzyme's structure and specificity. Our group 
at Glasgow has been searching for novel inhibitors and substrates for DHDPS 
for a number of years.
It was discovered early on that DHDPS was very specific for its natural 
substrates, tolerating very little change in structure or stereochemistry. What 
we hoped to show is evidence that DHDPS allows several pyruvate analogues 
to bind to the enzyme, by means of a Schiff’s base. We have detected these 
analogues bound to the enzyme using electrospray mass spectrometry.
Immobilisation of DHDPS using Eupergit resins was also studied to determine if 
this procedure would confer the stability necessary for multiple experiments 
using DHDPS. At present we throw away quantities of DHDPS when 
undertaking any inhibitor studies or biotransformations. It would therefore be 
ideal to be able to recover and reuse DHDPS time and time again. 
Immobilisation of enzymes is a standard technique for the generation of 
recoverable and reusable enzymes.
Eupergit resins are based on polymer supported epoxide groups. It is attack on 
these groups by nucleophiles, usually free amino groups, on the enzyme that is 
responsible for the immobilisation. DHDPS is known to have a nucleophile 
close to the active site which does not interfere with the activity of the enzyme. 
The presence of this nucleophilic species led us to believe that the 
immobilisation might be a realistic goal. This chapter will present the initial 
results concerning the immobilisation of DHDPS on Eupergit resins.
The biological test results for the compounds prepared in the previous chapters 
will be outlined at the end of the chapter along with some more detailed kinetic 
analysis of a couple of the better inhibitors. A description of how the testing 
was carried out and a standard enzyme assay will also be presented.
At Glasgow we have a genetically modified E. coli strain which we grow to 
provide large quantities of DHDPS. DHDPS isolated is used for biochemical 
testing of potential inhibitors, immobilisation experiments, electrospray mass
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spectrometry and for biotransformation studies. To begin this chapter a brief 
outline of the isolation procedure used to obtain homogeneous samples of 
DHDPS will be presented.
7.2 Isolation of DHDPS from E. coli
DHDPS was isolated from E. coli (MV1190/pDA2) grown in MM63 minimal 
medium supplemented with ampicillin at 30 °C. The purification procedure 
involves three chromatographic steps before the protein is homogeneous. The 
purification procedure used was developed by a former co-worker in 
biochemistry, E. Borthwick.66 This procedure was carried out by myself with the 
aid of Mr. J. Greene of the Universities Biochemistry department.
The cells were grown for 48 hours and were broken open by means of a French 
press at 95 MPa. The isolated material was subjected to centrifugation to 
remove any particulate material. A heat step, at 70 °C was used next and 
removes a number of proteins. The proteins precipitated after the heat step 
and were removed by centrifugation.
The first chromatographic step uses DEAE-Sephacel (an anion exchanging 
resin). The crude enzyme mixture was loaded onto the column and eluted with 
an increasing gradient of potassium chloride (0.1-1.0 M). Fractions of 
approximately 11 ml were collected and assayed to find the fractions containing 
DHDPS activity. These fractions were pooled and concentrated using dialysis. 
Ammonium sulfate was added, to a final concentration of 0.5 M, and the 
enzyme mixture was loaded onto a phenyl-Sepharose column (hydrophobic 
interaction). The column was eluted with a decreasing linear gradient of 
potassium chloride (0.5-0.0 M); again the fractions showing the highest DHDPS 
activity were pooled and concentrated by dialysis. The final purification step 
involved chromatography using a Mono-Q FPLC column (HR 10/10) eluting 
with a two phase gradient of 0.1-0.5 M potassium chloride over twenty minutes. 
This was followed by elution using a gradient of 0.5-1.0 M over a further forty 
minutes. Fractions with DHDPS activity were pooled and concentrated using 
dialysis, and then finally stored in buffer containing 50% glycerol at -20 °C.
The DHDPS recovered from this purification lost no activity when stored at -20 
°C for up to six months. A typical purification table is shown below as table 6. 
Depending on the use of the enzyme required, it may be necessary to remove 
the glycerol from the storage buffer. This is achieved by the use of 
centrifugation in centricons (membrane filtration devices, designed to retain
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proteins but remove molecules below a cut off molecular weight) washing out 
the glycerol with approximately 4 ml of water.
Protein
Step
Volume
(ml)
Cone.
(mg/ml)
Total
(mg)
Activity
(I.U.)
Specific
Activity
(units/mg)
Yield
(%)
Purification
(fold)
Crude
extract
38 31 1180 1240 1.1 100 1.0
Heat step 30 10 300 940 3.1 75 3.0
DEAE-
Sephacel
170 0.43 72 2710 38 218 35
Phenyl- 
Sepharose
192 0.25 48 2110 44 170 42
Mono-Q 35 1.0 35 1820 52 146 49
Table 6: Purification of DHDPS from E. Coli (MV1190/pDA2)
7.3 Electrospray mass spectrometry studies on DHDPS
In chapter two we saw the results of initial studies of DHDPS using electrospray 
mass spectrometry. It was possible to detect the binding of pyruvate (32) via a 
Schiffs base to DHDPS. This was seen as a corresponding increase in mass 
of the detected protein. The mass increase was consistent with one molecule 
of pyruvate being bound per enzyme molecule, see figures 19 and 127. 
Attempts to show the binding of ASA (23) to DHDPS had produced no evidence 
for the formation of a Schiffs base between ASA (23) and the enzyme.
o  c o 2h
NH2 + ll
^ ^ co2h
DHDPS Pyruvate (32) Schiffs base
31,272 88 31,342
Figure 127: binding of pyruvate (32) to DHDPS
We had hoped to extend this early work on the new electrospray mass 
spectrometer jointly owned by Glasgow and Strathclyde Universities. Our initial 
aims were to show the binding of pyruvate and try to obtain evidence for the 
binding of ASA (23).
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We were able to show the binding of pyruvate to DHDPS using the reduced 
Schiffs base as this is a more reliable technique. Attempts to observe the 
Schiffs base directly invariably led to the destruction of the enzyme and very 
messy data from the spectrometer.
Initial studies using the TFA salt of ASA (23) brought no sign of any enzyme 
with ASA (23) bound. The data obtained were very noisy and the experimental 
method was not reliable. It was decided to try to detect any ASA (23) bound as 
a reduced Schiffs base.
A series of experiments were set up using ASA (23) and sodium borohydride to 
enable the reduction of any Schiffs base adduct formed. The first involved 
incubation of three concentrations of ASA (23) (2, 4 and 8 mM) with DHDPS 
and then treatment with sodium borohydride after 20 minutes. Upon 
electrospray mass spectrometry no sign of any bound ASA (23) could be 
detected, the only signal present was that for the native enzyme.
The second set of experiments consisted of the addition of pyruvate (32) to the 
system in case the binding of pyruvate causes a conformational change that 
allows ASA (23) to bind to DHDPS. The same procedure was repeated with 
the three concentrations of ASA (23). The electrospray mass spectra of these 
experiments showed only the reduced Schiffs base with pyruvate.
Our last attempts to detect any covalent binding of ASA (23) involved the 
treatment of DHDPS, with a reduced pyruvate Schiffs base, with ASA (23) at 
the concentrations used above. Again the only product seen in the spectra was 
that of DHDPS with a reduced pyruvate Schiffs base. The results obtained 
using ASA (23) are summarised in table 7.
Method of preparation Concentration of 
ASA (mM)
Mass expected Mass obtained
DHDPS 2, 4 and 8 31,371 31,272
DHDPS and pyruvate 
(16 mM)
2, 4 and 8 31,441 31,342
DHDPS with reduced 
pyruvate
2, 4 and 8 31,441 31,342
Table 7: Summary of results from electrospray mass spectrometry using
ASA (23)
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It may be concluded, but not proven, that ASA (23) does not bind via a Schiffs 
base to DHDPS. If this is indeed the case, it must be held in the active site by 
some other means, such as electrostatic interactions or hydrogen bonding.
Our search for other substrates of DHDPS led us to try some pyruvate 
analogues such as pyruvaldehyde (266) and pyruvamide (267) in our 
electrospray mass spectrometry work.
O
A
R=CHO (266)
R=CONH2 (267)
Both compounds were added to DHDPS and incubated for twenty minutes 
before the addition of sodium borohydride. The reduced compounds were then 
taken and run on the electrospray mass spectrometer. Both compounds gave 
peaks with a corresponding mass increase. The full spectra, including the 
deconvoluted spectra (shown on the right) for pyruvaldehyde are shown in 
figure 128 and the spectra for pyruvamide are shown in figure 129. The 
formation of a Schiffs base between DHDPS and both of these compounds 
would indicate that they may be substrates for DHDPS. Figure 130 shows the 
weights of the adducts formed when the compounds are reduced onto DHDPS. 
The molecular weights are taken from the deconvoluted spectra at the top right. 
The spectra recorded for pyruvaldehyde are about twelve amu out but this can 
be accounted for by partial hydration of the aldehyde. The spectra recorded for 
the reduced Schiffs base formed when using pyruvamide (267) were found to 
be within seven amu of the calculated value. Replacing pyruvate with 
pyruvaldehyde gave rise to an enzymic reaction monitored by uv and shown 
below in figure 131. The rate of reaction was only 2% of that recorded for the 
natural substrate pyruvic acid (32). A fellow co-worker, Dr. P. Mallon is making 
a detailed investigation of these results.
O
( 3 " *  * A
DHDPS Schiffs base
31,272 R -C O N H  2 (267) R=CHO, 31,328
R=C O N H 2i 31,343
Figure 130: Mass increases expected when the reduced Schiff's bases are 
detected by eiectrospray mass spectrometry.
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Figure 128: Electrospray mass spectra for pyruvaldehyde with DHDPS 
(after sodium borohydride treatment)
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Figure 129: Electrospray mass spectra for pyruvamide with DHDPS (after
sodium borohydride treatment)
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Figure 131: Results of an assay using pyruvaldehyde (266) (b) instead of
pyruvate (a)
7.4 Immobilisation of DHDPS on Eupergit resins
The large quantities of DHDPS required for the biological investigations 
undertaken was more than could be supplied from Biochemistry. We therefore 
undertook a series of investigations to decide whether DHDPS could be 
immobilised on a polymer resin to lend long term reusability. The resins that we 
chose for this study were Eupergit C and C250L. These are polymer resins 
with epoxide groups at the termini. The immobilisation relies on a nucleophilic 
species on the enzyme attacking these epoxide groups, see figure 132.
Enz— NH2
O
Eupergit
OH
Eupergit Resin
Polymer cross-linking
Figure 132: Immobilisation of enzymes using Eupergit resins
147
Eupergit C and C250L are co-polymers consisting of methacrylamide, 
allylglycidyl-ether and /V-methylen-bis-methacrylamide. This produces an 
electroneutral polymer which is shaped to become spherical. The major 
difference between Eupergit C and C250L is the average number of epoxide 
groups per bead. Eupergit C has more than 600 terminal epoxide groups per 
bead, whereas Eupergit C250L only has, on average, greater than 250 groups 
per bead.
DHDPS was known to have a nucleophilic species near to the active site (see 
chapter two) and it was hoped that the enzyme could be immobilised with ease. 
The immobilisation procedure would take place at any pH between 1 and 12, 
however it was considered that an enzyme should be immobilised at a pH close 
to its pH of optimal activity. The other major constraint that was perhaps more 
damaging to DHDPS, was the need to immobilise at high ionic strength. The 
procedure called for buffer strengths of approximately 1 M; DHDPS might not 
retain any activity at such high ionic concentrations.
Initial studies using Eupergit C and following the procedure outlined in the 
literature supplied with the resins gave no immobilised enzyme. There were a 
number of probable reasons for this result, including the destruction of DHDPS 
under the conditions of reaction; multiple alkylation of DHDPS preventing 
access to the active site; and alkylation at the active site.
A further study was carried out following the literature procedure but adding 
pyruvate to a final concentration of 5 mM. This produced encouraging results 
with approximately 10% of the DHDPS being immobilised on the resin.
This result prompted a systematic study of the immobilisation of DHDPS on the 
resins. It was decided to study the immobilisation in both the potassium 
phosphate buffer recommended and imidazole (the buffer of choice for the 
activity assays).
The immobilisation experiments were set up as close to the literature procedure 
as possible using either 1 M concentrations of potassium phosphate or 
imidazole as the reaction buffer. An analogous set of experiments was run with 
the addition of pyruvate to a concentration of 5 mM. The results of these 
experiments can be seen in table 8. Reactions were monitored using a 
standard assay procedure for DHDPS. Pyruvate and ASA were added to 100 
mM imidazole buffer and mixed, 20 mg of the wet beads were then added and
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the reaction monitored for one hour, see figure 133 for the assay recorded 
using immobilised enzyme obtained from the potassium phosphate experiment.
Eupergit
Resin
Buffer Pyruvate Final reaction 
rate (Abs/min)
%
immobilised
C 1 M K3 PO4 Yes 0.000627 10.5
C 1 M K3 PO4 No None 0
C 250 L 1 M K3 PO4 Yes 0.00106 18
C 250 L 1 M K3 PO4 No None 0
C 1 M imidazole Yes 0.000483 8.1
C 1 M imidazole No None 0
C 250 L 1 M imidazole Yes 0.000761 11.5
C 250 L 1 M imidazole No None 0
Table 8: Results from immobilisation of DHDPS on Eupergit resins
As the results shown in table 8 indicate, the immobilisation of DHDPS on 
Eupergit resins is not an efficient process. The most interesting feature of the 
table is the fact that pyruvate was required to achieve any functional 
immobilised enzyme. This might indicate a protective role for pyruvate, where it 
is bound in the active site and prevents any destructive alkylation. This 
alkylation might be the result of attack by Lys161 on the epoxide of the Eupergit 
resins.
Samples of the immobilised material were re-run one week later to determine if 
there was any significant degradation in activity. The four samples which 
showed activity in the initial screening were found to give higher reaction rates 
one week later, see table 9 below. This effect was reproducible but we can 
provide no explanation for it. Longer term studies are required to determine 
how long the enzyme will stay active when bound to the beads.
Sample Initial Rate (mAbs/min) Rate at 7 days (mAbs/min)
C (pot. phos.) 0.627 ±0.0017 0.900± 0.0037
C (imidazole) 0.483 ± 0.081 1.140± 0.012
C-250L (pot. phos.) 0.761± 0.014 0.892± 0.0049
C-250L (imidazole) 0.792± 0.058 0.713± 0.013
Table 9: Assay results from a one week old sample of immobilised
DHDPS
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Figure 133: Assay recorded for immobilised DHDPS from potassium
phosphate over 1 hour
The low recovery of immobilised material on the Eupergit beads was a 
disappointment. From these results it may be concluded that the procedure at 
present is not efficient enough to warrant creating large amounts of immobilised 
enzyme. A systematic study of the conditions under which the immobilisation of 
DHDPS is achieved will be required to determine an optimised procedure.
7.5 Test results from inhibition studies with DHDPS
The study of inhibitors of DHDPS was based on the assay system outlined in 
chapter two (see figure 15). We monitored the change in the gradient, 
observed when an inhibitor is present. This chapter will present the test results 
for the compounds prepared in the previous chapters.
It was shown that when DHDPS condenses pyruvate (32) and ASA (23) that 
the diene L-DHDP (27) is produced. If DHDPR is not present, such as in a cell
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free assay system using purified DHDPS, the diene (27) is oxidised to produce 
DPA (33).55
We monitored the production of DPA (33) at 270 nm over the course of 3 
minutes. The standard assay consisted of a total volume of 1 ml, made up of 
150 j l i I  ASA (23), 150 pi pyruvate (32), 500 pi imidazole buffer at pH 7.4, 290 pi 
of water and 10 pi of DHDPS. When an inhibitor was being studied the quantity 
of water added was varied to keep the assay at 1 ml. The inhibitors were 
tested at 1 mM, 0.5 mM and 0.1 mM to obtain a % inhibition at the lowest 
concentration. The results are an average of three runs. We measured the 
inhibition as a percentage of a standard rate as shown in figure 134. 
Significant inhibition was taken to be 10% at 0.5 mM.
Blank (X)
0.5 mM inhibitor (I) 
- 1 . 0  mM inhibitor
Time
% inhibition ^ -x 1 0 0
Figure 134: Testing inhibitors of DHDPS
Below are listed the test results obtained for the compounds prepared in 
chapters three to six. Many of these compounds are racemic and the apparent 
IC50 values measured are not the true values. The same consideration has to 
be kept in mind when one considers the results for the amino acid aldehydes 
produced as these are present mainly as there hydrates. Thus the enzyme 
may only be recognising the small equilibrium concentration of the aldehyde 
leading to lower IC50 values.
Chapter three: ASA derivatives
Inhibitor Concentration
Compound
number
1 mM 0.5 mM 0.1 mM
139 1.5% 0% -
140 0% - -
151
137 3.5% 0% -
138 0.25% - -
129 12% 0% -
130 8% 0% -
148 3% 0% -
146 9.5% 0% -
149 0% - -
179 8% 1.5% 0%
180 5% 0% -
181 6.2% 0.5% 0%
None of the ASA derivatives proved to be effective inhibitors of DHDPS at the 
concentrations tested. Compound (179) was found to be an effective inhibitor 
at higher concentrations (40% at 5 mM). One of the better inhibition figures 
was recorded for the A/-formyl ASA analogue (146) showing 9% at 1 mM. The 
p-methylated compound (179) was found to be a substrate of DHDPS in place 
of ASA. The rate recorded was only 15% of that found with ASA. The product 
of this reaction will need to be isolated and characterised.
Chapter four: Isoxazolines
Inhibitor Concentration
Compound
number
1 mM 0.5 mM
197 8% 0%
198 12% 1.5%
199 11% 0%
200 5% 0%
201 1.5% 0%
202 3% 0%
203 0% -
207 0% -
208 0% -
212 0% -
214 7% 0%
215 9% 0%
216 5% 0%
152
None of the isoxazolines showed better than 12% inhibition at a concentration 
of 0.5 mM. The ring opened isoxazolines also gave poor figure for inhibition of 
DHDPS, with none of compounds (175)-1 (77) showing any inhibition at 
concentrations lower than 1 mM.
Chapter five: Glutamic acid y-semialdehyde analogues
Inhibitor Concentration
Compound
number
1 mM 0.5 mM 0.1 mM
221 5% 0% -
228 0% - -
239 3% 0% -
240 15% 1% 0%
242 2.5% 0% -
As was perhaps expected, the glutamic acid derivatives (221) and (228) were 
very poor inhibitors of DHDPS with low inhibition values even at very high 
concentrations. Compound (240) showed the best inhibition values of the 
group tested. However this is still very poor when compared to the best 
inhibitors that have been found.
Chapter six: Aromatic analogues and pyruvate derivatives
Inhibitor Concentration
Compound number 1 mM 0.5 mM 0.1 mM
247 40% 5% 0%
248 100% 100% 43%
249 0% - -
250 0% - -
251 0% - -
252 0% - -
253 100% 59% 27%
254 35% 0% -
41 100% 60% 25%
42 100% 64% 32%
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43 100% 51% 8%
44 100% 68% 31%
All of the aromatic compounds showed good inhibition against DHDPS with the 
diimidate (42), dinitrile (43), the A/-oxide (44), the diamide (254), /V-oxide diester 
(253) and the ditetrazole (41) being the most potent discovered. The two 
pyruvate derivatives (247) and (248) also exhibited good inhibition values 
against DHDPS. The saturated piperidine analogues proved to be poor 
inhibitors, this may be due to incorrect geometry of the ring. The rest of the 
compounds also exhibited poor inhibition when tested with DHDPS.
7.6 Determination of the type of inhibition using (43) and (44)
Some detailed kinetic evidence was required to determine how the inhibitors 
were affecting DHDPS. Pyridine-2,6-dicarboxylic acid A/-oxide (44) and the 
pyridine-2,6-dinitrile (43) were used as a representative sample of the aromatic 
inhibitors. Both were tested with DHDPS to determine the type of inhibition 
they exhibit.
To determine the type of inhibition it was necessary to keep one of the 
substrates at a high saturating concentration while the other substrate was 
varied through a range of values. This procedure was repeated three times 
with a different concentration of inhibitor present. The procedure was then 
repeated keeping the second substrate at a high saturating concentration while 
the other is varied as above.
For our studies on DHDPS this required either pyruvate (32) or ASA (23) to be 
held at a fixed concentration of 5 mM (about 10 times the Km value) while the 
other was varied through a series of decreasing concentrations (from 5xKm 
down to 0.5xKm)- The concentrations of inhibitor chosen were 0.04, 0.08 and 
0.16 mM.
The data obtained from each run were plotted as a Lineweaver-Burk plot and 
the line was extrapolated until it cut the X-axis. Once all the lines were plotted 
and extrapolated the point of intersection of the three lines indicated the type of 
inhibition (particular to the substrate being varied).
If the lines in the Lineweaver-Burk plots intersect on the Y-axis this is indicative 
of competitive inhibition of the compound under study with the substrate in 
question. However, if the lines never meet and remain parallel, this is an
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indication that the compound is an un-competitive inhibitor with respect to the 
substrate in question. Finally if the lines intersect on the X-axis this is taken as 
an indication that the compound under study is non-competitive with that 
substrate, 203,204 see figure 135.
1/V
1/S
Competitive Inhibition
1/V
1/S
Non-competitive Inhibition
The lines on the double recipriocal plots 
represent the reaction rates with differing 
concentrations of inhibitors.
1/S *
Un-competitive Inhibition 
Figure 135: Types of inhibition as visualised by Lineweaver-Burk plots
The data obtained when the study of (43) and (44) was carried out led to the 
conclusion that both of the aromatic inhibitors were non-competitive inhibitors, 
see figure 136 for the Lineweaver-Burk plot for compound (43) obtained when 
varying the pyruvate concentration (initially plotted by hand and then by 
computer using Cricket graph III, using the best-fit line function to generate the 
regression lines). The other plots are similar with the lines intersecting on the 
X-axis. Both compounds then appear to be non-competitive inhibitors with 
respect to both substrates. This means that compounds (43) and (44) are 
competing for a common site in the enzyme with pyruvate and ASA. This is 
probably the site in which l-DHDP (27) is held until released from the enzyme.
The Lineweaver-Burk plots allowed the determination of Kj values for both of 
the compounds under investigation. The Kj values for (43) were 0.34 mM 
against pyruvate (32) and 1.25 mM against ASA (23). The Kj values for (44) 
were 0.29 mM against ASA (23) and 0.06 mM against pyruvate (32).
Another of the more potent inhibitors that had been found was chelidonic acid 
(261). Determination of the type of inhibition shown by chelidonic acid (261)
1/V
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against DHDPS was attempted. The same procedure as above was 
implemented, but the data obtained were unreliable due to the high absorption 
of the assay cocktail. The data were however good enough to determine an 
1C50 value of 0.69 mM for chelidonic acid (261). Attempts to improve the data 
obtained (using smaller path length cuvette or narrowing the slit width on the 
spectrometer) proved to be useless.
Graph of 1/V against 1/[pyr] for increasing concentrations 
of pyridine-2,6-dicarboxylic acid A/-oxide
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Figure 136: Lineweaver-Burk plot for the inhibition of DHDPS by (43) 
obtained by the variation of the pyruvate concentration
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Chapter Eight: Experimental
8.1: General Notes
All melting points were measured with a Gallenkamp melting point apparatus 
and are uncorrected. Infra red spectra were recorded on a Philips analytical 
PU9800 FTIR spectrometer. Nuclear magnetic resonance spectra were 
recorded on a Perkin-Elmer R32 or a EM390 operating at 90 MHz and then on 
a Bruker AM200 SY or WP200 SY operating at 200 MHz (5h) or 50 MHz (5q) 
or a Bruker AM360 SY operating at 360 MHz (8 h ) or 90 MHz ( 8 q ). Lo w  
resolution mass spectra were determined using a VG updated A. E. I. MS 
spectrometer and high resolution mass spectra were determined using a VG 
updated MS 902 spectrometer.
Analytical TLC was carried out using Merck silica gel 60 F254 aluminium backed 
plates of 0.25 mm thickness. Compounds were visualised using UV light or by 
staining using vanillin solution, with heat development. Column 
chromatography was carried out using Merck silica gel 60 eluting with ethyl 
acetate/hexane mixtures unless otherwise stated.
All solvents and reagents were of analytical grade unless otherwise stated. 
Aqueous solutions were freeze dried using a Christ Alpha 1-4 freeze drier. All 
organic solvents were dried using standard purification and drying techniques, 
as detailed in Perrin and Armarego. 205
Numbering of compounds is used to aid the identification of peaks in the 13C 
and 1H NMR spectra.
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7.2: Experimental Detail for Chapter Three
DL-Allylalvcine f-Butvl Ester Hydrochloride (124)70
$ h 3 Cl®
The title compound was prepared using a modified version of the procedure 
utilised by Tudor etal.70 To a vigorously stirred suspension of DL-allylglycine (5 
g, 43.48 mmol) in dry dichloromethane ( 1 0 0  ml) at -78 C, was added dropwise 
via a dry-ice condenser, 2-methylpropene (30 ml). To the suspension was 
added concentrated sulfuric acid (4 ml). The suspension was then stirred for a 
further 8  h at -78 C and then allowed to warm to room temperature overnight. 
The pH of the resulting clear solution was adjusted to pH 9 using saturated 
sodium carbonate solution. The organic layer was separated and washed with 
brine (2 x 50 mi), dried with sodium sulfate, filtered and concentrated in vacuo 
to leave a yellow oil. The oil was then cooled to 0 C in an ice/water bath. With 
stirring, ethereal HCI (100 ml) was added and a white solid precipitated. The 
solid was collected by filtration under vacuum to yield 8.0 g (90% yield); mp 
115-117 C (lit. 70 115-117 C); x> max (KBr disc) 2980, 2880, 1735, 1570, 1500,
cm'1; Sh (200 MHz) (DzO) 1.32 (9H, s, 7,8 and 9 H), 2.54 (2 H, dd, 3-H2), 3.94 
(1H, dd, 2-H), 5.15 (2H, m, 5-H2), 5.60 (1 H, m, 4-H); 8q  (50 MHz) (D2 0) 28.3 
(C-7, 8  and 9), 35.4 (C-3), 53.8 (C-2), 86.9 (C-6 ), 122.7 (C-5), 131,2 (C-4) and
169.6 (C-1); m/z 130, 70 (1 0 0 %), 57, 43 and 41 (Found M+ , 172.1338; C, 
52.08; H, 8.78; N, 6.73. C9 H18N 02 requires M+, 172.1338; C, 52.05; H,
8.78; N, 6.75%).
DL-AAf-Butoxvcarbonvlallvlalvcine f-Butvl Ester 1125170
To a stirred solution of (124) (3.0 g, 14.4 mmol) in dioxane/water (1:2, 100 ml) 
was added sodium bicarbonate (2.42 g, 2 equiv.) and di-t-butyldicarbonate (3.3 
ml, 1 equiv.). The mixture was stirred at room temperature for 24 h and then 
the solvent was removed in vacuo. The resulting residue was partitioned 
between ethyl acetate (50 ml) and water (50 ml). The organic layer was 
separated and the aqueous layer was further extracted with ethyl acetate (2x50 
ml). The combined organic extracts were dried (Na2 S0 4 ), filtered and 
concentrated in vacuo to leave a pale yellow oil, 3.8g (98% yield); o)max 
(CHCI3) 3425, 2980, 1710, 1495 c rrr t; 5H (200 MHz) (CDCI3 ) 1.41 (18H, br s,
7-, 8 -, 9-, 12-, 13-, U -H 3 ), 2.45 (2 H, m, 3-H2), 4.20 (1H, m, 2-H), 5.06 (3H, m, 
5-H2 and NH) and 5.67 (1H, m, 4-H); 5q (50 MHz) (CDCI3 ) 27.9 (C-7, 8 and 9),
28.3 (C-1 2 , 13 and 14), 36.8 (C-3), 53.2 (C-2 ), 79.5 and 81.5 (C-6  and 1 1 ),
118.7 (C-5) 132.5 (C-4), 155.1 (C-10) and 171.1 (C-1); m/z 230, 170, 130, 114, 
70, 57 (1 0 0 %) and 41 (found: C, 61.95; H, 9.01; N, 5.25. C14H25NO4 requires 
C, 61.91; H, 9.21; N, 5.16%).
PL-AAf-Butoxvcarbonvlaspartic acid ft-semialdehyde f-Butvl Ester (126)70
HN o
.0
General procedure 1
A solution of compound (125) (1.0 g, 4.82 mmol) in anhydrous dichloromethane 
(50 ml) was cooled to -78 C (acetone/dry-ice bath). Ozone was then bubbled 
through the solution at -78 C until a blue colour persisted for 30 min. Excess 
ozone was removed by bubbling nitrogen through the reaction mixture. The 
ozonide formed during the reaction was decomposed reductively using 
triethylamine (9.64 mmol) at -78 C with stirring. The solution was allowed to 
warm up slowly overnight to room temperature. Dichloromethane was removed 
under reduced pressure to leave a light yellow oil which was purified using a 
silica column eluting with ethyl acetate/hexane. This left a pale yellow oil, 0.82 
g (74% yield), •omax (CHCI3 ) 3425, 2980, 1710 and 1495 cm-1; 8 h (2 0 0  MHz) 
(CDCI3) 1.44 (18H, br s, 6 -, 7-, 8 -, 1 1-, 1 2 - and 13-H3), 2.98 (2 H, m, 3 -H2), 4.48
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(1H, m, 2-H), 5.40 (1 H, br d, NH) and 9.74 (1H, s, 4-H); 5q (50 MHz) (CDCI3)
27.9 (C-6,7 and 8 ), 28.3 (C-11, 1 2  and 13), 36.8 (C-3), 46.3 (C-2 ), 80.0 and
82.6 (C-5 and -1 0 ), 155.3 (C-9), 169.9 (C-1) and 199.4 (C-4); m/z 172, 118, 72, 
57 (100%) and 41 (found: C, 56.95; H, 8.32; N, 5.20. C 13H23N0 5  requires C, 
57.07; H, 8.41; N, 5.12%).
Potassium Sait of DL-AZ-f-Butoxycarbonylalivlalycine (127) 70
2^Co9 K®
To a solution of DL-allylglycine (5.0 g, 43.4 mmol) in water (50 ml) was added 
dioxan (50 ml), potassium bicarbonate (4.78 g, 1.1 equiv.) and di-t-butyl 
dicarbonate (9.98 ml, 1.0 equiv.). The mixture was stirred at room temperature 
for 18 h. The solvents were removed under reduced pressure to leave a white 
solid, 9.11g (83% yield); Dmax (KBr disc) 3360, 2985, 1675, 1590 and 1530 
cm’1; §h (200 MHz) (D20) 1.27 (9H, s, 9-, 10- and 11-H3), 2.25 (2H, m, 3-H2), 
2.77 (1H, m, 2-H), 4.98 (2H, m, 5-H2) and 5.61 (1H, m, 4-H); 5q (50 MHz) 
(D20) 28.6 (C-8 , -9 and -1 0 ), 37.3 (C-3), 56.6 (C-2 ), 81.9 (C-7), 118.9 (C-5),
134.8 (C-4), 166.5 (C-6 ) and 180.2 (C-1); m/z 214 (MH+-K, 0.3%), 112, 57 
(100%) and 41.
DL-A/T-Butoxycarbonylallylglycine p-Methoxybenzyl Ester (128)70
OMe
OHN
.0
8
O
To a solution of (127) (8.1 g, 31.9 mmol) in dimethylformamide (DMF) (25 ml) 
was added 4-methoxybenzyl chloride (4.64 ml, 1.0 equiv.) with continuous 
stirring for 48 h. DMF was removed with xylene in vacuo and the resultant
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residue was partitioned between dichloromethane (50 ml) and aqueous sodium 
bicarbonate solution (60 ml). The organic extract was further washed with 
water (4x50 ml), dried (MgS04) and the solvent removed' under reduced
pressure to leave a yellow oil. Purification on a silica column eluting with ethyl 
acetate/hexane gave a clear oil, 1 0 .2  g (95% yield); i)max (CHCI3) 3440, 3020, 
2985, 1720, 1710, 1620, 1515 and 1500 cm '1; 5h (200 MHz) (CDCI3) 1.43 (9H, 
s, 16-, 17 and 18-H3), 2.50 (2H, dd, 3-H2), 3.79 (3H, s, 13-H3), 4.39 (1H, m, 2- 
H), 5.10 (5H, m, 5-H2 and 6 -H2), 5.67 (1 H, m, 4-H), 6.89 (2 H, d, JQ Hz, 9- and
11-H), 7.30 (2H, d, JQ Hz, 8 - and 12-H); 8 q  (50 MHz) (CDCI3) 28.3 (C-16, 17
and 18), 36.7 (C-3), 53.0 (C-2), 55.2 (C-13), 66.9 (C-6 ), 79.7 (C-15), 113.7 (C- 
7), 113.9 (C-8  and 12), 119.1 (C-5), 127.4 (C-1 1 ), 130.2 (C-9 and 1 1 ), 132.2 (C- 
4), 159.9 (C-14) and 171.9 (C-1); m/z335 (M+, 1.0%), 279, 170, 121(100%), 70 
and 57 (found : M+, 335.1720. C18H25NO5 requires M+, 335.1730).
DL-/V-f-Butoxycarbonvlaspartic Acid p-semialdehyde p-Methoxvbenzyl Ester70
14 OMe
’OHN
•O
7
O
A solution of (128) (9.98 g, 29.75 mmol) was ozonized as per general 
procedure 1. Triethylamine (2 equiv.) was added and the solution was allowed 
to warm up to room temperature and was stirred overnight. The solution was 
then concentrated in  vacuo and purification was achieved by column 
chromatography to give a light yellow oil, 9.2g (92% yield); umax (CHCI3 ) 3430, 
3030, 2980, 1735,1690, 1620 and 1500 cm-1; 8 h (200 MHz) (CDCI3 ) 3.81 (3H, 
s, I 2 -H3 ), 4.60 (1H, br m, 2 -H), 5.11 (2H, s, 3-H2), 5.42 (1 H, br d, NH), 6.89 
(2 H, d, J8 Hz, 8  and 10-H), 7.27 (2H, s, J 8  Hz, 7 and 11 -H) and 9.7 (1 H, s, 4- 
H); 5c (50 MHz) (CDCI3 ) 28.2 (C-15, 16 and 17), 46.0 (C-3), 48.8 (C-2 ), 55.2
(C-12), 67.4 (C-5), 80.2 (C-14), 113.9 (C-7 and 11), 115.1 (C-6 ), 128.7 (C-9),
130.2 (C-8  and 1 0 ), 160.0 (C-13), 171.2 (C-1) and 199.5 (C-4); m/z 337 (M+, 
0.5%), 281, 2 0 2 , 137, 121 (100%), 72 and 57 (found M+ , 337.1526. 
C17H23NO6 requires M+, 337.1519).
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Trifluoroacetate salt of DL-Aspartic Acid ft-Semialdehvde Hydrate 123)70
OH
HO COOH
A solution of (126) (750 mg, 2.22 mmol) in trifluoroacetic acid (4 ml) and 
anhydrous dichloromethane (5 ml) was prepared in a flame dried flask under a 
dry nitrogen atmosphere. This was stirred at 0 C for 2 h. The solvent was 
then removed in vacuo to give an oily residue. This was partitioned between 
ethyl acetate (5 ml) and water (5 ml). The water layer was further washed with 
ethyl acetate (3 x5  ml). Removal of the water in vacuo gave a yellow solid, 264 
mg (48% yield), mp 63-65 C (lit. 70 63-65 C); vmax (KBr disc) 3420 (broad), 
2925, 1675 and 1645 crrr1;SH (2 0 0  MHz) (D20) 1.98 (2 H, m, 3-H2), 3.82 (1 H, 
dd, 2 H) and 5.10 (1H, t, 4-H); 5C (50 MHz) (D2 0) 37.8 (C-3), 51.9 (C-2), 89.2 
(C-4) and 173.9 (C-1).; m/z (MH + , 137.0445. C4 H11NO4 requires MH + 
137.0450).
A/-(Diphenvlmethvlene1-2-amino-2-(2-propenyh-4-Pentenonitrile (132)
To a vigorously stirred bi-phasic mixture of A/-(diphenylmethylene)aminoaceto- 
nitrile (5.0 g, 22.73 mmol.), benzyltriethylammonium chloride (0.5 g), 50% 
aqueous sodium hydroxide solution (20 ml) and toluene (15 ml) at 0 C was 
added dropwise, via a syringe pump, allyl bromide (4.12 g, 1.5 equiv.). The 
reaction turned a deep red/black colour. The reaction was stirred at 0 C for a 
further 1 h and was then allowed to warm up to room temperature overnight. 
The reaction mixture was poured into dichloromethane (50 ml) and the organic 
layer was separated and kept. The aqueous layer was extracted with 
dichloromethane (2x30 ml) and combined with the previous organic extracts. 
The organic extracts were dried (Na2 S0 4 ), filtered and concentrated in vacuo to 
leave a yellow oil, which when purified (silica gel column) gave a clear oil, which 
solidified with time, 4.4 g (65% yield); 'Umax (CHCI3 ) 3050, 2257, 1637 and
CN Ph
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1607; 5H (2 0 0  MHz) (CDCI3 ) 2.7 (4H, 3-H2), 5.2 (4H, m, 5-H2), 5.7-6.0 (2 H, m,
4-H) and 7.1-7.6 (10H, m, aromatic protons); 5q  (50 MHz) (CDCI3 ) 45.9 (C-3),
61.7 (C-2), 119.1 (C-1), 120.3 (C-5), 128.6 (C-4), 168.2 (C-6 ) and 128.0, 128.2,
129.4, 129.6, 130.6, 131.7, 135.2 and 139.9 (aromatic carbons); m/z 300 (M+, 
11.8%), 259, 233, 217, 192, 165, 130, 104 and 77 (100%) (found: M+ , 
300.3960. C21H20N2 requires M+, 300.3955).
/V-(Diphenylmethvlene1-2-amino-propanoitrile (1331 
1
CN Ph
N Ph
To a vigorously stirred bi-phasic mixture of A/-(diphenylmethylene)aminoaceto 
nitrile (5.0 g, 22.73 mmol.), benzyltriethylammonium chloride (0.5 g), 50% 
aqueous sodium hydroxide solution (20 ml) and toluene (15 ml) at 0 C was 
added dropwise, via a syringe pump, iodomethane (4.84 g, 1.5 equiv.). The 
reaction turned a deep red/black colour instantaneously. The reaction was 
stirred at 0 C for a further 1 h then allowed to warm up to room temperature 
overnight. The reaction mixture was then poured into dichloromethane (50 ml) 
and the organic layer was separated. The aqueous layer was extracted with 
dichloromethane (2x30 ml) and combined with the previous organic extracts. 
The organic extracts were dried (Na2 S0 4 ), filtered and concentrated in vacuo to 
leave a yellow oil, which when purified (silica gel column) gave a yellow oil, 4.8 
g (90% yield); umax 3020, 2930, 2230, 1610 and 1500 (CHCI3) cm '1; 8 h (200
MHz) (CDCI3 ) 1.5 (3H, d, J 6.7 Hz, 3-H3), 4.4-4.5 (1H, q, J 6.7 Hz, 2-H), 7.1-7.8 
(1 0 H, m, aromatic protons); 8 q (50 MHz) (CDCI3 ) 2 1 .0  (C-3), 48.2 (C-2 ), 120.4
(C-1), 127.3, 128.2, 128.69, 128.9, 129.4, 129.7, 130.1 (aromatic carbons),
172.3 (C-4); m/z 234 (M+, 31.8%), 218, 207, 180, 165, 105, 77 (100%) and 51 
(found: M+, 234.2950. C16H 14N2 requires M+, 234.2954).
A/-(Diphenylmethylene1-2-amino-4-pentenonitrile (131)
To a vigorously stirred bi-phasic mixture of A/-(diphenylmethylene)aminoaceto- 
nitrile (5.0 g, 22.73 mmol.), benzyltriethylammonium chloride (0.5 g), 25% 
aqueous sodium hydroxide solution (20 ml) and toluene (15 ml) at 0 C was 
added dropwise, via a syringe pump, ally! bromide (4.12 g, 1.5 equiv.). The 
reaction turned a deep red/black colour. The reaction was stirred at 0 C for a 
further 1 h and then allowed to warm up to room temperature overnight. The 
reaction mixture was then poured into dichloromethane (50 ml) and the organic 
layer was separated. The aqueous layer was extracted with dichloromethane 
(2x30 ml) and combined with the previous organic extracts. The organic 
extracts were dried (Na2S0 4 ), filtered and concentrated in vacuo to leave a 
yellow oil, which when purified (silica gel column) gave a clear yellowish oil, 5.4 
g (91.4% yield); umax 3080, 3015, 2235, 1605 and 1515 (CHCI3); 5h (200
MHz) (CDCI3 ) 2.5-2,7 (2H, m, 3-H2), 4.3 (1H, t, J 6.75 Hz, 2-H), 5.1-5.3 (2 H, m,
5-H2), 5.6-5.9 (1H, m, 4-H), 7.1-7.8 (1 0 H, m, aromatic protons); 5q  (50 MHz)
(CDCI3 ) 39.1 (C-3), 53.0 (C-2 ), 119.2 (C-1 ), 119.6 (C-5), 129 (C-4), 125.2,
127.4, 128.2, 129.4, 131.2, 131.9, 135.1 and 138.3 (aromatic carbons), 173.1 
(C-6 ); m/z 260 (M+, 8.4%), 219, 165,116 (100%) and 77 (found: M+, 260.1303. 
C18H16N2 requires M+, 260.1310).
A/-(Diphenvlmethylene)-2-amino-2-methyl-4-pentenonitrile (135)
CN Ph
N ^ R ,
Method 1
To a solution of (131) (1 g, 3.85 mmol.) in acetonitrile (15 ml) was added finely 
powdered potassium hydroxide (1.05 equiv.). The suspension was stirred 
vigorously and cooled to 0  C before iodomethane was added dropwise, via a 
syringe pump, over 1 h. The reaction was allowed to warm up to room 
temperature over a period of 3 h. Addition of water (25 ml) and ethyl acetate 
(25 ml) was followed by separation of the organic layer and further extraction of 
the aqueous layer with ethyl acetate (2x25 ml). The organic layers were 
combined, dried (MgS0 4 ), filtered and concentrated in vacuo to leave a pale 
yellow oil, 950 mg (89.5% yield) which was starting material by 1 H NMR 
spectroscopy.
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Method 2
To a flame dried flask, under a dry nitrogen atmosphere, was added 
diisopropylamine (0.8 g, 2.1 equiv.) in anhydrous tetrahydrofuran (10 ml). This 
solution was cooled to -2 0  C (acetone/dry ice bath) and butyllithium (0.51 g,
2.1 equiv.) was added dropwise over a period of 10 min. The solution was 
stirred at -2 0  C for a further 2 0  min before being cooled to -78 C and (131) 
(1.0 g, 3.85 mmol) was added dropwise over 15 min. The solution was stirred 
for a further 30 min before iodomethane (1.15 g, 2.1 equiv.) was added to 
quench the anion. The mixture was allowed to warm up to room temp over a 
period of 1 h, and then poured into a saturated solution of ammonium chloride 
and then diluted with ether (40 ml). The organic layer was separated and the 
aqueous layer was extracted with ether (2x30 ml). The combined organic 
extracts were dried (MgS0 4 ), filtered and concentrated in vacuo. The 
remaining yellow oil was purified by column chromatography, to leave a pale 
yellow oil, 0.90 g (85% yield); a)max 3090, 2950, 2230, 1595 and 1510 (CHCI3); 
5h (200 MHz) (CDCI3 ) 1.64 (3H, s, 6 -H3 ), 2.57-2.83 (2H, m, 3-H2), 5.20-5.29
(2 H, m, 5 -H2 ), 5.81-6.02 (1H, m, 5-H) and 7.14-7.61 (10H, m, aromatic 
protons); 5c (50 MHz) (CDCI3 ) 28.4 (C-6 ), 48.4 (C-3), 57.3 (C-2 ), 1 2 0 .1 1  (C-1 ),
120.16 (C-5), 128.1 (C-4), 128.4, 128.5, 129.5, 130.6,132.2,135.2,139.9 
(aromatic carbons) and 168.3 (C-7); m/z 274 (M+, 10.7%), 233, 180, 165, 130 
(1 0 0 %), 103 and 77 (found: M+, 274.1476. C i9H 18N2 requires M+ 274.1466).
The procedure above could be used to generate compound (135), starting from 
compound (133). The reaction was carried out using allyl bromide as the 
electrophile, and the product was isolated as an oil. The isolated yellow oil was 
purified by column chromatography, to leave a pale yellow oil, 0.9 g (77% 
yield); analysis as above.
Method 3
2-Amino-2-methyl-4-pentenonitrile (1391
CN
165
To a mixture of 2 M HCI (10 ml) and ether (15 ml) was added (135) (1.0 g, 3.65 
mmol). The solution was stirred vigorously for 2 h before the organic layer was 
separated and discarded. The aqueous layer was then adjusted to pH 9 with 
saturated sodium carbonate solution. The aqueous layer was extracted with 
ethyl acetate (2x25 ml). The combined organic extracts were dried (MgSCU), 
filtered and concentrated in vacuo to leave a yellow oil 0.3 g (75% yield); \)max
(CHCI3) 3080, 2920 and 2240 cm '1; 5h (2 0 0  MHz) (CDCI3) 1.69 (3 H, s, 6 -H3 ), 
2 .6-3.0 (2 H, m, 3-H2), 5.4 (2H, m, 5-H2), 5.8-6.0 (1H, m, 4-H); Sq (50 MHz) 
(CDCI3 ) 22.67 (C-6 ), 41.9 (C-3), 61.1 (C-2 ), 1 2 2 .2  (C-1), 123.9 (C-5) and 130.6 
(C-4); m /z  110 (M+ , 14.5%), 95, 84, 69 (100%), 55 and 41 (found: M+, 
110.0845. CgHioN2 requires M+, 110.0842).
2-Amino-2-methvl-4-pentenoic Acid Hydrochloride (1371
1
COOH
The aminonitrile (139) (713 mg, 6.48 mmol) was stirred in a solution of 4M 
sodium hydroxide (15 ml) at reflux for 18 h. The solution was allowed to cool to 
room temperature and was washed with ethyl acetate (15 ml) to remove any 
organic contaminant. The solution was then acidified to pH 1 using 2M HCI 
solution. The aqueous layer was again washed with ethyl acetate (15 ml) and 
was then partially concentrated in vacuo to leave approximately 2  ml of 
suspended amino acid. The amino acid suspension was then freeze dried 
overnight to leave a white solid which contained the amino acid and 
contaminating sodium chloride; Umax (KBr disc) 3430, 2990, 2500, 1734, 1636
cm '1; 8 h (200 MHz) (D20) 2.15 (3H, s, 6 -H3 ), 2.3-2.6 (2 H, m, 3-H2), 5.1-5.2 
(2 H, m, 5-H2) and 5.6-5.8 (1H, m, 4-H); 8c  (50 MHz) (D20) 22.8 (C-6 ), 42.2 (C-
3), 61.9 (C-2), 122.7 (C-5), 131.2 (C-4) and 175.0 (C-1), m/z 129 (M+, 0.8%), 
114, 8 8 , 6 8  and 42 (100%) (found: M+ , 129.0771. C eH nN 0 2 requires 
129.0787).
A/-(Diphenylmethvlene1-2-amino-2-ethyl-4-pentenonitrile (136)
To a flame dried flask, under a dry nitrogen atmosphere, was added 
diisopropylamine (0.80 g, 2.1 equiv.) in anhydrous tetrahydrofuran (10 ml). This 
solution was cooled to -2 0  C (acetone/dry ice bath) and butyllithium (0.51 g,
2.1 equiv.) was added dropwise over a period of 10 min. The solution was
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stirred at -2 0  C for a further 2 0  min before being cooled to -78 C and (131) 
(1.0 g, 3.85 mmol) was added dropwise over 15 min. The solution was then 
stirred for a further 30 min before ethyl iodide (0.90 g, 1.5 equiv.) was added to 
quench the anion. After allowing the solution to warm to room temp over a 
period of 1 h, the contents of the flask were poured into a saturated solution of 
ammonium chloride and diluted with ether (40 ml). The organic layer was 
separated and the aqueous layer was extracted with ether (2x30 ml). The 
combined organic extracts were dried (MgSCU), filtered and concentrated in 
vacuo. The remaining yellow oil was purified by column chromatography, to 
leave a pale yellow oil, 0.98 g (88.5% yield);
Ph
(CHCI3) 3065, 2253, 1610 and 1506 cm"1; 8 h (2 0 0  MHz) (CDCI3)
3H, t, J 7.4 Hz, 7 -H3 ), 1.90-2.15 (2 H, m, 6 -H2), 2.59-2.78 (2H, m, 3-H2), 5.17- 
5.26 (2H, m, 5-H2), 5.77-5.98 (1H, m, 4-H) and 7.19-7.61 (10H, m, aromatic 
protons); 5c (50 MHz) (CDCI3 ) 9.13 (C-7), 35.0 (C-6 ), 46.0 (C-3), 62.3 (C-2 ),
119.4 (C-1 ), 120.1 (C-5), 127.4-139.9 (C-4 and aromatic carbons) and 168.0 
(C-8 ); m/z 288 (M+, 10.4%), 261, 247 (100%), 219, 165, 144, 116, 91 and 77 
(found M+, 288.1620. C20H20N2 requires M+, 288.1622).
2-Amino-2-ethvl-4-pentenonitrile (140)
n h 2
CN
To a mixture of 2 M HCI (10 ml) and ether (15 ml) was added (136) (1.0 g, 3.47 
mmol). The solution was stirred vigorously for 2 h before the organic layer was 
separated and discarded. The aqueous layer was then adjusted to pH 9 with 
saturated sodium carbonate solution. The aqueous layer was extracted with 
ethyl acetate (2x25 ml). The combined organic extracts were dried (MgS0 4 ), 
filtered and concentrated in vacuo to leave, after chromatography, an orange oil
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0.367 g (85% yield); 8h (200 MHz) (CDCI3) 1.1 (3H, t, J 7.4 Hz, 7-H3), 1.5-1.8
(2H, m, J 7.3 Hz, 6 -H2), 2.2-2.6 (2 H, m, 3-H2), 5.2-5.4 (2 H, m, 5-H2) and 5.8-
6.0 (1 H, m, 4-H); 8c  (50 MHz) (CDCI3 ) 8.4 (C-7), 33.1 (C-6 ), 43.8 (C-3), 53.5
(C-2), 121.3 (C-5), 123.1 (C-1) and 131.2 (C-4); m/z 124 (M+, 2.4%), 98, 9 7 , 84 
(1 0 0 %), 6 8  and 41 (found: M+, 124.1009. C7 H i2N2 requires M+, 124.0998).
2-Amino-2-ethvl-4-pentenoic Acid (1381
1
COOH
The aminonitrile (140) (720 mg, 5.81 mmol) was heated and stirred in a solution 
of 4M sodium hydroxide (15 ml) at reflux for 18 h. The solution was allowed to 
cool to room temperature and was washed with ethyl acetate (15 ml) to remove 
any organic contaminant. The solution was then acidified to pH 1 using 2M HCI 
solution. The aqueous layer was washed with ethyl acetate (15 ml) and was 
then partially concentrated in vacuo to leave approximatly 2  ml of suspended 
amino acid. The amino acid suspension was then freeze dried overnight to 
leave a white solid which contained the amino acid and contaminating sodium 
chloride; Umax (KBr disc) 3400, 3010, 2530, 1705, 1625 cm '1; 8h (200 MHz)
(D20 ) 0.75 (3H, t, J 7.6 Hz, 7H3), 1.6-1.9 (2H, m, 6 H2), 2.3-2.6 (2H, m, 3 H2), 
5.0-5.2 (2H, m, 5H2) and 5.4-5.7 (1H, m, 4H); 8q  (50 MHz) (D2 0) 8.3 (C-7),
29.5 (C-6 ), 40.5 (C-3), 65.0 (C-2 ), 123.4 (C-5), 130.5 (C-4) and 174.5 (C-1); m/z 
143 (M+, 0.7%), 114, 102, 99 and 42 (100%) (found: M+, 134.1810. C7 H i3N02 
requires M+, 134.1798).
Attempted Preparation of A/-t-Butoxycarbonvl-2-amino-2-methvl-4-pentenoic
Acid
Method 1
To a solution of (137) (1.0 g, 5.57 mmol) in water (50 ml) was added dioxan (50 
ml), potassium bicarbonate (612 mg, 1.1 equiv.) and di-t-butyl dicarbonate (1.3 
g, 1.1 equiv.). The mixture was stirred at room temperature for 18 h. The 
solvents were removed under reduced pressure to leave a white solid. Upon 
analysis the solid proved to be starting material.
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1
COOH O 9
0
Method 2
To a solution of (137) (250 mg, 1.51 mmol) in dioxan/water (1 :1 , 30 ml) was 
added triethylamine (229 mg, 1.5 equiv.) with continuous stirring at room 
temperature. Addition of BOC-ON (409 mg, 1.1 eqiuv.) was carried out slowly 
over 5 min. The solution was stirred overnight at room temperature. Water (10 
ml) was added and the mixture was washed with ethyl acetate (2x20 ml). The 
aqueous layer was then concentrated in vacuo until the volume was 
aproximately 1 ml and it was then transferred to a freeze drier. A white solid 
was isolated from the freeze drier which upon analysis proved to be starting 
material.
Method 3
To a solution of (137) (1.0 g, 6.0 mmol) in dry acetonitrile (10 ml) was added 4- 
dimethylaminopyridine (50 mg, 0.40 mmol) and di-t-butyldicarbonate (1.45 g,
1.1 equiv.). The mixture was stirred at room temperature for 18 h. The 
resulting brownish mixture was concentrated in vacuo at room temperature and 
the oily residue was partitioned between ethyl acetate (15 ml) and 1M KHSO4 
solution (15 ml). The organic portion was discarded and the pH of the aqueous 
layer was adjusted to 2 using 3M HCI solution. The aqueous layer was then 
extracted with ethyl acetate (2x15 ml). The organic extracts were dried, filtered 
and concentrated in vacuo to leave no product. Concentration of the aqueous 
layer gave a residue which by NMR spectroscopy showed only the unmodified 
amino acid to be present.
The three proceedures outlined above were carried out on the a-ethyl analogue 
(138) and the same results were obtained, that is no A/-BOC amino acid was 
isolated.
Attempted Preparation of Methyl 2-amino-2-methyl-4-Pentenoate Hydrochloride
Into a suspension of (137) (300 mg, 1.81 mmol) in anhydrous methanol (15 ml) 
was bubbled anhydrous hydrochloric acid gas at 0  C until the solid had 
dissolved. The flask was then stoppered and allowed to stand at room
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temperature for 2  h. The solution was cooled to 0 C and ether (150 ml) was 
added and the mixture was stirred until a solid precipitated. The solid was 
analysed by NMR spectroscopy and was found to be the HCI salt of the amino 
acid (analysis as for compound 137).
A/-f-Butoxvcarbonyl-2-methvlallylglycine f-Butyl Ester (1411
14
15
To a solution of diisopropylamine (0.79 g, 2.1 equiv.) in anhydrous 
tetrahydrofuran (THF) (10 ml) at -20 C was added butyllithium (0.5 g, 2.1 
equiv.), dropwise over a period of 15 min. This solution was stirred for a further 
30 min at -2 0  C before the temperature was reduced to -78 C and the solution 
was diluted with anhydrous THF (35 ml). A/-f-Butoxycarbonylallylglycine f-butyl 
ester (125) (1.0 g, 3.7 mmol) in anhydrous THF (25 ml) was added dropwise to 
the reaction over a period of 10 min. The solution turned a yellowish colour and 
was stirred at -78 C for 20 min to allow complete generation of the anion, 
lodomethane (0.79 g, 1.5 equiv.) was then added to quench the anion and the 
solution was allowed to warm up to room temperature. The reaction mixture 
was heated at 40 C (water bath) overnight. Once cooled to room temperature 
the reaction was poured into saturated ammonium chloride solution (2 0  ml) 
and ether (30 ml) was added. The organic layer was separated and the 
aqueous layer was extracted with ether (2x25 ml). The organic extracts were 
combined, dried (Na2S0 4 ), filtered and concentrated in vacuo to give the title 
compound as a light yellow oil. Chromatographic purification produced a clear 
oil, 0.9g (85.6% yield); Dm a x  (CHCI3) 3050, 2910, 1740, 1710 and 1385 cm '1; 
5h (200 MHz) (CDCI3 ) 1 .4-1.6  (21H, 3xs, 6-,9-,10-,11-,13-,14- and 15-H3), 2.4-
2.9 (2 H, m, 3 H2), 5.0-5.2 (2H, m, 5H2), 5.3 (1 H, brs, NH), 5.6-5.8 (1H, m, 4H);
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5q (50 MHz) (CDCI3 ) 23.2 (C-6 ), 22.7 and 28.2 (C-9,10,11,13,14 and 15), 41.0 
(C-3), 59.0 (C-2 ), 81.4 (C-8  and 1 2 ), 118.8 (C-5), 132.6 (C-4), 154.1 (C-7) and
173.0 (C-1); m/z 285 (M+, 1.2%), 270, 244, 229, 228, 171, 156, 115 and 57 
(100%) (found: M+, 285.3720. C15H27NO4 requires M+, 285.3713).
A/-t-Butoxvcarbonyl-2-methylaspartic Acid ft -semialdehyde t-Butyl Ester (1441
HN
O
A solution of (141) (0.5 g, 1.75 mmol) was ozonized according to general 
procedure 1 . To the stirred blue solution at -78 C was added triethylamine 
(0.35 g, 2 equiv.) and the solution was allowed to warm up to room temperature 
and was stirred overnight. The solution was then concentrated in vacuo and 
purification of the residue was achieved by column chromatography to give a 
light yellow oil, 0.4 g (80% yield); 'Upnax (CHCI3 ) 2920, 1740, 1710 and 1390 
cm'1; 8 h (2 0 0  MHz) (CDCI3) 1.4-1.6  (2 1 H, 3xs, 5-, 7-, 8 -, 9-, 1 2 -, 13- and 14- 
H3), 2.9 (2H, m, 3-H2), 5.6 (1H, brs, NH) and 9.7 (1H, brs, 4-H); 5c (50 MHz), 
(CDCI3 ) 22.51 (C-5), 26.0 and 26.6 (C-7, 8 , 9, 1 2 , 13 and 14), 47.6 (C-3), 55.0 
(C-2 ), 80.7 (C-6  and 11), 152.6 (C-1 0 ), 170.6 (C-1) and 198.1 (C-4); m/z 287 
(M+, 2.6%), 272, 259, 202, 198, 144, 109, 57 (100%) and 41 (found: M+ , 
286.3450. C14H25NO5 requires M+, 287.3448).
Trifluoro acetate salt of g-methyl aspartic acid ft -semialdehyde (1291
OH
HO
Compound (144) (100 mg, 0.35 mmol) was dissolved in anhydrous 
dichloromethane (5  ml) and stirred in a flame dried flask under a dry nitrogen 
atmosphere at 0  C. To this solution was added trifluoroacetic acid (2  ml) and 
the reaction was stirred for a further 2 h. Once the solvent had been removed
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the title compound was isolated as a hygroscopic yellow solid, 38 mg (41% 
yield); vmax (CHCI3 ) 3385 (broad), 3015 and 1718 cm'1; Sh (200 MHz) (D2 0) 
1.45 (3H, s, 5 -H3 ), 3.2 (2H, m, 3-H2), 4.9 (1H, t, 4-H); 8 c (50 MHz) (D2 0 ) 23.2 
(C-5), 52.1 (C-3), 57.5 (C-2 ), 95.1 (C-4), 175.4 (C-1 ); m /z 150 (M+, 0 .1%), 
(found: M+, 150.0770. CsHi2 N0 4  requires M+, 150.0763).
A/-t-Butoxvcarbonvl-2-ethylallylalvcine t-Butvl Ester (1421
O
To a solution of diisopropylamine (0.79 g, 2.1 equiv.) in anhydrous 
tetrahydrofuran (THF) (10 ml) at -20 C was added butyllithium (0.5 g, 2.1 
equiv.), dropwise over a period of 15 min. This solution was stirred for a further 
30 min at -2 0  C before the temperature was reduced to -78 C and the solution 
was diluted with anhydrous THF (35 ml). A/-t-Butoxycarbonylallylglycine t-butyl 
ester (125) (1.0 g, 3.7 mmol) in anhydrous THF (25 ml) was prepared and was 
added dropwise to the reaction over a period of 10 min. The solution turned a 
yellowish colour and was stirred at -78 C for 20 min to allow complete 
generation of the anion. Ethyl iodide (0.87 g, 1 .5 equiv.) was then added to 
quench the anion and the solution was allowed to warm up to room 
temperature. The reaction was heated at 40 C (water bath) overnight. After 
cooling the reaction mixture was poured into saturated ammonium chloride 
solution (20 ml) and diluted with ether (30 ml). Separation of the organic layer 
and further extraction of the aqueous layer with ether (2x25 ml) gave the 
organic extracts which were combined, dried (Na2 S0 4 ), filtered and 
concentrated in vacuo to give the title compound as a light yellow oil. 
Chromatographic purification produced a colourless oil, 0.83g (75% yield); 
Vmax (CHCI3) 3065, 2930, 1745, 1700 and 1390 cm'1; Sh ( 2 0 0  MHz) (CDCI3)
1.1 (3 H, t, J Hz, 7-H3), 1.4 (18H, 2xs, 9-, 10-, 11 -, 13-, 14- and 15-H3), 1.45-1.6  
(2H, m, 6 -H2), 2.3-2.6 (2 H, m, 3-H2), 5.1-5.3 (2H, m, 5-H2), 5.4 (1 H, brs, NH) 
and 5.6-6.7 (1H, m, 4-H), 5q (50 MHz) (CDCI3 ) 8 .6  (C-7), 24.2 (C-6 ), 28.6 and
29.8 (C-9, 1 0 , 1 1 , 14, 15 and 16), 41.2 (C-3), 61.3 (C-2 ), 80.6 (C-8  and 13),
123.9 (C-5), 132.3 (C-4), 155.4 (C-12) and 174.9 (C-1), m/z 301 (M+, 5.4%),
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272, 244, 215, 212, 187, 158, 123 and 57 (100%) (found: M+ , 301.3825. 
C15H27NO5 requires M+, 301.3819).
/V-f-Butoxvcarbonyl-2-ethvlaspartic Acid ft-semialdehvde f-Butvl Ester f1451
A solution of (142) (0.5 g, 1.67 mmol) was ozonized according to general 
procedure 1 . Triethylamine (0.34 g, 2  equiv.) was added and the solution was 
allowed to warm up to room temperature and was stirred overnight. The 
solution was then concentrated in vacuo and purification was achieved by 
column chromatography to give a light yellow oil, 0.39 g (77% yield); t>max
(CHCI3 ) 2940, 1740, 1735, 1715 and 1390 cm '1, 5h (2 0 0  MHz) (CDCI3) 1.0 
(3H, t, J 8.5 Hz, 6 -H3 ), 1.5 (18H, 2xs, 8 -, 9-, 10-, 12-, 13- and 14-H3), 1.5-1.6  
(2 H, m, 5-H2), 2.7-2.9 (2 H, m, 3-H2), 5.4 (1 H, brs, NH) and 9.75 (1H, s, 4-H), 
5c (50 MHz) (CDCI3 ) 9.2 (C-6 ), 24.2 (C-5), 28.6 and 29.8 (C-8 , 9, 1 0 , 13, 14
and 15), 41.2 (C-3), 61.3 (C-2 ), 80.6 (C-7 and 1 2 ), 155.4 (C-11) ,174.9 (C-1 ), 
and 201.4 (C-4), m/z 301 (M+’ 1.9%), 272, 260, 244, 231, 212, 155, 123, 57 
(100%) and 41 (found: M+, 301.3712. C15H27NO5 requires M+ 301.3708).
Trifluoro acetate salt of g-ethyl aspartic acid p-semialdehyde (130)
Compound (145) (100 mg, 0.33 mmol) was dissolved in anhydrous 
dichloromethane (5 ml) and deprotected as for compound (23) to leave the title 
compound was isolated as a hygroscopic yellow solid, 35 mg (38% yield); Umax 
(CHCI3) 3450, 3005 and 1712 cm’1; 8 h (200 MHz) (D2 0) 1.10 (3H, t, J7.9 Hz,
6
6
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6 -H3), 1.65 (2H, m, 5-H2), 3.24 (2 H, m, 3-H2) and 5.23 (1H, m, 4-H); 5q (50 
MHz) (D20) 10.5 (C-6 ), 25.4 (C-5), 49.8 (C-3), 60.8 (C-2), 98.3 (C-4) and 176.6 
(C-1); m/z 164 (M+, 0.4%) (found: M+ , 164.0925. C6 H14N 0 4 requires M+, 
164.0919).
Attempted preparation of /V-FButoxvcarbonyl-2-hvdroxymethvlallylalvcine t-
Butyl Ester (143)
NHBOC
HO
To a solution of diisopropylamine (0.53 ml, 2.1 equiv.) in anhydrous 
tetrahydrofuran (THF) (1 0  ml) at -2 0  C was added butyllithium (2.53 ml, 2.1  
equiv.), dropwise over a period of 15 min. This solution was stirred for a further 
30 min at -20 C before the temperature was reduced to -78 C and the solution 
was diluted with anhydrous THF (35 ml). A/-t-Butoxycarbonylallylglycine f-butyl 
ester (125) (0.5 g, 1.85 mmol) in anhydrous THF (25 ml) was prepared and 
added dropwise to the reaction over a period of 10 min. The solution turned a 
yellowish colour and was stirred at -78 C for 2 0  min to allow complete 
generation of the anion. Paraformaldehyde (0 .2 0  g, 4.0 equiv.) was then added 
to quench the anion and the solution was allowed to warm up to room 
temperature. The mixture was heated at 40 C (water bath) overnight. Once 
cooled to room temperature the mixture was poured into saturated ammonium 
chloride solution (20 ml) and was diluted with ether (30 ml). Separation of the 
organic layer and further extraction of the aqueous layer with ether (2x25 ml) 
yielded the organic extracts which once combined, dried (Na2 S0 4 ), filtered and 
concentrated in vacuo gave the starting material.
/V-Formylallvlalvcine f-Butvl Ester (1471
Dicyclohexylcarbodiimide (2.86 g, 2 equiv.) was added to a solution of formic 
acid (0.89 g, 4 equiv.) in dichloromethane (15 ml) at 0  C with stirring for 15 
min. A cooled solution of (124) (1.0 g, 4.82 mmol) and A/-methylmorpholine 
(0 .9 7  g, 2  equiv.) in dichloromethane (1 0  ml) was added and the resultant 
mixture was stirred in a water bath for 20 h. The reaction mixture was washed 
with 5 % aqueous citric acid solution (2 x2 0  ml), aqueous sodium bicarbonate 
solution (2x15 ml) and brine (2x20 ml). The organic layer was dried (Na2SC>4 ),
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filtered and removal of the solvent in vacuo gave a clear oil, 0.91 g (95% yield);
Umax (CHCI3 ) 3405, 3010, 1725, 1685 and 1490 cm '1; 5h ( 2 0 0  MHz) (CDCI3)
1.5 (9H, s, 7-, 8 - and 9-H3), 2.5 (2H, m, 3-H2), 4.7 (1H, dd, 2-H), 5.1 (2H, m, 5- 
H2), 5.7 (1 H, m, 4-H), 6 .6  (1H, brs, NH) and 8 .2  (1 H, d, 1 0 -H); 5c (50 MHz)
(CDCI3 ) 27.8 (C-7, -8  and -9 ), 36.5 (C-3), 50.6 (C-2 ), 82.3 (C-6 ), 118.9 (C-5),
131.9 (C-4), 160.5 (C-1 0 ) and 170.3 (C-1); m/z 199 (M+, 0 .1%), 158, 143, 126, 
98, 70 and 57 (1 0 0 %) (found: M+, 199.1202. C 10H17NO3 requires M+, 
199.1208).
A/-Formylaspartic Acid ft-semialdehyde f-Butyl Ester (1481
A solution of compound (147) (900 mg, 4.6 mmol) was saturated with ozone 
according to general procedure 1. Triethylamine (1.87 g, 2 equiv.) was added 
with stirring and the solution was allowed to warm up to room temperature 
overnight. Removal of the solvent in vacuo followed by silica gel flash 
chromatography gave the product as a clear oil, 0.68 g (75% yield); Umax
(CHCI3) 3415, 3025, 2985, 1735, 1685 and 1500 cm '1; 5h (200 MHz) (CDCI3)
1.44 (9H, s, 6 -, 7- and 8 -H3 ), 3.08 (2H, dd, 3-H2), 4.75 (1H, dd, 2-H), 6.58 (1H, 
brs, NH), 8.17 (1 H, s, 9-H) and 9.7 (1H, s, 4-H), 5c (50 MHz) (CDCI3 ) 27.8 (C-
6 , -7 and -8 ), 45.7 (C-3), 46.7 (C-2 ), 83.3 (C-5), 160.6 (C-9), 169.1 (C-1) and
199.1 (C-4); m/z 172 (M+ - CHO), 158,128, 100, 72, 57 (100%) and 41.
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/V-Formvlaspartic Acid [3-semialdehyde Hydrate (146)
1
HO COOH O
Compound (148) (100 mg, 0.5 mmol) was dissolved in anhydrous 
dichloromethane (5 ml) and stirred in a flame dried flask under a dry nitrogen 
atmosphere at 0 C. To this solution was added trifluoroacetic acid (2 ml) and 
the reaction was stirred for a further 2  h. Once the solvent had been removed 
the title compound was isolated as a yellow oil, 75 mg (92% yield); Umax 
(CHCI3) 3420 (broad), 2920, 1770, 1725, 1665 and 1520 cm '1; 8 h (200 MHz)
(CHCI3) 1 .7 (2 H, m, 3-H2), 4.2 (1H, m, 2-H), 4.7 (1 H, m, 4-H) and 7.7 (1 H, s, 5- 
H), 8q  (50 MHz) (CDCI3 ) 38.9 (C-3), 49.3 (C-2), 8 8 .8  (C-4), 164.9 (C-5) and
175.5 (C-1 ); m/z 163 (M+, 0.8%), 144, 135, 119, 118, 44 and 28 (100%) (found: 
M+, 163.0488. C5 H9 NO5 requires M+, 163.0481).
A/-f-Butoxvcarbonvlalvcine (1611 164
1
c o 2h
o
To a solution of glycine (10 g, 133.3 mmol) in water/dioxane mixture (200 ml, 
1 :1 ) was added potassium bicarbonate (16.0 g, 1 .2  equiv.) and di-f- 
butyldicarbonate (29 g, 1.1 equiv.). The resulting suspension was stirred for 12 
h then the mixture was washed with ether (75 ml). The aqueous layer was 
adjusted to pH 2 with 2M HCI solution. The aqueous layer was then extracted 
with ethyl acetate (2x70 ml). The organic extracts were dried (Na2 S0 4 ), filtered 
and the solvent removed under reduced pressure to leave an off-white solid, 23 
g (98% yield); m.p. 88-89 C (lit. , 163 m.p 87-88 C); 8 h (360 MHz) (CDCI3) 1.45
(9 H, s, 5-, 6 - and 7-H3) 3.9 (2H, d, J5.5 Hz, 2-H2), 5.3 (1H, brs, NH) and 11.3 
(1 H, brs, C 0 2 H); 8 q  (90 MHz) (CDCI3 ) 28.2 (C-5, -6  and -7), 42.1 (C-2 ), 80.4
(C-4), 156.0 (C-3) and 174.6 (C-1); m/z 174 (M+-H, 0.1%), 130, 74 and 57 
(100%) (found: M+-H, 174.1720. C7 H12N04 requires M+-H 174.1712).
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/V-t-Butoxvcarbonylalanine (1621165
C 0 2H o 6
2
7
To a solution of alanine (5 g, 56.1 mmol) in water/dioxane mixture (150 ml, 1:1) 
was added potassium bicarbonate (6.7 g, 1.2 equiv.) and di-f-butyldicarbonate 
(13.5 g, 1.1 equiv.). The resulting suspension was stirred for 12 h before the 
mixture was washed with ether (60 ml). The pH of the aqueous layer was 
adjusted to 2 with 2M HCI solution. The aqueous layer was then extracted with 
ethyl acetate (2x50 ml). The organic extracts were dried (Na2S0 4 ), filtered and 
the solvent removed under reduced pressure to leave an off-white solid, 10.0 g 
(95% yield); m.p. 79-81 C (lit.,164 m.p. 80-82 C); 5h (200 MHz) (CDCI3) 1.3
(3H, d, J 6.5 Hz, 3 -H3 ), 1.45 (9H, s, 6-, 7- and 8 -H3 ) 4.1 (1H, m, 2-H), 5.6 (1H, 
brs, NH) and 11.0 (1H, brs, C 02H); 8q (50 MHz) (CDC«3) 18.4 (C-3), 29.4 (C-6,
-7 and -8), 48.9 (C-2), 80.6 (C-5), 160.9 (C-4) and 175.5 (C-1); m/z 188 (M+-H, 
0.3%), 173, 143, 88 and 57 (100%) (found: M+-H, 188.0925. C8H14N 04 
requires M+-H 188.0919).
General Procedure 2
A mixture of frans-crotyl alcohol (6.5 ml, 18.6 mmol), /V-f-butoxycarbonylglycine 
(3.25 g, 18.6 mmol), dicyclohexylcarbodiimide (3.8 g, 18.6 mmol) and a 
catalytic amount of 4-(dimethylamino)pyridine (100 mg) in anhydrous ether (30 
ml) was stirred at room temperature for 18 h. After removal of the precipitated 
dicyclohexylurea by filtration, the solution was washed with saturated sodium 
bicarbonate solution (2x10 ml), dried (MgS04), filtered and concentrated at 
reduced pressure. The crude oil was purified by silica gel chromatography to 
leave a colourless oil, 3.4 g (80% yield); Dmax (CHCI3 ) 3490, 3000, 1720 and 
1500 cm"1; 8h (200 MHz) (CDCI3) 1.4 (9H, s, 5-, 6- and 7-H3), 1.7 (3H, dd, J
(B-2-Butenyl AZ-ff-butoxycarbonvhamino-acetate (1561
O 5
.6
O
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6.3, 1.25 Hz, H -H 3), 3.88 (2 H, brd, J 5.7 Hz, 2-H2), 4.55 (2 H, brd, J 6.4 Hz, 8 - 
H2), 5.3 (1 H, brt, J 5.3 Hz, NH) and 5.7 (2H, m, 9- and 10-H); Sq (50 MHz)
(CDCI3 ) 17.4 (C-11), 28.0 (C-5, -6  and -7), 42.1 (C-2 ), 65.5 (C-8 ), 79.4 (C-4), 
124.3 (C-10), 131.6 (C-9 ), 155.5 (C-3) and 169.9 (C-1); m /z  174 (M- 
CH2 CH=CH(Me), 0.5%), 130, 74, 57 (100%) and 41 (found: M- 
CH2 CH=CH(Me), 174.1715. C 7 H12N04  requires M, 174.1711).
(Fl-2-Butenvl A/-r(f-butoxvcarbonvlamino1proDionate (1651
The title compound was prepared using general procedure 2 with the following 
reagents: frans-crotyl alcohol (1.34 g, 7.1 mmol), /V-f-butoxycarbonylalanine 
(3.15 g, 7.1 mmol), dicyclohexylcarbodiimide (3.71g, 7.1 mmol) and 4- 
(dimethylamino)pyridine (10 mg). The product was isolated as a clear oil, 1 .2  g 
(70% yield); umax (CHCI3 ) 3450, 3000, 1740 and 1500 cm '1; Sh (2 0 0  MHz) 
(CDCI3 ) 1.36 (3H, d, J7.2 Hz, 3 -H3), 1.42 (9 H, s, 6 -, 7- and 8 -H3 ), 1.7 (3 H, M ,J
6.3, 1.15 Hz, 1 2 -H3 ), 4.3 (1H, brt, 2 -H), 4.6 (2 H, d, J 6.3 Hz, 9H2) and 5.6 (2 H, 
m, 1 0 - and 11-H); Sq (50 MHz) (CDCI3 ) 17.3 (C-12), 17.9 (C-3), 27.8 (C-6 , -7
and -8 ), 48.9 (C-2), 65.4 (C-9), 79.1 (C-5), 124.3 (C-10), 131.1 (C-11), 154.8 
(C-4) and 172.8 (C-1); m/z 188 (M-CH2CH=CH(CH3), 0.3%), 174, 144, 87, 57 
(100%), 55 and 41 (found; M-CH2CH=CH(CH3), 188.1965. C8 H i4 N 0 4 requires 
M-CH2 CH=CH(CH3), 188.1971).
2-(3-Methyhbutenyl /\Mf-butoxycarbonylamino)acetate (166)
The title compound was prepared using general procedure 2 with the following 
reagents: 3 -m ethyl-2-buten-1-o l (1.4 ml, 14.29 m mol), A/-f-
butoxycarbonylglycine (2.5 g, 14.29 mmol), dicylohexylcarbodiimide (2.9 g, 
14.29 mmol) and 4-(dimethylamino)pyridine (10 mg). The product was isolated 
as a clear oil, 2.43 g (70% yield); Umax (CHCI3 ) 3320, 2975, 1680, 1490 cm *^;
178
Sh (200 MHz) (CDCI3 ) 1.45 (9H, s, 5-, 6 - and 7-H3), 1.75 (6 H, 6, J 8.7 Hz, 1 1 -
and I 2 -H3 ), 4.0 (2 H, d, J6.1 Hz, 2-H2), 4.5 (2H, brd, J6.5 Hz, 8 -H2), 5.5 (1H, 
brt, J 5.8 Hz, NH) and 5.7 (1 H, m, 9-H); 5q  (50MHz) (CDCI3 ) 17.9 (C-12), 22.6
(C-1 1 ), 28.9 (C-5, -6  and -7), 41.9 (C-2 ), 64.8 (C-8 ), 80.1 (C-4 ), 118.6 (C-9 ),
138.9 (C-10), 154.5 (C-3) and 174.2 (C-1); m/z 188 (M-CH=CMe2, 1 .1%), 187, 
130, 74, 69 and 57 (1 0 0 %) (found: M-CH=CMe2, 188.1980. C8 H14N 04 
requires M-CH=CMe2, 188.1971).
2-(3-Methvl)butenvl AAff-butoxvcarbonylaminolpropionate (1671
3
O
The title compound was prepared using general procedure 2 with the following 
reagents: 3-methyl-2-buten-1-ol (2.1 ml, 21.16 mmol), AA(f-butoxy- 
carbonyi)alanine (4.0 g, 21.16 mmol), dicylohexylcarbodiimide (4.4 g, 21.16 
mmol) and 4-(dimethylamino)pyridine (20 mg). The product was isolated as a 
clear golden oil, 3.41 g (62% yield); Umax (CHCI3 ) 3450, 3000, 1740, 1660 cm" 
1; §h ( 2 0 0  MHz) (CDCI3 ) 1.4 (3H, d, J 7.2 Hz, 3-H3), 1.5 (9H, s, 6 -, 7- and 8 -
H3), 1.75 (6 H, d, J 8.9 Hz, 11-and 12-H3), 4.3 (1H, brt, J 7.2 Hz, 2-H), 4.7 (2H, 
d, J 7.2 Hz, 9-H2) and 5.35 (1H, m, 10-H); 5c  (50 MHz) (CDCI3 ) 17.8 (C-13);
18.4 (C-3), 25.5 (C-1 2 ), 28.0 (C-6 , -7 and -8 ), 49.1 (C-2 ), 61.9 (C-9), 79.4 (C-5),
118.1 (C-10), 139.2 (C-11 ), 155.1 (C-4) and 173.2 (C-1 ); m /z  201 (M+- 
CH=CMe2, 3.3%), 144, 8 8 , 69 and 57 (100%) (found M+-CH=CMe2 201.1001. 
C9 H15NO4. requires M+-CH=CMe2 201.0997).
3-Methyl- A/Tf-butoxycarbonylaminol-4-pentenoic Acid (1571163
General Procedure 3
Into a flame dried 3-necked round-bottomed flask, under a dry nitrogen 
atmosphere, equipped with a condensor and a suba-seal, was placed a solution 
of diisopropylamine (0.95 g, 9.39 mmol) in anhydrous THF (10 ml) at 0 C. To 
this was added, dropwise over 10 min, 1.6M n-butyllithium in hexanes (0.6 g, 
9.39 mmol). After 10 min the solution was cooled to -78 C (acetone/dry-ice 
bath) and compound (156) (1.0 g, 4.37 mmol) in anhydrous THF (5 ml) was 
added over about 60 s. Stirring was continued at -78 C for 10 min and then
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trimethylsilyl chloride (1.1 g, 9.39 mmol) was added and the solution was stirred 
for a further 5 min before being allowed to warm up to room temperature over a 
period of 15 min. The mixture was then heated at reflux for 1 h, cooled, and 
diluted with methanol (1 0  ml), to hydrolyse the silyl ethers, and stirred for 5  min. 
The solution was diluted with ether (25 ml) and extracted with 2M sodium 
hydroxide solution (4x5 ml). The combined aqueous extracts were then 
acidified to pH 1 with 3M HCI solution and extracted with chloroform (3x10 ml). 
The organic extracts were dried (MgS0 4 ), filtered and concentrated at reduced 
pressure to produce 0 .6 8  g (6 8  % yield) of the rearranged product as a mixture 
of diastereomers;
1
COOH
'11
t>max (CHCI3) 3300, 2975, 1780 and 1600 cm '1; 5h (2 0 0  MHz) (CDCI3 ) 1.1
(3H, d, J7.0 Hz, 4 -H3 ), 1.4 (9H, s, 9-, 10- and H -H 3 ), 2.7 (1H, m, 3-H), 4.2 (1H, 
m, 2 -H), 5.1 (2H, m, 6 -H2), 5 .8  (1H, m, 5-H) and 10.9 (1H, brs, C 0 2 H); Sq (50
MHz) (CDCI3 ) 15.0 (C-4), 28.3 (C-9, -10 and -11), 40.3 (C-3), 57.2 (C-2 ), 80.1 
(C-8 ), 116.2 (C-6 ), 138.5 (C-5), 155.5 (C-7) and 176.2 (C-1) (signals visible for 
the minor diastereoisomer 14.7 (C-4), 39.9 (C-2 ) and 58.8 (C-3); m/z 173 (M 
-(Me)HCCH=CH3, 1.5%), 128, 112, 101, 74, 57 (100 %) and 55 (found: M- 
(Me)HCCH=CH3, 173.0687. C7 H n N 0 4 requires M-(Me)HCCH=CH3, 
173.0674).
2.3-Dimethvl-N-(f-butoxvcarbonvlamino1-4-pentenoic Acid (158)
COOH
The title compound was prepared using general procedure 3 with the following 
reagents: (£)-2-(3-methyl)butenyl-AA(f-butoxycarbonylamino)propionate (1.55 g, 
6.38 mmol) was added to a solution of LDA generated from diisopropylamine 
(1.34 g, 13.73 mmol) and 1.6 M butyllithium (0 .8 8  g, 13.73 mmol) and then 
trimethylsilyl chloride (1.5 g , 13.73 mmol) was added. After removal of the
180
organic solvent the product was isolated as a pale yellow solid, 1 .2  g (80 % 
yield); mp 122-125 C; \) max (CHCI3) 3300, 2980, 1715, 1625 cm '1; 8 h (200
MHz) (CDCI3 ) 1.1 (3H, d, J 6.9 Hz, 3-H3), 1.4 (12H, brs, 5-, 10-, 11-and 12-H3),
2.7 (1H, m, 4-H), 5.2 (2 H, m, 7-H2), 5.8 (1 H, m, 6 -H) and 10.4 (1 H, brs, CO2 H); 
5C (50 MHz) (CDCI3 ) 15.1 (C-5), 20.4 (C-3), 28.3 (C-10, -11 and -1 2 ), 4 5 .4  (C-
4), 61.9 (C-2 ), 80.0 (C-9), 117.4 (C-7), 137.9 (C-6 ), 155.4 (C-8 ) and 177.6 (C-1) 
(signals visible for the other diastereoisomer 14.87 (C-5), 44.80 (C-4), 61.59 (C- 
2 ), 118.17 (C-7) and 178.14 (C-1); m/z 187 (M-(Me)HCCH=CH3, 1 .2  %), 128, 
126, 89, 74, 57 (100 %) and 55 (found: M-(Me)HCCH=CH3, 187.1901. 
C8 H13NO4 requires M-(Me)HCCH=CH3 , 187.1897).
3.3-Dimethyl-A/-(f-butoxvcarbonvlamino1-4-pentenoic Acid (1591
1
COOH
o
The title compound was prepared using general procedure 3 with the following 
reagents. 2-(3-Methyl)butenyl-A/-(t-butoxycarbonylamino)acetate (166) (1.0 g, 
4.11 mmol) was added to a solution of LDA generated from diisopropylamine 
(0.87 g, 8.85 mmol) and 1.6 M butyllithium (0.57 g, 8.85 mmol) and then 
trimethylsilyl chloride (0.96 g , 8.85 mmol) was added. After removal of the 
organic solvent the product was isolated as a pale yellow solid, 0.79 g (79 % 
yield); mp 123-125 C; umax (CHCI3 ) 3440, 2890, 1710 and 1500 cm '1; 5h
(200 MHz) (CDCI3 ) 1.1 (6 H, brs, 4- and 5-H3), 1.4 (9H, s, 10-, 11- and 12-H3),
4.0 (1 H, d, J 8.3 Hz, 2 -H), 5.1 (2 H, m, 7-H2), 5.9 (1H, m, 6 -H) and 10.6 (1 H, 
brs, C 0 2 H); 6 q  (50 MHz) (CDCI3 ) 23.6 and 24.1 (C-4 and -5), 28.2 (C-10, -11
and -12), 39.5 (C-3), 60.9 (C-2 ), 80.0 (C-9), 114.0 (C-7), 142.7 (C-6 ) and 176.2 
(C-1); m/z 174 (M-(Me)2 CC=CH2 , 1.9 %), 117, 72, 69 and 57 (100%) (found: M- 
(Me)2 C=CH2, 174.0770. C7 H i2N04 requires M-(Me)2C=CH2, 174.0763).
2.3.3-Trimethvl-/V-(f-butoxycarbonylamino)-4-pentenoic Acid (160)
The title compound was prepared using general procedure 3 with the following 
reagents. 2-(3-Methyl)butenyl-N-(t-butoxycarbonylamino)acetate (167) (2.0 g,
7.8 mmol) was added to a solution of LDA generated from diisopropylamine 
(1.6 g, 16.4 mmol) and 1.6 M butyllithium (1.05 g, 16.4 mmol) and then 
trimethylsilyl chloride (1.8 g , 16.4 mmol) was added. After removal of the
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organic solvent the product was isolated as a light brown solid, 150 mg (7 .5  % 
yield);
1
COOH
mp 1 1 0 -1 1 2  C, -Umax (CHCI3) 2950, 1710, 1660 and 1600 cm“1; 8 h (2 0 0  MHz)
(CDCI3 ) 1.1 (3H, s, 3 -H3 ), 1.37 (6 H, s, 5- and 6 -H3 ), 1.4 (9H, s, 1 1 -, 1 2 - and 
13H3), 5.3 (2H, m, 8 -H2), 6.0 (1H, m, 7-H) and 10.5 (1H, brs, C 0 2 H); 5q (50
MHz) (CDCI3 ) 18.4 (C-3), 21.9 and 22.8 (C-5 and -6 ), 28.3 (C-11, -1 2  and -13),
43.2 (C-4), 50.3 (C-2 ), 80.1 (C-10), 114.9 (C-8 ), 142.7 (C-7), 155.5 (C-9) and
177.5 (C-1 ); m/z 188 (M-(Me)2CCH=CH2, 0.7%), 173, 131, 116, 87, 69 and 5 7  
(100%) (found: M-(Me)2CCH=CH2, 188.1962. C8 H14N 0 4 requires M-
(Me)2CCH=CH2, 188.1971).
p-Methoxvbenzvl 3-methvl-A/-( f-butoxvcarbonylaminol-4-pentenoate (1731
14
OMe
12
O
General procedure 4
To a solution of compound (157) (0.5 g, 2.18 mmol) in anhydrous 
dimethylformamide (DMF) (10 ml) was added potassium bicarbonate (0.44 g, 2 
equiv.) and 4-methoxybenzyl chloride (0.37 g, 2.4 mmol). The mixture was 
stirred at room temperature for 48 h. The solution was diluted with ethyl 
acetate (25 ml) and washed with saturated brine (5x20 ml) and water (20 ml). 
The organic layer was dried (Na2 S04), filtered and concentrated under reduced 
pressure to leave an orange coloured oil which was purified by silica gel 
chromatography to leave a pale yellow oil, 0.65 g (85.4% yield); 'Umax (CHCI3 )
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3010, 1720, 1600 cm '1; 8h (200 MHz) (CDCI3) 1.0 (3H, d, J7.0 Hz, 4 -H3 ), 1 .4  
(9H, s, 9 -, 10- and H -H 3 ), 2 .6  (1H, m, 3 -H), 3.8 (3H, s, 19-H3), 4.3 (1H, m, 2- 
H), 5.0 (4 H, m, 6 - and 12-H2), 5.7 (1H, m, 5-H), 6.9 (2H, d, J 8.7 Hz, 14- and 
16-H) and 7.3 (2 H, d, J 8.7 Hz, 15- and 17-H); Sq (50 MHz) (CDCI3 ) 15.3 (C-4 ),
28.3 (C-9 , -1 0  and -1 1 ), 40.8 (C-3), 55.3 (C-19), 57.4 (C-2 ), 6 6 .8  (C-1 2 ), 116.1 
(C-6 ), 138.7 (C-5) 113.9, 127.5, 130.3, 155.4 (aromatic carbons), 159.7 (C-7 ) 
and 171.6 (C-1 ); m/z 349 (M+, 0.1%), 294, 1 2 1 , 91, 84 (100%) and 73 (found: 
M+, 349.4160. C19H27NO5 requires M+ 349.4153).
p-Methoxvbenzvl 3.3-dimethvl-A/-( f-butoxvcarbonylamino)-4-pentenoate (1741
The title compound was prepared using general procedure 4 with the following 
reagents. Compound (158) (0.46 g, 1.88 mmol) was used with 4- 
methoxybenzyl chloride (0.28 ml, 1.5 equiv.) and potassium bicarbonate (188 
mg, 1.1 equiv.). The product was isolated as a clear oil after silica gel 
chromatography, 0.6 g (85.6% yield);
OMe
2013
.0
o
Umax (CHCI3) 3030, 1715, 1600 cm '1; 8 h (200 MHz) (CDCI3) 1 .0  (6 H, d, J4.6
Hz, 4 -and 5-H3), 1.5 (9H, s, 10-, 11-and 12-H3), 3.9 (3H, s, 20-H3 ),4.1 (1H, d, 
J 9.2 Hz, 2-H), 5.0 (5 H, m, 7- and 13-H2 and NH), 5.8 (1H, dd, J11, 17 Hz, 6 - 
H), 6.9 (2H, d, J 6 .6  Hz, 15- and 17-H) and 7.3 (2H, d, J6.8  Hz, 16- and 18-H); 
8c  (50 MHz) (CDCI3 ) 23.3 and 24.3 (C-4 and -5), 28.2 (C-10, -11 and -1 2 ), 40.4
(C-3), 55.2 (C-20), 60.9 (C-2 ), 66.5 (C-13), 80.1 (C-9), 113.8, 127.47, 130.3,
143.0 (aromatic carbons), 151.3 (C-8 ) and 171.7 (C-1); m /z  322 (M- 
CH2=CHCH2, 1.9%), 254, 2 2 2 , 1 21  (1 0 0 %), 91, 69 and 57 (found; M- 
CH2 =CHCH2, 322.1652. C i7H24N0 5  requires M-CH2 =CHCH2, 322.1648).
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o-Methoxvbenzyl 2,3-dimethyl-N -( f-butoxvcarbonvlaminol-4-pentenoate (175)
14 OMe
2013
.0
O
The title compound was prepared using general procedure 4 with the following 
reagents. Compound (159) (0.50 g, 2.06 mmol) was used with 4- 
methoxybenzyl chloride (0.51 g, 1.5 equiv.) and potassium bicarbonate (227 
mg, 1.1  equiv.). The product was isolated as a clear oil after silica gel 
chromatography, 0.63 g (84.3% yield); v max (CHCI3 ) 3030, 1715, 1600 cm""*; 
5H (200 MHz) (CDCI3 ) 1.0 (3H, d, J7  Hz, 5-H3), 1.4 (12H, s, 3-, 10-, 11- and
I 2 -H3 ), 3.7 (3H, s, 2 O-H3 ), 5.1 (4H, m, 7- and 13-H2), 5.7 (1H, m, 6 -H), 6.9 (2H, 
m, 15- and 17-H2) and 7.4 (2 H, m, 16- and 18-H2); 5q (50 MHz) (CDCI3 ) 14.7
(C-5), 20.3 (C-3), 28.1 (C-1 0 , -11 and -12), 41.5 (C-4), 56.6 (C-20), 60.2 (C-2 ),
65.9 (C-13), 80.1 (C-9), 117.2 (C-7), 138.4 (C-6 ), 113.8, 127.5, 130.3, 143.0 
(aromatic carbons), 153.7 (C-8 ) and 170.9 (C-1); m/z 363 (M+, 0.8%), 308, 1 2 1 , 
91, 84 (100%), 87 and 73 (found: M+ , 363.4420. C 20H29NO5 requires M + 
363.4413).
p-Methoxybenzyl 3-methyl-A/4 f-butoxvcarbonylaminolaspartic Acid |3-
semialdehvde (1761
OMe
11
O
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The title compound was prepared by saturating a solution of compound (173) 
(250 mg, 0.72 mmol) with ozone in accordance with general procedure 1. 
Triethylamine (0 .2  ml, 2  equiv.) was added to decompose the ozonide formed 
and the solution was allowed to warm up to room temperature overnight. The 
compound was purified by silica gel chromatography to give the title compound 
as a clear oil, 2 0 0  mg (80% yield); “Umax (CHCI3 ) 3400, 3040, 1745, 1720, 1610 
and 1500 cm '1; Sh (200 MHz) (CDCI3) 1.1 (3H, d, J 7 Hz, 4-H3), 1.4 (9H, s, 8 -,
9- and IO-H3 ), 3.0 (1H, m, 3-H), 3.8 (3H, s, I 8 -H3 ), 4.7 (1H, m, 2-H), 5.1 (2H, s, 
11-H2), 6.9 and 7.4 (4H, m, 13-, 14-, 15- and 16-H), 9.6 (1H, s, 5-H); Sq (50
MHz) (CDCI3 ) 9.50 (C-4), 28.1 (C-8 , -9 and -10), 49.0 (C-3), 53.6 (C-2 ), 55.1 
(C-18), 67.3 (C-11), 80.0 (C-7), 113.9, 127.0 and 130.3 (aromatic carbons),
160.0 (C-6 ), 171.1 (C-1 ) and 200.1 (C-5); m/z 351 (M+, 0.7%), 311, 294, 249, 
186, 130, 121 (100%) and 57 (found: M+, 351.1672. C i8H25N0 6 requires M+, 
351.1675).
p-Methoxvbenzvl 3.3-dimethyl-A/-(f-butoxvcarbonvlamino1aspartic Acid [3-
semialdehvde (1771
14
OMe
12
.0
OO
The title compound was prepared by saturating a solution of compound (174) 
(500 mg, 1.44 mmol) with ozone in accordance with general procedure 1. 
Triethylamine (0.4 ml, 2 equiv.) was added to decompose the ozonide formed 
and the solution was allowed to warm up to room temperature overnight. The 
compound was purified by silica gel chromatography to give the title compound 
as a clear oil, 450 mg (90% yield); umax (CHCI3) 3400, 3010, 2920, 1740, 1720
and 1695 cm '1; Sh (200 MHz) (CDCI3) 0.9 and 1.0 (6 H, 2xs, 4- and 5-H3), 1.3 
(9H, s, 9-, 10- and H -H 3 ), 3.7 (3H, s, 19-H3), 4.6 (1H, brd, J 9.5 Hz, 2-H), 5.0 
(2 H, s, 1 2 -H2), 5.2 (1H, brd, J 9.5 Hz, NH), 6 .8  (2 H, m, 15- and 17-H), 7.2 (2 H, 
m, 14- and 18-H) and 9.5 (1H, s, 6 -H); Sq (50 MHz) (CDCI3 ) 17.5 and 18.8 (C-4
and -5), 28.1 (C-9, -1 0  and -11), 49.9 (C-3), 55.1 (C-19), 57.3 (C-2 ), 67.3 (C- 
1 2 ), 80.2 (C-8 ), 113.8 (C-15 and -17), 126.8 (C-13), 130.5 (C-14 and -18),
185
155.5 (C-16), 159.8 (C-7), 170.2 (C-1) and 201.9 (C-6 ); m/z 365 (M+, 1 .1%), 
308, 121  (1 0 0 %) and 57 (found: M+, 365.1832. C1 9H 27N0 6 requires M+, 
365.1831).
p-Methoxvbenzvl 2.3-dimethvl-A/-f f-butoxvcarbonylaminolaspartic Acid ft-
semialdehyde (1781
OMe
12
.0
’OO
The title compound was prepared by saturating a solution of compound (175) 
(300 mg, 0.86 mmol) with ozone in accordance with general procedure 1. 
Triethylamine (0.17 g, 2 equiv.) was added to decompose the ozonide formed 
and the solution was allowed to warm up to room temperature overnight. The 
compound was purified by silica gel chromatography to give the title compound 
as a clear oil, 280 mg (93% yield); Dmax 3510, 2985, 1745, 1718 and 1693
(CHCI3) cm '1; 5h (200 MHz) (CDCI3 ) 1.2 (3H, d, J 7.3 Hz, 5-H3), 1.4 and 1.5 
(1 2 H, 2xs, 3-, 9-, 10- and H -H 3 ), 2.9 (1 H, m, 4-CH), 3.6 (3H, s, 19-H3), 4.9 
(2 H, s, 12-H2), 6 .8  (2 H, m, 15- and 17-H), 7.3 (2 H, m, 14- and 18-H) and 9.6 
(1H, brs, 6 -H); Sq (50 MHz) (CDCI3 ) 16.2 (C-5), 22.4 (C-3), 29.0 (C-9-, -10 and
-11), 52.1 (C-4), 54.3 (C-19), 55.4 (C-2 ), 68.1 (C-1 2 ), 80.6 (C-8 ), 115.6, 128.1,
128.7 and 130.2 (aromatic carbons), 161.5 (C-7), 172.4 (C-1 ) and 201.5 (C-6 ); 
m/z 365 (M+ , 0.8%), 308, 264, 121 and 57(100%) (found: M+ , 365.1836. 
C19H27NO6 requires M+, 365.1831).
Trifluoro acetate salt of [3-Methvlaspartic acid (3-semialdehvde (179)
OH
c o 2hh o
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Compound (176) (100 mg, 0.28 mmol) was dissolved in anhydrous 
dichloromethane (5 ml) and was deprotected as for compound (23) to leave the 
title compound as a hygroscopic yellow solid, 45 mg (60% yield); 5h (200 MHz)
(CHCI3) 1.1 (3H, d, 4-CH3), 3.3 (1 H, m, 3-H), 3.8 (1H, m, 2 -H) and 4.9 (1 H, m, 
5-H); 5c  (50 MHz) (D2 0) 15.0 (C-4), 42.0 (C-3), 68.3 (C-2 ), 93.9 (C-5) and
174.6 (C-1); m/z 150 (M+, 1.3%) (found: M+, 150.0769. C5 H12N 0 4 requires 
M+, 150.0763).
Trifluoroacetate salt of ocp-Dimethylaspartic acid [3-semialdehvde (1801
OH NH3 CF3COO
HO
Compound (178) (100 mg, 0.5 mmol) was dissolved in anhydrous 
dichloromethane (5 ml) and was deprotected as for compound (23) to leave the 
title compound as a hygroscopic pale yellow solid, 75 mg (92% yield); 8 h (200
MHz) (CHCI3 ) 1.2 (3H, s, 3 -H3 ), 1.5 (3H, m, 5-H3), 3.2 (1 H, m, 4-H) and 5.2 
(1H, m, 6 -H); 5q (50 MHz) (CDCI3 ) 19.5 (C-5), 24.2 (C-3), 56.2 (C-4), 61.5 (C-
2 ), 99.1 (C-6 ) and 175.8 (C-1); m /z  164 (0.2%) (found: M+ , 164.0926. 
C6 H14NO4 requires M+, 164.0919).
Trifluoroacetate salt of pp-dimethvlaspartic acid ft-semialdehyde (1811
® 0  
OH NH3 C F3COO
HO
Compound (177) (100 mg, 0.5 mmol) was disolved in anhydrous 
dichloromethane (5 ml) and was deprotected as for compound (23) to leave the 
title compound as a white solid, 75 mg (92% yield); 5|-| (200 MHz) (CHCI3 ) 1.1 
(6 H, s, 4- and 5-H3), 3.8 (1H, m, 2-H) and 5.1 (1H, m, 6 -H); 5q (50 MHz) 
(CDCI3 ) 19.4 and 20.1 (C-4 and -5), 51.2 (C-3), 58.4 (C-2 ), 95.3 (C-6 ) and
175.2 (C-1 ); m/z 164 (0.1%) and 1 2 0  (found: M + , 164.0925. C 6 H14NO4 
requires M+, 164.0919).
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f-Butyl 2-(f-butoxycarbonvlamino1-4-epoxvpentanoate (1821
O 12
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To a solution of compound (125) (1.0 g, 3.7 mmol) in anhydrous 
dichloromethane (30 ml) at 0  C (ice/water bath) was added meta- 
chloroperbenzoic acid (0.7 g, 4.06 mmol). The solution was stirred for 2 h at 0 
C and then for a further 18 h at room temperature. The solution was diluted 
with dichloromethane and was washed with sodium bicarbonate solution (4x15 
ml) and then saturated brine solution (2x20 ml). The organic layer was dried 
(Na2 S0 4 ), filtered and concentrated under reduced pressure to leave the title 
compound as a clear oil which was purified by silica gel chromatography to give 
the title compound as a clear oil, 0.95 g (90% yield); Dmax 3500, 3430, 3020,
2985, 1715, 1500 and 910 (CHCI3) cm'1; 5h ( 2 0 0  MHz) (CDCI3 ) 1.4 and 1.5; 
(18H, s, 7-, 8 -, 9-, 12-, 13- and 14-H3), 1.9 (2H, m, 3-H2), 2.5 (1 H, m, 5-H), 2.7 
(1H, m, 5-H), 3.0 (1H. m, 4-H), 4.4 (1H, m, 2 -H) and 5.5 (1H, d, J 7.7 Hz, NH); 
5c (50 MHz) (CDCI3 ) 27.6 and 28.0 (C-7, -8 , -9, -1 1 , - 1 2  and -13), 35.3 (C-3),
46.2 (C-5), 48.8 (C-4), 52.1 (C-2), 79.3 (C-6 ), 81.7 (C-11), 155.0 (C-1 0 ) and
170.8 (C-1); m/z 216, 186, 160, 130, 116, 8 6 , 57 (100%) and 41 (found: M- 
C5 H11, 216.2084. C9 H14NO5 requires M-C5 H1-1 ,216.2076).
Compound (182) (100 mg, 0.35 mmol) was dissolved in anhydrous 
dichloromethane (5 ml) and was deprotected as for compound (23) to leave the 
title compound as a hygroscopic yellow solid, 54 mg (63% yield); Dmax (CHCI3 )
3000, 2980, 1595, 1500 and 1240 cm'1; 5h (200 MHz) (D2 0 ) 2 .1 0  (2 H, m, 3-
Trifluoroacetate salt of 2-amino-4-epoxvpentanoate (183)
© 0 
n h 3 c f 3c o 2
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H2), 2.42 (1H, m, 5-H), 2.6 (1H, m, 5-H), 3.0 (1 H, m, 4-H) and 4.35 (1H, m, 2- 
H); 5q (50 MHz) (D2 0) 36.2 (C-3), 46.8 (C-5), 52.1 (C-4), 54.5 (C-2) and 174.5
(C-1 ); m/z 132 (M+ , 1 .2 %), 114, 8 6 , 74, 45 (1 0 0 %) (found; M+ , 132.0662. 
C5 H10NO3 requires M+, 132.0658).
Attempted preparation of f-Butvl M  NButoxvcarbonvlaminol-2 - 
difluoromethvlallvlalvcine (184)
Method 1
To a solution of diisopropylamine (0.79 g, 2.1 equiv.) in anhydrous THF (10 ml) 
at -20 C was added butyllithium (0.5 g, 2.1 equiv.), dropwise over a period of 
15 min. This solution was stirred for a further 30 min at -2 0  C before the 
temperature was lowered to -78 C and the solution was diluted with anhydrous 
THF (35 ml). A/T-Butoxycarbonylallylglycine f-butyl ester (125) (1.0 g, 3.7 
mmol) in anhydrous THF (25 ml) was added dropwise to the reaction over a 
period of 10 min. The solution turned a yellowish colour and was stirred at -78 
C for 2 0  min to allow complete generation of the anion. 
Chlorodifluoromethane was bubbled through the reaction until saturation point 
had been reached. The reaction mixture turned a dark red colour immediately 
upon addition of the gas. The mixture was kept at -78 C for 3 h before being 
allowed to warm up to room temperature. The reaction was diluted with 
saturated ammonium chloride solution (20 ml) and then ether (30 ml) was 
added. Separation of the organic layer and further extraction of the aqueous 
layer with ether (2x25 ml) yielded organic extracts which were combined, dried 
(Na2 S0 4 ), filtered and concentrated in vacuo to afford an inseparable mixture 
of products which by NMR spectroscopy showed that no desired product had 
been formed.
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Method 2
The above procedure was repeated using hexamethyldisilazane as the base, 
generated from hexamethyldisilane (1 .0  g, 6 .2  mmol) and butyllithium (0 .5  g,
6 .2  mmol). This was an attempt to reduce the formation of difluorocarbene. 
The reaction procedure was repeated as above. The instant darkening of the 
reaction was not seen but on work up and NMR spectroscopy there proved to 
be no product present.
4-Pentenoic Acid f-Butvl Ester (151)
To a solution of 4-pentenoic acid (0.5 g, 5 mmol) in dichloromethane (50 ml) at 
-78 C was added, dropwise, via a dry-ice condenser, 2 -methylpropene (10 ml). 
To the suspension was added concentrated sulfuric acid (1.5 ml). The 
suspension was then stirred for a further 8  h at -78 C and then allowed to 
warm to room temperature overnight. The solution was concentrated in vacuo 
and partitioned between ethyl acetate and brine (1:1, 50 ml). The organic layer 
was separated and washed once more with brine (15 ml) before being dried 
(MgSCU), filtered and concentrated under reduced pressure to leave the ester 
as a yellow oil 39 mg (5% yield); 'Umax (CHCI3 ) 2935, 1735 , 1650 and 1390 
cm '1; 5h (2 0 0  MHz) (CDCI3) 1.44 (9 H, s, 7-, 8 - and 9-H3), 2.40 (4H, m, 2- and 
3-H2), 5.00 (2 H, m, 5-H2) and 5.95 (1 H, m ,4-H); 5q (50 MHz) (CDCI3 ) 29.1 (C- 
7, -8  and -9), 29.0 (C-3), 34.6 (C-2 ), 80.0 (C-6 ), 115.1 (C-5), 136.8 (C-4) and
172.2 (C-1); m/z 156 (M+, 1.2%), 99, 57 (100%) and 55 (found: M+, 156.1150. 
C9 H16O2 requires M+, 156.1146).
Preparation of methyl pent-4-enoate (1521
o
To a solution of pent-4-enoic acid (0.5 g, 5.0 mmol) in anhydrous methanol (30 
ml) at 0 C was added, dropwise via a syringe pump, thionyl chloride (0.7 g, 1 .2  
equiv.). After the addition the flask was allowed to warm slowly to room 
temperature, stirring was stopped and the solution was left standing for a
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further 30 min. The solution was then concentrated under reduced pressure 
and partitioned between ethyl acetate (50 ml) and brine (50 ml). The organic 
layer was separated and the aqueous layer was further extracted with ethyl 
acetate (2x30 ml). The combined organic extracts were dried (MgSCU), filtered, 
and the solvent was removed in vacuo to leave a clear oil, 57 mg (10% yield); 
Umax (CHCI3) 3080, 2940, 1740 and 1650 cm '1; S|-| (2 0 0  MHz) (CDCI3) 2.38
(4H, m, 2 - and 3-H2), 3.65 (3H, s, 6 -H3 ) 5.00 (2H, m, 5 -H2) and 5.95 (1 H, m ,4-
H); 8 c  (50 MHz) (CDCI3 ) 28.8 (C-3), 35.1 (C-2), 58.0 (C-6 ) 115.6 (C-5), 136.0
(C-4) and 171.5 (C-1); m/z 114 (M+, 0.9%), 99, 74 (100%) and 55 (found: M+, 
114.0675. C 6 H10O2 requires M+, 114.0678).
Preparation of succinate semialdehvde (1491
O
The title compound was prepared by saturating a solution of pent-4-enoic acid 
(1 .0  g, 1 0 .0  mmol) with ozone in accordance with general procedure 1 . 
Triethylamine (2.02 g, 2 equiv.) was added to decompose the ozonide formed 
and the solution was allowed to warm to room temperature overnight. The 
compound was purified by silica gel chromatography to yield the title compound 
as a clear oil, 0.5 g (50% yield); t)max (CHCI3 ) 2950, 2826, 1730 and 1650 cm ' 
1; Sh (200 MHz) (CD3 OD) 3.1-3.27 (2H, m, 3-H2), 3.70-3.77 (2H, t, J7.7 Hz, 2-
H2), 6.31-6.38 (0.99H, t, J 5.6 Hz, 4-H) 6.56 (2-H, brs, 2x4-OH) and 9.44 (0.5H, 
s, 4-H); 5c  (50 MHz) (CD3OD) 30.7 (C-3), 33.9 (C-2), 99.6 (C-4) and 177.1 (C-
1) (signals due to aldehyde 31.1 (C-3), 33.9 (C-3), 178.1 (C-1 ) and 201.7 (C-4); 
m/z 120 (M+, 3.4%), 102 (M+, 0.1%), 76, 58 and 44 (found: M+ , 120.0423. 
C4 H8O4 requires M+, 120.0420).
succinate semialdehvde (1541 
OH
1
Compound (151) (100 mg, 0.5 mmol) was dissolved in anhydrous 
dichloromethane (5 ml) and was deprotected as for compound (23) to leave the 
title compound as a hygroscopic yellow solid, 75 mg (92% yield); The
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compound isolated gave spectra identical to those detailed above for 
compound (149).
8.3: Experimental Detail for Chapter Four
Preparation of Ethvl Chlorooximidoacetate (192)182
o
To a stirred solution of glycine ethyl ester hydrochloride (20 g, 14.3 mmol) in 
water (1 0 0  ml) at 0  C (ice/water bath) was added, via a syringe pump, conc. 
hydrochloric acid (1 2  ml) over about 30 min. To the solution at 0 C was added 
sodium nitrite (1 0  g) in water (15 ml), again via a syringe pump, over a period of 
30 min. This procedure was repeated with a second addition of both 
components (amounts as for previous addition) and then the reaction was 
stirred for a further 2  h while being allowed to warm to room temperature. 
Saturated brine solution (25 ml) was added and the solution was extracted with 
ether (3x20 ml). The combined organic extracts were dried (Na2 S0 4 ), filtered 
and concentrated under reduced pressure to leave the title compound as a 
white solid, 10.9 g (50% yield) after recrystallisation from ether; mp 79-80 C 
(lit. 183 80 C); v max (KBr disc) 3317, 1750, 1618, 1310 cm '1; 5h (200 MHz)
(CDCI3) 1.40 (3 H, t, J 7.1 Hz, 4 -H3 ), 4.4 (2 H, q, J7.1 Hz, 3-H2) and 10.7 (1H, 
brs, OH); 5c (50 MHz) (CDCI3 ) 13.8 (C-4), 63.9 (C-3), 132.6 (C-2) and 159.8
(C-1 ); m/z 151 and 153 (M+, 1.0 and 0.3%), 136, 134, 125, 123, 108, 106, 70 
(100%), 64, 63,62, 61 and 54.
Preparation of methyl sorbate (209)
cc^ Me
To a solution of sorbic acid (3 g, 26.8 mmol) in anhydrous methanol (30 ml) at 0 
C was added, dropwise via a syringe pump, thionyl chloride (2.4 ml, 1.2 
equiv.). After the addition the flask was allowed to warm slowly to room
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temperature, stirring was stopped and the solution was left standing for a 
further 30 min. The solution was then concentrated under reduced pressure 
and partitioned between ethyl acetate (50 ml) and brine (50 ml). The organic 
layer was separated and the aqueous layer was further extracted with ethyl 
acetate (2x30 ml). The combined organic extracts were dried (MgS0 4 ), filtered, 
and the solvent was removed in vacuo to leave a clear oil, 3.1 g (92% yield); 8 h
(200 MHz) (CDCI3) 1.8 (3H, d, J 5.3 Hz, I-H 3 ), 3.7 (3H, s, 7-H3), 5.8 (1 H, d, J
15.4 Hz, 5-H), 6.2 (2H, m, 2- and 4-H) and 7.2 (1H, m, 3-H); 8q (50 MHz)
(CDCI3 ) 18.6 (C-1), 51.4 (C-7), 118.6 (C-5), 129.8 (C-2), 139.4 (C-3), 145.2 (C- 
4) and 167.7 (C-6 ); M/Z 126 (M+ , 30.9%), 111, 95, 67 (100%), 52 and 41 
(found M+ 126.0681. C7 H10O2 requires M+, 126.0678).
3-Ethoxvcarbonyl-5-cvano-2-isoxazoline (1971
O
O
General Procedure 5
To a suspension of ethyl chlorooximidoacetate (192) (500 mg, 3.3 mmol) in 
ether (5 ml) was added with stirring, at room temperature, acrylonitrile (0.4 g, 3 
equiv.). A syringe pump was used to add, dropwise, a solution of sodium 
carbonate (350 mg, 3.3 equiv.) in water (5 ml). After the addition was complete 
the solution was stoppered and stirred, overnight. The organic layer was then 
separated and the aqueous layer was further extracted with ether (2 x10  ml) and 
the combined organic extracts were dried (Na2 S0 4 ), filtered and concentrated 
under reduced pressure to leave an oil 500 mg (90% yield); Dmax (CHCI3 )
2920, 2245, 1710 and 1645 cm '1; 8h (2 0 0  MHz) (CDCI3) 1.4 (3H, t, J7.1 Hz,
I-H3 ), 3.7 (2 H, M X , Jab 18 Hz, 5-H2), 4.4 (2 H, q, J7A  Hz, 2-H2) and 5.6 (1H, 
ABX, JAx +  Jbx14.4 Hz); Sq (50 MHz) (CDCI3 ) 13.8 (C-1 ), 39.7 (C-5), 62.7 (C-
2), 68.3 (C-6 ), 116.3 (C-7), 151.7 (C-4) and 158.8 (C-3); m/z 168 (M+, 3.4%),
142, 139, 123, 113, 95 and 69 (found; M+ , 168.0531. C z H s N ^  requires
M+, 168.0533).
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3-Ethoxvcarbonvl-5-methoxvcarbonvl-2-isoxazoline (198)
O
O <
o
o
8
The title compound was prepared as for general procedure 5 with the following 
reagents. Ethyl chlorooximidoacetate (1 g, 6 .6  mmol), methyl acrylate (5 .7  g, 3 
equiv.) and sodium carbonate (700 mg, 3.3 equiv.) were dissolved in a mixture 
of water and ether (1 :1 , 20 ml). The compound was isolated as an oil, 0.9g 
(6 8 % yield); o max (CHCI3 ) 2937, 1749, 1720 and 1627 cm '1; Sh (2 0 0  MHz)
(CDCI3 ) 1.4 (3 H, t, J 7.1 Hz, I-H 3 ), 3.5 (2 H, d, J 9 .9  Hz, 5-H2), 3.7 (3H, s, 8 - 
H3), 4.3 (2 H, q, J 7.1 Hz, 2-H2) and 5.3 (1H, t, J 9.6 Hz, 6 -H); Sq (50 MHz)
(CDCI3 ) 13.9 (C-1), 37.4 (C-5), 52.8 (C-8 ), 62.2 (C-2 ), 79.6 (C-6 ), 151.1 (C-4),
159.6 (C-6 ) and 169.3 (C-3); m/z 201 (M+ , 1.4%), 156, 142 (100%), 114, 96 
and 70 (found: M+, 201.0638. C8 H n N 0 5 requires M+, 201.0634).
The title compound was prepared as for general procedure 5 with the following 
reagents. Ethyl chlorooximidoacetate (1 g, 6 .6  mmol), allyl alcohol (1.13 g, 3 
equiv.) and sodium carbonate (700 mg, 3.3 equiv.) were dissolved in a mixture 
of water and ether (1:1, 20 ml). The compound was isolated as an oil, 0.73g 
(64% yield); umax (CHCI3 ) 3375, 3016, 1739, 1710 and 1645 cm '1; 5h (2 0 0
MHz) (CDCI3 ) 1.2 (3H, t, J7.1 Hz, I-H 3 ), 3.1 (2 H, m, 5 -H2), 3.4-3.7 (3H, m, 7- 
H2 and OH), 4.2 (2 H, q, J7.1, 2 -H2) and 4.7 (1H, m, 6 -H); Sq (50 MHz) (CDCI3 )
13.9 (C-1), 34.6 (C-5), 62.0 (C-7), 62.8 (C-2 ), 84.0 (C-6 ), 151.8 (C-4) and 160.4 
(C-1); m/z 173 (M+ , 1 .8 %), 142, 128, 114, 96 and 70 (100%) (found: M+, 
173.0684. C 7 H11NO4 requires M+, 173.0685).
3-Ethoxycarbonvl-5-hvdroxymethvl-2-isoxazoline (2 0 1 )
O
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3-Ethoxycarbonyl-5-acetvl-2-isoxazoline (1991 
O
O <8
The title compound was prepared as for general procedure 5 with the following 
reagents. Ethyl chlorooximidoacetate (1 g, 6 .6  mmol), methylvinylketone (1.4 g, 
3 equiv.) and sodium carbonate (700 mg, 3.3 equiv.) were dissolved in a 
mixture of water and ether (1:1 , 20 ml). The compound was isolated as an oil,
1.05 g (8 6 % yield); u max (CHCI3 ) 2937, 1749, 1720 and 1627 cm '1; 8 h (200
MHz) (CDCI3 ) 1 .2  (3 H, t, J7.1 Hz, I-H 3 ), 2.1  (3 H, s, 8 -H3), 3.3 (2 H, ABX, 5-H2),
4.1 (2 H, q, J 7.1 Hz, 2-H2) and 5.0 (1H, ABX, 6 -H); 8 q (50 MHz) (CDCI3 ) 14.1
(C-1), 26.4 (C-8 ), 35.8 (C-5), 62.3 (C-2), 86.1 (C-6 ), 151.7 (C-4), 159.8 (C-1 ) 
and 205.1 (C-7); m/z 185 (M+, 1.0%), 156, 142, 111, 96 and 70 (100%) (found: 
M+, 185.0690. C8 H h N 0 4 requires M+, 185.0685).
3-Ethoxvcarbonvl-5-methvl-5-((2 1-propenvn-2-isoxazoline (211)
The title compound was prepared as for general procedure 5 with the following 
reagents. Ethyl chlorooximidoacetate (500 mg, 3.3 mmol), 2,3- 
dimethylbutadiene (0.81 g, 3 equiv.) and sodium carbonate (350 mg, 3.3 equiv.) 
were dissolved in a mixture of water and ether (1:1, 20 ml). The compound was 
isolated as an oil, 0.31 g (48% yield);
Umax (CHCI3) 3050, 1745, and 1627 cm '1; 8 h (200 MHz) (CDCI3) 1.0 (3H, t, J
(50 MHz) (CDCI3 ) 13.5 (C-7), 17.8 (C-1 0 ), 24.5 (C-1), 43.2 (C-2), 61.2 (C-5), 
91.3 (C-6 ), 1 1 0 .8  (C-9), 144.8 (C-8 ), 150.1 (C-4) and 160.1 (C-3); m/z 197 (M+,
O
9
7.1 Hz, I-H 3 ), 1.2 (3H, s, 7 -H3 ), 1.5 (3H, brs, IO-H3 ), 2.8 (2 H, AB, JAb 17.6 Hz, 
5 -H2), 4.0 (2H, q, J7A  Hz, 2-H2), 4.6 (1H, m, 9 -H2) and 4.8 (1H, brs, 9-H2); 8q
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0.4%), 168, 129, 124, 114, 96 and 70 (found: M+ , 197.2281. C ioH15N 03 
requires M+, 197.2274).
3-Ethoxycarbonvl-4.5-tetramethylene-2-isoxazoline (203)
O
9
8
7
The title compound was prepared as for general procedure 5 with the following 
reagents. Ethyl chlorooximidoacetate (500 mg, 3.3 mmol), cyclohexene (0.81 
g, 3 equiv.) and sodium carbonate (350 mg, 3.3 equiv.) were dissolved in a 
mixture of water and ether (1 :1 , 20 ml). The compound was isolated as an oil, 
0 .2 0  g (31% yield); u max (CHCI3 ) 2937, 1749, 1721 and 1627 cm '1; 8 h (2 0 0
MHz) (CDCI3 ) 1.3 (3H, t, J7A  , 1-H3), 1.5-2.1 (8 H, m, 7-, 8 -, 9- and 10-H2), 3.2 
(1H, brq, J 7.8 Hz, 5-H) and 4.3-4.6 (3H, m, 2-H2 and 6 -H); 6 q (50 MHz)
(CDCI3 ) 13.9 (C-1), 19.6, 2 1 .2 , 24.6 and 25.4 (C-7, -8 , -9 and -10), 43.3 (C-5),
61.7 (C-2), 82.5 (C-6 ), 155.0 (C-4) and 160.8 (C-3); m/z 197 (M+, 25.4%), 152, 
141, 124 (100%), 106, 96 and 79 (found: M+, 197.2263. C 10H 15NO3 requires 
M+, 197.2274).
The title compound was prepared as for general procedure 5 with the following 
reagents. Ethyl chlorooximidoacetate (1 g, 6 .6  mmol), acrolein (1.2 g, 3 equiv.) 
and sodium carbonate (700 mg, 3.3 equiv.) were dissolved in a mixture of water 
and ether (1 :1 , 20 ml). The compound was isolated as an oil, 56 mg (5% yield); 
Umax (CHCI3) 2937, 1732, 1712 and 1635 cm '1; 5h (200 MHz) (CDCI3) 1.3
3-Ethoxycarbonvl-5-formvl-2-isoxazoline (2001
O
O
O
(3 H, t, J 7.1 Hz, 1-H3), 3.3 (2 H, m, 5-H2), 4.4 (2H, q, J 7.1 Hz, 2-H2), 4.8 
(0.75H, m, 7-H), 5.2 (1H, m, 6 -H) and 9.7 (0.25H, s, 7-H); m/z 171 (M+, 0.1%),
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142 (100%), 113 and 70 (found: M+, 171.0533. C7 H9 NO4 requires M+, 
171.0529).
Attempted preparation of (2 1 2 a) and (2 1 2 b)
C02Me
,C02Me
O O
(212a) (212b)
General procedure 5 was used with the following reagents. Ethyl 
chlorooximidoacetate (0.5 g, 3.3 mmol), methyl sorbate (209) (1.3 g, 3 equiv.), 
sodium carbonate (350 mg, 3.3 equiv.) were dissolved in a mixture of water and 
ether (1:1, 20 ml). The compound, which was isolated as an oil, upon NMR 
spectroscopic analysis was found to be the nitrile oxide dimer.
To a solution of nitroethane (0.75 g, 10 mmol), acrylonitrile (1.06 g, 20 mmol) 
and triethylamine (0.02 ml) in anhydrous benzene (50 ml) was added, dropwise, 
phenyl isocyanate (2.5 ml, 23 mmol) over a period of 2 h. Once the addition 
was complete the reaction was stirred at room temperature for a further 18 h. 
The resulting suspension was filtered, to remove precipitated diphenylurea, 
water (75 ml) was added and the biphasic mixture was stirred for 2 h at room 
temperature. The organic layer was then separated and the aqueous layer was 
further extracted with ether (2x15 ml). The combined organic extracts were 
dried (MgS0 4 ), filtered and concentrated in vacuo to leave the title compound 
as an oil which was purified by silica gel chromatography to leave 0.65 g (6 6 % 
yield); umax (CHCI3) 2994, 2247 and 1632 cm"1; 8 h (200 MHz) (CDCI3 ) 2 . 0  
(3H, s, I-H 3 ), 3.4 (2 H, ABX, 3-H2) and 5.2 (1 H, ABX, 4-H); 8 q (200 MHz) 
(CDCI3 ) 1 2 .3  (C-1), 44.4 (C-3), 65.8 (C-4), 117.6 (C-5) and 155.6 (C-2 ); m/z 
110 (M+, 44.9%), 84, 80 and 57 (found; M+, 110.0472. C5 H6 N2O requires M+, 
110.0479).
5-Cyano-3-methvl-2-isoxazoline (207)
O
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5-Methoxvcarbonvl-3-methvl-2-isoxazoline (2081
To a solution of nitroethane (0.75 g, 10 mmol), methyl acrylate (1.72 g, 20 
mmol) and triethylamine (0.02 ml) in anhydrous benzene (50 ml) was added, 
dropwise, phenyl isocyanate (2.5 ml, 23 mmol) over a period of 2 h. Once the 
addition was complete the reaction was stirred at room temperature for a further 
18 h. The resulting suspension was filtered to remove precipitated 
diphenylurea and water (75 ml) was added and the biphasic mixture was stirred 
for 2 h at room temperature. The organic layer was then separated and the 
aqueous layer was further extracted with ether (2x15 ml). The combined 
organic extracts were dried (MgS0 4 ), filtered and concentrated in vacuo to 
leave the title compound as an oil which was purified by silica gel 
chromatography to leave 0.83 g (58% yield); Dmax (CHCI3 ) 3010, 1725 and
1642 cm '1 ; Sh (200 MHz) (CDCI3 ) 1.9 (3H, s, 1 -H3), 3.3 (2H, ABX, 3-H2), 3.7 
(3H, s, 6 -H 3 ), 5.0 (1 H, ABX, 4-H); Sq (200 MHz) (CD3 COCD3 ) 12.3 (C-1), 42.3 
(C-3), 52.5 (C-6 ), 77.6 (C-4), 155.5 (C-2) and 171.6 (C-5); m/z 143 (M+ , 3.3%), 
113, 84, 72 and 56 (1 0 0 %) (found: M+ , 143.0586. C 6 H9 N 0 3  requires M+ , 
143.0580).
5-Bromomethvl-3-ethoxvcarbonvl-2-isoxazoline (2021
O
The title compound was prepared as for general procedure 5 with the following 
reagents. Ethyl chlorooximidoacetate (1 g, 6 . 6  mmol), allyl bromide (2.4 g, 3 
equiv.) and sodium carbonate (700 mg, 3.3 equiv.) were dissolved in a mixture 
of water and ether (1:1, 20 ml). The compound was isolated as an oil, 1.25 g 
(80% yield); umax (CHCI3 ) 2982, 1718, 1592, 1261 and 929 cm '1 ; 8 h ( 2 0 0
MHz) (CDCI3 ) 1.4 (3H, t, J7.1 Hz, 1 -H3), 3.0-3.6 (4H, m, 5 -H 2  and 7-H2) , 4.4 
(2 H, q, J 7.1 Hz, 2 -H2) and 5.1 (1H, m, 6 -H); 5q  (50 MHz) (CDCI3 ) 14.0 (C -1 ),
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32.5 (C-7), 38.1 (C-5), 62.2 (C-2 ), 81.7 (C-6 ), 151.1 (C-4) and 160.2 (C-3); m/z 
237 and 235 (M+, 79Br 40.8% and 81Br 39.2%), 209 and 207,192 and 190, 142 
(100%), 114 and 70 (found: M+ , 236.9825 and 234.9840. C7 H10NO3Br 
requires M+, 234.9847 (79Br) and 236.9824 (s1Br)).
A second compound was isolated from this, and many of the other, reactions. It 
is a minor impurity and is formed by the dimerisation of the dipolar component 
(206). The compound was isolated by silica gel chromatography and is shown 
below together with its characterisation data.
o
©N
Umax (CHCI3) 2988, 1750, 1627, 1480, 1246 and 1066 cm '1; 5h (200 MHz)
(CDCI3 ) 1.40 (3H, t, J 7.1 Hz, Me), 1.47 (3H, t, J7.1 Hz, Me), 4.4 (2H, q, J7.1 
Hz, CH2) and 4.6 (2 H, q, J7A  Hz, CH2); Sq (50 MHz) (CDCI3 ) 13.7 (Me), 65.6
(CH2), 106.5 (£=N-0'), 148.3 (£=N), 155.0 (2=0) and 156.6 (2=0); m/z 184 
(M-C2 H6 0), 157, 112, 100, 84 and 53 (1 0 0 %) (found M-C2 H6C, 184.0114. 
C6 H4 N2O5 requires M-C2 H6 0 , 184.0119).
Attempted preparation of 3-Ethoxvcarbonyl-2-isoxazoline-4.5-dicarboxylic
anhydride (2041
O
O
General procedure 5 was used with the following reagents. Ethyl 
chlorooximidoacetate (1.0 g, 6 .6  mmol), maleic anhydride (2.4 g, 3 equiv.) and 
sodium carbonate (700 mg, 3.3 equiv.) were dissolved in a mixture of water and 
ether (1:1, 20 ml). The compound was isolated as an oil. By NMR analysis the 
compound was shown to be the dimer (206) as detailed above.
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Attempted preparation of 3-Ethoxvcarbonvl-2-isoxazole-4.5-dicarboxvlic acid
I2Q51
General procedure 5 was used with the following reagents. Ethyl 
chlorooximidoacetate (1 .0  g, 6 .6  mmol), dimethyl acetylenedicarboxylate (2.81 
g, 3 equiv.) and sodium carbonate (700 mg, 3.3 equiv.) were dissolved in a 
mixture of water and ether (1:1, 20 ml). The compound was isolated as an oil, 
and by NMR spectroscopy was shown to be the dimer (206) as detailed above.
Preparation of 2-(A/-(t-Butylcarbonvlamino)-3-(3-t-butoxycarbonvh-2-(isoxazolin-
4-yhpropanoate (2131
The title compound was prepared as for general procedure 5 with the following 
reagents: ethyl chlorooxim idoacetate (0.5 g, 3.3 mmol), N-{t-
butoxycarbonyl)allylglycine-f-butyl ester (2.7 g, 3 equiv.) and sodium carbonate 
(350 mg, 3.3 equiv.) were dissolved in a mixture of water and ether (1:1, 20 ml). 
The title compound was isolated as an oil, 0.84 g (70% yield); Dmax (CHCI3 ) 
3500-3250, 1719, 1523, 1441 cm'1; Sh (200 MHz) (CDCI3) 1.32 (3H, q, J 7.7 
Hz, 9 -H3 ), 1.54 (18H, 2xs, 1 2 -, 13-,14-, 16-, 17- and I 8 -H3 ), 2.17 (2 H, dd, J 6 .0  
and 6 .0  Hz, 3-H2), 2.9-3.4 (2 H, ABX, Jab 18.0 Hz, Jax  7.5 Hz, JBx  11-0 Hz, 5- 
H2),4.05 (2H. t, J 7.7 Hz, 8 -H2), 4.43 (1H, m, 2-H) and 4.89 (1H, m, 4-H); 8 c  
(50 MHz) (CDCI3 ) 14.7 (C-9), 28.6 (C-12, -13, -14, -16, -17 and -18), 37.3 (C- 
3), 38.7 (C-5), 51.1 (C-2), 63.1 (C-8 ), 80.0 (C-4), 80.9 and 81.1 (C-11 and -15),
151.1 (C-6 ), 155.8 (C-10), 160.8 (C-7) and 171.6 (C-1); m/z (found M+ , 
364.1246. C i7H2qN2C>7 requires M+, 364.1265).
O
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Ethvl 4.5-dihydroxy-2-oxopentanoate (216) 
o
2
O OH
To a flame dried flask under a nitrogen atmosphere was added compound 
(201) (500 mg, 2.9 mmol), 10% palladium on carbon (approx. 20 mg), formic 
acid (0.7 ml, 4 equiv.) and anhydrous methanol (7 ml). The suspension was 
stirred at room temperature for 12 h. The spent palladium on carbon was 
removed by filtration through a celite pad. The celite pad was washed with 
methanol (2x10 ml) and removal of the solvent in vacuo left an orange oil. The 
oil was taken up in ether (5 ml) and 20% citric acid solution (5 ml) was added 
and the two phase mixture was stirred for 30 min. The organic layer was 
separated and the aqueous layer was further extracted with ether (2x5 ml). The 
combined organic extracts were dried (Na2 S0 4 ), filtered and concentrated 
under reduced pressure to leave (216), after silica gel chromatography, as a 
clear oil 45 mg (8.9% yield); v max (CHCI3) 3450, 2926, 1745 and 1670 cm '1; 
8 h (200 MHz) (CDCI3 ) 1.4 (3H, t, J 7.1 Hz, 1 -H3), 3.5 (2 H, m, 5-H2), 3.9 (3H, m, 
8 -H3 ), 4.4 (2H, q, J7.1 Hz, 2 -H2 ), 5.4 (1H, m, 6 -H) and 6.9 (1 H, brs, 6 -OH); m/z 
204 (M+, 0.1%), 189, 175, 120, 76 and 53.
Ethvl 4-hvdroxv-5-methyl-2-oxoalutarate (215)
The title compound was prepared as detailed above with the following reagents. 
Compound (198) (255 mg, 1.27 mmol), ammonium formate (80 mg, 1 mmol), 
10% palladium on carbon (aprox. 50 mg) and anhydrous methanol (10 ml) were
201
mixed and stirred overnight under a dry nitrogen atmosphere. Work up was as 
detailed above and after silica gel chromatography two clear oils were isolated,
o o
o  OH
(a) 57 mg (22% yield) and (b) 35 mg (13% yield); analysis for compound (a) 
showed it to be the starting material; umax (CHCI3 ) 2937, 1749, 1720 and 1627
cm'1 ; 5h (200 MHz) (CDCI3) 1.4 (3H, t, J7.1 Hz, 1-H3), 3.5 (2 H, d, J 9.9 Hz, 5-
H2), 3.7 (3H, s, 8 -H 3 ), 4.3 (2 H, q, J7A  Hz, 2-H 2) and 5.3 (1H, t, J 9.6 Hz, 6 -H); 
5c (50 MHz) (CDCI3 ) 13.9 (C-1), 37.4 (C-5), 52.8 (C-8 ), 62.2 (C-2), 79.6 (C-6 ),
151.1 (C-4), 159.6 (C-6 ) and 169.3 (C-3); m/z 201 (M + , 1.4%), 156, 142 
(100%), 114, 96 and 70 (found: M+ , 201.0638. C sH nN O s requires M + , 
201.1743); analysis for compound (b) showed it to be the title compound; 'umax
(CHCI3 ) 3415, 2942, 1740 and 1685 cm '1 ; 5h (200 MHz) (CDCI3 ) 1.4 (3H, t, J
7.1 Hz, I-H 3 ), 3.5 (2H, m, 5-H2), 3.9 (3H, m, 8 -H3 ), 4.4 (2H, q, J 7.1 Hz, 2-H2), 
5.4 ( 1 H, m, 6 -H) and 6.9 (1H, brs, 6 -OH); m/z 204 (M+, 0.1%), 189, 175, 120, 
76 and 53.
Ethyl 4-hvdroxv-2.5-dioxohexanoate (214)
O O
O OH
The title compound was prepared as detailed above with the following reagents. 
Compound (199) (150 mg, 0.81 mmol), ammonium formate (80 mg, 1 mmol), 
10% palladium on carbon (aprox. 50 mg) and anhydrous methanol (10 ml) were 
mixed and stirred overnight under a dry nitrogen atmosphere. Work up was as 
detailed above and after silica gel chromatography a clear oil was isolated, 25 
mg (16% yield); omax (CHCI3) 3395, 2942,1750 and 1672 cm '1 ; 5h (200 MHz)
(CDCI3 ) 1.26 (3H, t, J 7.2 Hz, I -H 3 ), 2.05 (3H, 5, 8 -H 3 ), 3.71-3.85 (2H, m, 5- 
H2), 4.14 (2 H, q, J 7.2 Hz, 2-H2), 4.15-4.45 (1H, m, 6 -H) and 5.36 (1H, brs, 6 - 
OH).
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8.4: Experimental Detail for Chapter Five
5-Methyl glutamate Hydrochloride (2211206
° % ^ ° H
MeO
6
2
H
O
To a suspension of L-glutamic acid (10 g, 68.8 mmol) in anhydrous methanol 
(50 ml), at 0 C, was added thionyl chloride (10.9 g, 1.3 equiv.). After the 
addition the flask was allowed to warm to room temperature. Stirring was 
stopped and the flask was allowed to stand for 30 min. The solution was 
cooled to 0 C and ether (200 ml) was added. A short period later a white solid 
formed. The solid was filtered off and washed with ether (2x50 ml). The solid 
was dried under vacuum in a desiccator to remove any remaining water and 
sulfur dioxide. This left a white solid, 10.8 g (79% yield); i)max (KBr disc) 3450,
2910, 1745 and 1715cm'1;5|H (200 MHz) (D20) 1.76 (2H, m, 3-H2), 2.25 (2H, 
m, 4-H2), 3.35 (3H, s, 6-H3) and 3.38 (1H, m, 2-H); 5c (50 MHz) (D20) 25.7 (C-
3), 30.2 (C-4), 52.7 (C-2), 53.5 (C-6), 172.3 (C-5) and 175.7 (C-1); m/z 162 
(MH+ , 0.1%), 117, 116, 102, 84 (100%) and 56 (found MH+ 162.0766. 
C6H12N 0 4 requires MH+ 162.0763).
To a solution of 5-methylglutamate hydrochloride (221) (10 g, 50.6 mmol) in 
water (95 ml) and 4M sodium hydroxide solution (13 ml) was added sodium 
bicarbonate (8.5 g, 2 equiv.). The solution was stirred at room temperature and 
benzyl chloroformate (10 ml, 1 equiv.) was added slowly over a period of 3 h. 
The solution was then stirred overnight, and washed with ether (2x50 ml) to 
remove any organic contaminants. The aqueous layer was acidified to pH 1, 
using 3M hydrochloric acid solution, and extracted with ether (3x50 ml). The
5-Methvl /V-(benzvloxycarbonvnalutamate (222)206
MeO
6
14 13O
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combined organic extracts were dried (Na2 S0 4 ), filtered and concentrated 
under reduced pressure to leave a clear green oil which was purified using 
silica gel chromatography to leave a clear oil, 11.5 g (77% yield); v max (CHCI3 )
3325, 2900, 1740 and 1720 cm'1; 8h (200 MHz) (CDCI3) 2.05 (2 H, m, 3 -H2), 
2.46 (2H, m, 4-H2), 3.63 (3H, s, 6 -H3 ), 4.43 (1 H, m, 2-H), 5.10 (2 H, s, 8 -H2), 
5.67 (1 H, d, J 8.0 Hz, NH), 7.3 (5H, m, 10-, 11-, 12-, 13- and 14-H) and 9.99 
(1H, brs, 1-OH); Sq (50 MHz) (CDCI3 ) 26.5 (C-3), 29.2 (C-4), 50.5 (C-6 ), 53.1
(C-2 ), 6 6 .9  (C-8 ), 128.1, 128.2, 128.3, 128.5, 128.6, 135.1 (C-9 , -1 0 , -1 1 ,-1 2 , 
-13 and -14), 156.0 (C-7), 171.7 (C-5) and 173.1 (C-1); m /z 295 (M+ , 0.8%), 
280, 251, 236, 221, 91 (100%) and 74 (found M+ 295.1049. C i4 H 17N 0 6 
requires M+, 295.1051).
Benzvl 5-methyl A/-(benzvloxvcarbonynalutamate (223)
15
MeO
13
A solution of 8 -methyl A/-(benzyloxycarbonyl)glutamate (222) (580 mg, 1.97 
mmol) in anhydrous dimethylformamide (10 ml) was prepared. To this solution 
was added benzyl bromide (336 mg, 1 equiv.) and sodium bicarbonate (182 
mg, 1.1 equiv.). The solution was stirred at room temperature for 48 h and 
poured into saturated brine (20 ml) and ethyl acetate (20 ml). The organic layer 
was separated and washed again with brine (5x15 ml). The organic layer was 
then dried (MgS0 4 ), filtered and concentrated under reduced pressure to leave 
after silica gel chromatography, a clear oil, 381 mg (50% yield); 5h (200 MHz)
(CDCI3) 1.9-2.5 (4H, m, 3- and 4-H2), 3.6 (3H, s, 6 -H3 ), 4.43 (1H, m, 2 -H), 5.08 
(2H, s, 8 -H2), 5.14 (2H, s, 15-H2), 5.6 (1H, brd, J8.1 Hz, NH) and 7.32 (10H, m,
10-, 11-, 12-, 13-, 14-, 17-, 18-, 19-, 20- and 21-H); 5q (50 MHz) (CDCI3 ) 27.4
(C-3), 29.9 (C-4), 51.8 (C-6 ), 53.4 (C-2 ), 67.0, 67.3 (C-8  and -15), 128.0, 128.1, 
128.2, 1.28.3, 128.5, 128.6, 135.1, 136.2 (C-9, -1 0 , -1 1 , -1 2 , -13, -14, -16, -17, 
-18, -19, -20 and -2 1 ), 156.1 (C-7), 171.7 (C-1) and 173.1 (C-5); m/z370 (M+-
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CH3, 1.5%), 326, 311,279, 91(100%), 74 (found M+-CH3, 370.1280. 
C21H23NO6 requires M+-CH3, 370.1285).
BenzvlA/-(benzyloxycarbonvl)alutamate (224)
14
HO
12
Benzyl 8 -methyl A/-(benzyloxycarbonyl)glutamate (223) (1.0 g, 2.6 mmol) was 
dissolved in methanol (5 ml) and to the solution was added 2M sodium 
hydroxide solution (7 ml). The solution was stirred vigorously for 2 h before 
being concentrated in vacuo. The residue was partitioned between ether (10 
ml) and water (10 ml). The ether layer was separated and discarded. The 
remaining aqueous layer was acidified to pH 2 using 3M hydrochloric acid. The 
acidified solution was extracted with ethyl acetate (2x15 ml). The combined 
organic extracts were dried (Na2 S0 4 ), filtered and concentrated in vacuo to 
leave a clear oil, 0 .8 8 g (91% yield); Dmax (CHCI3 ) 3350, 2890, 1718 and 1515
cm-1; 5h (200 MHz) (CDCI3) 1 .7-2.1 (2 H, m, 3-H2), 2.2-2.3 (2H, m, 4-H2), 4.2
(1H, m, 2-H), 4.9 (4H, brs, 7- and 14-H2), 5.8 (1H, d, J 8.1  Hz, NH), 7.1 (1 0 H, s, 
aromatic protons) and 10.1 (1H, brs, 5-OH); 5q  (50 MHz) (CDCI3 ) 26.8 (C-3),
29.8 (C-4), 53.0 (C-2 ), 67.3 (C-7 and -14), 128.0, 128.1, 128.2, 128.5, 128.6,
134.5, 135.9 (aromatic carbons), 156.6 (C-6 ), 176.0 (C-1) and 178.1 (C-5); m/z 
312 (M-C2 H3O2 , 0 .1%), 280, 249, 178, 108 and 91 (1 0 0 %) (found: M-C2 H3 O2 , 
312.1228. C i8H i8N04 requires M-C2 H30 2, 312.1231).
Attempted preparation of benzvl-A/-(benzvloxvcarbonvl)qlutamic Acid y-
semialdehvde (2251
Benzyl A/-(benzyloxycarbonyl)glutamate (224) (0.9 g, 2.43 mmol) was placed in 
a round bottomed flask equipped with a dry ice condensor. The flask and 
condensor were cooled to -78 C and methylamine (1 0  ml) was added via the
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condensor. The solution was stirred at -78 C and lithium metal (0.18 g, 10 
equiv.) was added in small pieces until the solution turned a blue colour. The 
remaining pieces of lithium were added over 40 min in order to keep the 
solution blue. Solid ammonium chloride (1 g) and then ice/concentrated
14
12
hydrochloric acid (13 g, 7ml) were added and the solution was extracted with 
ether (2x15 mi). The organic extracts were washed with sodium bicarbonate 
solution (1 0  ml), dried (Na2S0 4 ), filtered and concentrated under reduced 
pressure to leave an inseparable mixture of products.
f-Butyl 8 -methvlalutamate hydrochloride (2261
MeO
O
To a solution of 5-methylglutamate hydrochloride (221) (1.0 g, 5.06 mmol) in 
anhydrous dichloromethane (50 ml), at -78 C, was added 2 -methylpropene (15 
ml) and conc. sulfuric acid (5 ml). The solution was stirred for 6  h at -78 C 
before being allowed to warm to room temperature overnight. The pH of the 
solution was adjusted to 9 by addition of saturated sodium bicarbonate solution. 
The aqueous layer was then extracted using ethyl acetate (3x50 ml). The 
organic layer was dried (MgS0 4 ), filtered and concentrated in vacuo to leave a 
yellow oil. The yellow oil was stirred and cooled to 0 C and upon the addition 
of ethereal HCI (75 ml) a white solid precipitated, 0.5 g (42% yield); 8 h (2 0 0
MHz) (D20) 1.37 (9H, s, 8 -, 9- and 10-H3), 2 .1 1  (2 H, q, J7.1 Hz, 3-H2), 2.51 
(2H, m, 4-H2), 3.59 (3H, s, 6 -H3 ) and 3.94 (1H, t, J 6 .8  Hz, 2-H); (50 MHz)
206
(D20) 27.4 (C-3), 29.6 (C-8 , -9 and -10), 31.9 (C-4), 55.1 (C-2), 59.3 (C-6 ), 88.5 
(C-7), 171.0 (C-1 ) and 177.3 (C-5); m/z .218 (M+, .1%), 161, 117, 144, 7 4  and 
57 (100%) (found M+, 218.1390. C10H20NO4 requires M+, 218.1387).
f-Butvl 5-methvl A/-(benzvloxvcarbonvlamino)alutamate (227)
MeO
6
8
O
To a solution of compound (226) (3.0 g, 11.8 mmol) in water (95 ml) and 4M 
sodium hydroxide solution (13 ml) was added sodium bicarbonate (2.0 g, 23.6 
mmol) and benzyl chloroformate (2 .2  g, 13.0 mmol). The solution was stirred 
for 3 h before any organic impurities were removed by washing with ether (50 
ml). The pH of the aqueous layer was adjusted to 2 using 3M HCI. The 
aqueous layer was then extracted with ethyl acetate (3x25 ml). The combined 
organic extracts were dried (Na2 S0 4 ), filtered and concentrated in vacuo to 
leave a clear oil, 3.36 g (81% yield); b\-\ (200 MHz) (CDCI3 ) 1.41 (9H, s, 8 -, 9-
and IO-H3 ), 1.85-2.22 (2H, m, 3-H2), 2.40 (2H, m, 4-H2); 3.60 (3H, s, 6 -H3 ), 
4.21 (1H, m, 2-H); 5.06 (2H, s, 12-H2), 5.19 (1H, brd, NH) and 7.26 (5H, m, 14-, 
15-, 16-, 17- and 18-H); 5c  (50 MHz) (CDCI3 ) 27.8 (C-8 , -9 and -10), 27.9 (C-
3), 29.9 (C-4), 51.6 (C-6 ), 53.8 (C-2 ), 6 6 .8  (C-1 2 ), 82.3 (C-7), 128.0, 128.4,
136.2 (C-13, -14, -15, -16, -17 and -18), 155.9 (C-11), 170.9 (C-1) and 173.1 
(C-5); m /z250 (M+-C 02 tBu, 15.4%), 206, 174, 107 and 91 (100%) (found M+- 
CO^Bu, 250.1065. C13H16NO4 requires M ^C O ^B y, 250.1075).
f-Butyl A/-(benzvloxvcarbonylamino1alutamate (2281
To a solution of compound (227) (2.0 g, 5.7 mmol) in methanol (10 ml) was 
added 2 M sodium hydroxide (6  ml). The solution was stirred vigorously for 2 h 
before being concentrated. The residue was partitioned between water (10 ml) 
and ether (10 ml). The ether washings were discarded and the aqueous layer 
was acidified to pH 2. The acidified solution was then extracted using ethyl 
acetate (2x25 ml). The combined organic extracts were dried (Na2SC>4 ),
207
filtered and concentrated in vacuo to leave a clear oil, 1.72 g (90% yield);
7
HO
O
Umax (CHCI3) 3250, 1740, 1710 and 1512 cm '1; Sh (200 MHz) (CDCI3) 1.45 
(9H, s, 7-, 8- and 9-H3), 1.93-2.42 (2H, m, 3-H2), 2.41 (2H, m, 4-H2), 4.44 (1H, 
m, 2-H), 5.09 (2H, s, 11-H2), 5.82 (1H, d, J 8.0 Hz, NH), 7.27 (5H, m, 13-, 14-, 
15-, 16- and 17-H) and 10.14 (1H, brs, 5-0 H); 8C (50 MHz) (CDCI3) 27.0 (C-3),
27.8 (C-7, -8 and -9), 29.9 (C-4), 53.7 (C-2), 67.2 (C-11), 82.6 (C-6), 128.0,
128.1. 128.4, 136.2 (C-12, -13, -14, -15, -16 and -17), 156.3 (C-10), 171.5 (C-1) 
and 177.8 (C-5); m/z 281 (MH+-*Bu, 4.6%), 236, 192, 146, 108 and 91 (100%) 
(found: MH+-*Bu, 281.0901. C i 3H isN06 reqiures MH+-*Bu, 281.0895).
Attempted preparation of f-Butvl A/-(benzyloxvcarbonvhglutamic acid y-
semialdehvde (225)
Compound (228) (0.96 g, 2.85 mmol) was reduced according to the procedure 
outlined for compound (225). The same work up was followed and isolation of 
any characterisiable products was not achieved.
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f-Butvl 2-(benzvloxvcarbonylannino1-5-hvdroxvpentanoic acid (229)
7
O
14
15
Method 1
Compound (228) (150 mg, 0.4 mmol) was dissolved in anhydrous THF (10 ml). 
The solution was cooled to 0  C and stirred. Addition of borane/THF (0.7 ml, 0.7 
mmol) or borane/dimethylsulfide (0.4ml, 0.7 ml) was carried out over 15 min. 
The resulting solution was then stirred for a further 3 h before being poured into 
methanol (5 ml) and stirred for 1 min. The solvent was removed under reduced 
pressure and the resulting residue partitioned between ethyl acetate (1 0  ml) 
and brine (10 ml). The organic layer was separated and the brine was 
extracted again with ethyl acetate (2x10 ml). The combined organic extracts 
were dried (Na2SC>4 ), filtered and concentrated in vacuo to leave an oil, 135 mg 
(90% yield); 1H and 13C NMR spectroscopy were identical to those recorded for 
the starting material.
Method 2
A solution of compound (223) (500 mg, 1.26 mmol) was dissolved in anhydrous 
THF (15 ml) and stirred at room temperature. To this solution was added 
lithium borohydride, as a powder, and the resulting suspension was heated at 
reflux (oil bath) for 4 h. Once the solution had cooled to room temperature 
saturated ammonium chloride solution (10 ml) was added. The reaction was 
diluted with ethyl acetate and the organic layer was separated and kept. 
Further extraction with ethyl acetate (2x10 ml), combination of the organic 
extracts, drying (Na2 S0 4 ), and removal of the solvent under reduced pressure 
gave the title compound as an oil, 244 mg (60% yield); 8 h (200 MHz) (CD3OD)
1.4-1.9 (4H, m, 3- and 4-H2), 3.5 (2 H, m, 5-H2), 4.6 (1 H, brs, 2 -H), 5.1 (2 H, s, 
14-H2) and 7.3 (5H, m, 16-, 17-, 18-, 19- and 2 0 -H); (5 0  mHz) (CD3OD)
29.6 (C-3), 31.0 (C-4), 55.1 (C-2 ), 63.6 (C-5), 68.3 (C-14), 129.7, 129.9, 130.4,
139.0 (C-15, -16, -17, -18, -19 and -2 0 ) and 171.5 (C-1); m/z 2 2 2  (M+-HC02, 
4.9%), 178, 91 (1 0 0 %), 79 and 77 (found M+-H C 02, 222.1130. C12H 16N0 3 
requires M+-HC02, 222.1126).
f-Butvl AMbenzvloxycarbonyllglutamic Acid y-semialdehvde (230)
HO
11
Compound 229 (100 mg, 0.3 mmoi) was dissolved in anhydrous benzene (5 ml) 
with gentle warming. Dimethylsulfoxide (2.5 ml) was added to the solution with 
stirring. Anhydrous pyridine (24 mg, 0.3 mmol), anhydrous trifluoroacetic acid 
(17 mg, 0.15 mmol) and dicylohexylcarbodiimide (185 mg, 0.9 mmol) were 
added to the solution with vigorous stirring. The flask was stoppered and 
stirred at room temperature for 18 h. Benzene (15 ml) was added and the 
precipitated dicyclohexylurea was filtered off and washed with benzene (2x5 
ml). The combined filtrates were washed with water (3x10 ml). The organic 
layer was dried (Na2S04), filtered and concentrated under reduced pressure to 
leave a pale brown oil, 41 mg (51% yield); t)max 3590, 2980, 1735, 1680 and
1505 cm '1; 5h (200 MHz) (CDCI3) 1.8-2.35 (4H, brm, 3- and 4-H2), 3.0-3.45
(1H, 2xbrd, OH), 4.1 (1H, brm, 2-H), 4.9 (2H, s, 7-H2), 5.5 (1H, brm, 5-H) and
7.05-7.49 (5H, m, 8-13-H); 5c  (50 MHz) (CDCI3 ) 30.9 and 32.2 (C-3 and -4),
59.5 and 60.1 (C-2 ), 65.8 (C-7), 82.0 and 82.7 (C-5), 128.1, 128.5, 129.4 and
137.6 (C-8-13), 150.5 (C-6 ) and 176.5 (C-1); m/z 222 (M+-C 02 H, 0.6%), 143, 
129, 91 (100%), 79, 77 and 56.
AZ-lBenzvloxvcarbonvlaminolserine f2371200
To a solution of L-serine (10.5 g, 100 mmol) in 1M sodium bicarbonate solution 
(400 ml) at room temperature was added benzyl chloroformate (24.0 g, 1.4 
equiv.). After stirring for 4 h the aqueous layer was washed with ether (2x75
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ml). The aqueous layer was cooled to -5 C (ice/water/salt bath) and was 
carefully acidified with conc. hydrochloric acid. The title compound precipitated 
and was filtered off and washed with water (2x25 ml). The combined filtrates 
were extracted with ethyl acetate (2x75 ml). The combined organic extracts 
were dried (Na2 SC>4 ), filtered and concentrated under reduced pressure to 
leave a white solid, which when combined with the precipitate gave the title 
compound, 23.03g (97.5% yield);
COOH
mp 118-119 C (lit. 200 117-119 C); 5 h (2 0 0  MHz) (D20) 3.6 (2H, m, 3-H2), 4.0 
(1H, m, 2-H), 4.9 (2H, s, 5-H2) and 7.1 (5H, brs, 7-, 8 -, 9-, 10- and 11-H); §c 
(50 MHz) (D2 0) 56.8 (C-2), 62.1 (C-3), 67.9 (C-5), 128.5, 129.1, 129.5, 137.0 
(C-6 , -7, -8 , -9, -10 and -1 1 ) and 174.1 (C-1); m/z 239 (M+, 0.3%), 148, 131, 
108, 91 (1 0 0 %) and 77 (found M + , 239.0798. C n H 13N 0 5 requires M+, 
239.0790).
Methyl (2S)-2-(benzvloxvcarbonvlamino)-3-hydroxvpropanoate (238) 200
A stirred solution of compound (237) (5.0 g, 20.9 mmol) in anhydrous methanol 
(40 ml) was cooled to 0  C and thionyl chloride (2.3 ml, 1 .5 equiv.) was added 
dropwise. The mixture was then stirred at 0  C for 30 min before being allowed 
to warm to room temperature. Stirring was continued for 18 h at room 
temperature before the solvent was removed under reduced pressure, to afford 
a crude oil which was partitioned between dichloromethane (50 ml) and 
saturated sodium bicarbonate solution (50 ml). The organic layer was 
separated and kept, the aqueous layer was back-extracted with 
dichloromethane (2x35 ml). The combined organic extracts were washed with
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brine (30 ml), water (30 ml) and dried (Na2S0 4 ). After filtration the solvent was 
removed under reduced pressure to afford an oil, which was purified using silica 
gel chromatography. The title compound was isolated as a clear oil, 5.13 g 
(97% yield); [a ]2° +6 .2  (c 6.4, CHCI3) {lit.,200 [a ] 22 +7.2 (c 6.36 CHCI3 )};
Umax (CHCI3 ) 3400-3200, 3105, 2960 and 1725 cm"1; 5h (200 MHz) (CDCI3 )
3.7 (3H, s, I 2 -H3 ), 3.8-4.0 (2H, ABX, 3-H2), 4.4 (1H, ABX, 2-H), 5.1 (2H, s, 5- 
H2), 6.1 (1H, brd, J SA Hz, NH) and 7.4 (5H, m, 7-, 8 -, 9-, 10- and 11-H); Sq
(50 MHz) (CDCI3 ) 52.6 (C-1 2 ), 56.1 (C-2 ), 62.8 (C-3), 67.1 (C-5), 128.0, 128.2,
128.5, 136.0 (C-6  ,-7, -8 , -9, -10 and -1 1 ), 156.4 (C-4) and 171.3 (C-1); m /z253 
(M+, 3.4%), 223, 194, 162, 150, 108, 91 (100%) and 65 (found: M+, 253.0949. 
C12H15NO5 requires M+, 253.0946).
Methyl (4S1-3-benzyloxvcarbonvl-2.2-dimethyloxazolidine-4-carboxvlate (239)
A solution of compound (238) (500 mg, 1.98 mmol) in anhydrous benzene (30 
ml) with 2,2-dimethoxypropane (0.35 ml, 1.5 equiv.) and p-toluenesulfonic acid 
(19 mg) was heated under Dean-Stark conditions for 1 h. The deep orange 
coloured reaction mixture was poured into saturated sodium bicarbonate 
solution (30 ml) and extracted with ether (3x40 ml). The combined organic 
extracts were washed with water (25 ml), dried (Na2 S0 4 ), filtered and 
concentrated to afford a crude oil, purification of which by silica gel 
chromatography gave the title compound as a clear oil, 468 mg (81% yield); 
[a ] 20 -52.2 (c 1.3, CHCI3 ) {lit.,200 [a ] 22 -52.1 (c 1.31, CHCI3 )};Umax 3115'
3065, 2995, 1765, 1740 and 1715 cm' 1 ; 5h (200 MHz) (CDCI3 ) 1.48 (1 H, s, 5- 
or 6 -H3 ), 1.56 (2 H, s, 5- or 6 -H3 ), 1.64 (1H, s, 5- or 6 -H3 ), 1.71 (2H, s, 5- or 6 - 
H3), 3.62 (2 H, s, I 5 -H3), 3.75 (1H, s, 15-H3), 4.00-4.17 (2 H, m, 3 -H2), 4.47-4.52 
(0.71 H, dd, J 6.5 and 2.9 Hz, 2-H), 4.52-4.60 (0.29H, dd, J 6.2 and 3.0 Hz, 2- 
H), 5.10 (1.33H, AB system, J 12.4 Hz, 8 -H2), 5.18 (0.67H, AB system, J 12.4 
Hz, 8 -H2) and 7.45 (5H, m, 10-, 11-, 12-, 13- and 14-H); 5q (50 MHz) (CDCI3)
24.1, 25.0, 25.2, 26.0 (C-5 and -6 ), 52.4, 52.5 (C-15), 58.8, 59.5 (C-2), 6 6 .2 ,
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6 6 .6 , 66.7, 67.6 (C-3 and 8 ), 94.8, 95.4 (C-4), 127.7, 128.0, 128.2, 128.4,
128.6, 136.3 (C-9, -10, -11, -1 2 , -13 and -14), 151.7 (C-7) and 171.2 (C-1); m/z 
293 (M+, 1.0%), 278, 234, 190, 186, 128, 107, 91 (100%) and 65 (found: M+, 
293.1254. C 15H19NO5 requires M+, 293.1258).
(4 S^-3-Benzvloxvcarbonyl 2.2-dimethvloxazolidine-4-carbaldehyde (240)
13
A stirred solution of compound (239) (250 mg, 0.85 mmol) in anhydrous toluene 
(2 0  ml) was cooled to -78 C and diisobutylaluminium hydride (1.5M, 0 .21  g, 1.7 
equiv.) was added dropwise, keeping the internal temperature below -70 C. 
After the mixture had been stirred at -78 C for a further 2 h, methanol (5 ml) 
was slowly added, and the internal temperature was kept below -70 C. The 
reaction mixture was poured into ice cold 1 M HCI (1 0  ml) and extracted with 
ethyl acetate (3x20 ml). The combined organic extracts were washed with 
brine (2 0  ml), dried (Na2 S0 4 ), filtered and concentrated under reduced 
pressure to afford a crude oil. The compound was purified by silica gel 
chromatography to leave the title compound as a clear oil, 216 mg (97% yield); 
[a ]2D°+67.5 (c 1 .0 0 , CHCI3 ) (lit.,200 [a ] 2Q5 +70 (c 1 .0 1 , CHCI3 )}; u max 3120,
2995, 1740 and 1720 cm '1; Sh (360 MHz) (CDCI3 ) 1.50 (1 .2 H, s, 5- or 6 -H3 ), 
1 .57 (1.8 H, s, 5- or 6 -H3 ), 1.59 (1.2H, s, 5- or 6 -H3 ), 1.67 (1 ,8 H, s, 5- or 6 -H3), 
3.91-4.75 (3H, m, 2 -H and 3-H2), 5.11-5.20 (2 H, m, 8 -H2), 7.27-7.36 (5H, m,
10-, 11-, 12-, 13- and 14-H), 9.54 (0.6H, s, 1-H) and 9.6 (0.4H, s, 1-H); 5c (50
MHz) (CDCI3 ) 23.6, 24.7, 25.7, 26.6 (C-5 and -6 ), 63.6, 64.2, 64.5, 65.1, 67.2,
68.0 (C-2 , -3 and -8 ), 94.8, 95.3 (C-4), 127.9, 128.1, 128.3, 128.6, 136.1 (C-9, 
-1 0 , -1 1 , -1 2 , -13 and -14), 151.9 (C-7) and 199.0 (C-1); m /z  248 (M+-CH3, 
0.1%), 234, 190, 144, 108, 91 (100%) and 65 (found M+-CH3, 248.0929. 
C13H14NO4 requires M+-CH3 , 248.0919).
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(4 S)-3-Benzvloxvcarbonvl-4-|Y 1 R.S) - 1 -hvdroxvalM1-2.2-dimethvloxazolidine
{2411
OH
15
A solution of compound (240) (1.0 g, 3.8 mmol) in anhydrous THF (20 ml) was 
added dropwise over 30 min to vinylmagnesium bromide (1 M solution, in THF,
7.6 ml, 2  equiv.) at -78 C; the reaction was then quenched by slow addition of 
saturated ammonium chloride (5 ml). After this the reaction mixture was poured 
into saturated aqueous ammonium chloride (15 ml) and extracted with ether 
(3x25 ml). The combined organic extracts were washed with brine (30 ml), 
dried (MgSCU), filtered and concentrated under reduced pressure to leave a 
crude oil. Purification by silica gel chromatography yielded the title compound 
as a clear oil, 1.01 g (91% yield); u max (CHCI3 ) 3590-3200, 3095, 1705 and 
1670cm‘ 1; 5h (360 MHz) (CDCI3 ) 1.42-1.66 (6 H, m, 7- and 8 -H3 ), 3.90-4.13
(4H, m, 3-H, 4-H and 5-H2), 5.09-5.20 (4H, m, 9-H2 and 1 -H2), 5.72-5.96 (1H, 
m, 2H) and 7.24-7.34 (5H, m, 12-, 13-, 14-, 15- and 16-H); 8 c  (50 MHz)
(CDCI3 ) 22.9, 24.6, 25.7, 26.3, 27.0 (C-7 and -8 ), 60.6, 62.2 (C-4), 64.6, 65.1,
67.2, 67.7 (C-5 and -1 0 ), 73.1, 73.6 (C-3), 94.8 (C-6 ), 116.4, 118.0 (C-1), 128.1,
128.2, 128.6 (C-2, -12, -13, -14, -15 and -16), 136.6, 137.5 (C-11) and 152.1 
(C-9); m/z 234 (M+-C3 H50, 10.6%), 190, 144, 127, 108, 91 (100%) and 79 
(found: M+-C3 HsO, 234.1133. C 13H16NO3 requires M+-C3 HsO, 234.1126).
(3 f?S.4SV4-(BenzvloxvcarbonylaminoF5-r f-butyldimethvlsiloxy]pent-1 -en-3-ol
(2421
The oxazolidine (241) (600 mg, 2.75 mmol) was dissolved in anhydrous 
methanol (30 ml) and p-toluenesulfonic acid (100 mg) was added. The reaction 
mixture was stirred for 5 h at room temperature after which imidazole (1.4 g, 8 
equiv.) was added and the solvent was removed under reduced pressure to 
afford a crude oil. The crude oil was redissolved in anhydrous DMF (25 ml) and 
t-butyldimethylsilyl chloride (382 mg, 1.2 equiv.) was added and the mixture 
was stirred overnight. The solution was poured into water (30 ml) and extracted
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with dichloromethane (3x40 ml). The combined organic extracts were washed 
with saturated sodium bicarbonate solution (20 ml), dried (MgS04), filtered and 
concentrated under reduced pressure to leave an oil, which was purified by 
silica gel chromatography to afford an oil, 400 mg (57% yield);
N
H
OH
Umax (CHCI3) 3660-3300, 3095, 2955, 2855 and 1725 cm-1 ; 5h (2 0 0  MHz) 
(CDCI3 ) 3.5-3.9 (4H, m, 4-H, 5-H2 and OH), 4.3-4.5 (1H, m, 3-H), 5.0-5.4 (4H, 
m, 1- and 6 -H2 ), 5.7-6.0 (2H, m, 2-H and NH) and 7.3-7.4 (5H, m, 8 -, 9-, 10-,
1 1 - and 12 -H); 5C (50 MHz) (CDCI3 ) 54.0 (C-4), 58.9, 60.2 (C-7), 65.3 (C-5),
70.3, 72.2 (C-3), 114.6, 115.0 (C-1 ), 126.3, 126.4, 126.5, 126.9, 135.7, 135.9 
(C-7, -8 , -9, -1 0 , -11 and -12), 155.5 and 155.5 (C-5); m /z308 (M+^Bu, 1 .6 %), 
250, 234, 177, 165, 91 and 75 (100%) (found: M+^Bu, 308.1318. 
C i5H22N0 4Si requires M+-tBu, 308.1312).
8.5: Experimental Detail For Chapter Six
Methyl pyruvate dimethvlhvdrazone (247)
O
.N,
N' 'O'
To a solution of methyl pyruvate (0.5 g, 5.7 mmol) in ethanol (25 ml) was added 
1 ,1 -dimethylhydrazine (0.58 g, 1.0 equiv). The solution was heated at reflux 
with stirring for 24 h. Once the solution had cooled the solvent was removed 
under reduced pressure to leave the title compound as a pale yellow solid, 0.58 
(71% yield); 5h (200 MHz) (CDCI3 ) 1.98 (3H, s, 4-H3), 2.69, 2.71 (6 H, 2 xs, 5- 
and 6 -H3 ), 3.67 (3 H, s, 1-H3); 6q  (50 MHz) (CDCI3 ) 15.6 (C-4), 46.8 (C-5 and
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-6 ), 52.4 (C-1), 144.6 (C-3) and 165.6 (C-2 ); m/z 144 (M+ ,5.1%), 129, 8 6  and 
71 (found M+ 144.0891. C6Hi2N20 2 requires M+ 144.0896).
Methyl pyruvate methvlhvdrazone (248)
O'
The title compound was prepared by the procedure detailed above for the 
dimethylhydrazone. Methyl pyruvate (0.5 g, 4.9 mmol) and methylhydrazine 
(0.37 g, 1.0 equiv.) were used to give the title compound as a white solid, 0.48 
g (75% yield); 5H (200 MHz) (CDCI3) 1.86 (3H, s, 4-H3), 3.1 (3H, s, 5-H3), 3.73 
(3H, s, 1 -H3) and 5.76 (1 H, brs, NH); 5q (50 MHz) (CDCI3) 10.1 (C-4), 38.0 (C- 
5), 52.2 (C-1), 130.6 (C-3) and 165.7 (C-2); m/z 130 (M+, 1.0%), 115, 8 6  and 
71 (found M+ 130.0742. C5 H10N2O2 requires M+ 130.0740).
Dimethyl c/s-piperidine-2.6-dicarboxvlate (249176
MeO 2 C CC^ Me 
8 9
A solution of dimethyl dipicolinate (1.0 g, 5.1 mmol) in chloroform (20 ml) was 
hydrogenated at atmospheric pressure and room temperature for 24 h with 
Pt0 2  (0.10 g) as catalyst. The catalyst was removed by filtration through Celite. 
The filtrate was concentrated to afford a white solid. Crystallisation from 
methanol gave dimethyl cis piperidine-2,6 -dicarboxylate (249) as a white 
powder (0.94 g, 94%); mp 2 1 0  - 2 1 2  °C; Umax 2990, 1740, 1320 and 1150 cm' 
1; SH (250 MHz) (CDCI3) 1.38 - 1.83 (4H, m, 4- and 6 -H2), 2.40 (2 H, m, 5-H2) 
3.80 (6 H, s, 1- and 9-H3) and 4.20 (2H, m, 3- and 7-H); m/z201 (M+, 28%), 147 
(42%) and 84 (1 0 0 %) (Found: C, 53.78; H, 7.53; N, 6.96. C9 H15N 0 4 requires 
C, 53.77; H, 7.52; N, 6.96%).
Dimethyl A/-methvl-c/s-piperidine-2.6-dicarboxvlate (250176
Me02C CO2M6
A mixture of cis piperidine-2,6 -dicarboxylic acid hydrochloride (0.50 g, 2.9 
mmol), 37% formaldehyde solution (0.48 g), 90% formic acid (0.60 ml) and 
sodium bicarbonate (0.25 g, 2.9 mmol) was heated at reflux for 17 h. 
Precipitated sodium chloride was filtered off and the filtrate was concentrated to 
an oil, 0.36 g, 75%; m.p. 212-216 C (lit.76 , 212 -2 1 5  C), \)max 3450, 2990, 
1740 and 1050 cm '1; 5h (2 0 0  MHz) (CDCI3 ) 1.75 - 1.82 (6 H, 4-, 5- and 6 -H2), 
3.10 (3H, s, IO-H3 ), 3.75 (2 H, m, 3- and 7-H) and 3.80 (6 H, s, 1 - and 9-H3); 5c 
(50 MHz) (CDCI3 ) 22.01 (C-5), 28.41 (C-4 and -6 ), 42.95 (C-10), 53.2 (C-1 and 
-9), 69.24 (C-3 and -7) and 173.42 (C-1 and -9); m/z 187 (M+, 6 %), 142 (42%) 
and 82 (100%) (Found: C, 42.90; H, 6.27; N, 6.27. C 8 H14O4 N requires C, 
42.90; H, 6.30; N, 6.26%).
Dimethyl trans-A/-methvlpiperidine-2.6-dicarboxvlate (2511207
5
O O
To a flame dried flask under a dry nitrogen atmosphere was added anhydrous 
methanol (1 0  ml). The flask was cooled to 0  C and acetyl chloride (0.5 ml, 2.3 
equiv.) was added dropwise over 10 min. Upon warming to room temperature, 
frar?s-A/-methylpipecolinic acid* (100 mg, 0.5 mmol) was added and the 
resulting solution was stirred for 30 min followed by heating at reflux for 16 h. 
After cooling to room temperature, the solvent was removed to leave a white 
solid, 90 mg (79% yield); \)max (KBr disc) cm”1; 5h (200 MHz) (CDCI3 ) ; 8 q  (50 
MHz) (CDCI3 ) ; m/z 215 (M+ , 0.2%), 201, 156, 142 (100%), 97, 83 and 70 
(found M+, 215.1155. C i0 H17NO4 requires M+, 215.1153).
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Dimethyl fra/7S-piperidine-2.6-dicarboxvlate (252)207
5
4 6
\ 9
O O
The title compound was prepared using the procedure detailed above for the 
preparation of the /V-methyl analogue. fra/is-Pipecolinic acid (100 mg, 0.5 
mmol), acetyl chloride (0.5 ml, 2.3 equiv.) and anhydrous methanol (10 ml) 
were reacted to give the title compound as a white solid, 80 mg (69% yield); 
u m a x  (KBr disc) cm '1; 5H (200 MHz) (CDCI3); 8 q  (50 MHz) (CDCI3) ; m/z 2 0 2  
(MH + , 1 .9 %), 201, 143 (100%), 83, 82 and 55 (found MH+, 202.1067. 
C9 H16NO4 requires MH+, 202.1075).
A modified version of the preparation reported by Couper et al.76 was used to 
obtain the title compound. Dimethyl pyridine-2,6 -dicarboxyiate (1.31 g, 6.7 
mmol) was dissolved in dichloromethane (25 ml). To the solution was added 
mete-chloroperbenzoic acid (1.93 g, 11.2 mmol). The solution was stirred at 0 
C for 5 h. The solution was washed with sodium bicarbonate solution (4x20 
ml). The organic layer was dried (Na2S0 4 ), filtered and concentrated under 
reduced pressure to leave the A/-oxide, 1 .1 g (78% yield); 5h (200 MHz) (CDCI3 )
4.03 (6 H, s, 1- and 9-H3), 7.37-7.62 (1H, m, 5-H), 7.64-8.11 (2H, m, 4- and 6 -
H); 8 q (50 MHz) (CDCI3 ) 52.1 (C-1 and -9), 128.0 (C-4 and -6 ), 138.4 (C-5),
148.0 (C-3 and -7) and 164.5 (C-2  and -8 ); m/z 211 (M+, 0.4%), 196, 181, 152, 
94, 105, 77 and 51 (found M+, 211.0483. C9 H9 NO5 requires M+, 211.0478).
Dimethyl pvridine-2.6-dicarboxvlic acid /V-oxide (253176
5
MeOOC COOMe
2 8 9
0 ©
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Preparation of pyridine-2.6-dicarboxamide (254)75
4
h 2n o c N CONH2
7
Pyridine-2,6 -dicarboxylic acid (1.0 g, 6.0 mmol) was dissolved in thionyl 
chloride (15 ml) and was heated at reflux, with stirring, for 2 h. The solution 
was concentrated under reduced pressure and the residue kept. A solution of 
ether (50 ml) saturated with ammonia was prepared. The soution was cooled 
to 0 C and the residue was carefully added to it. The amide was collected by 
filtration and was recrystalised from ethanol to leave the amide as a white solid, 
0.65 g (6 6 % yield); umax 3400, 3100, 1670 and 1590 cm ' 1 5h (200 MHz)
(CD3 COCD3 ) 7.31 (1H, brs, 4-H), 7.72 (2H, m, 3- and 5-H) and 8.49 (1.4H, brs, 
NH2); 5c (50 MHz) (CD3 COCD3 ) 114.6 (C-3 and -5), 129.6 (C-4), 139.4 (C-2
and -6 ) and 155.8 (C-1 and -7); m/z 165 (M+, 13.9%), 122, 105, 77, 50 and 
44(100%) (found M+, 165.0540. C7 H7 N3O2 requires M+, 165.0537).
A solution of compound (254) (1.0 g, 6.0 mmol) in toluene (20 ml) was heated 
in toluene at reflux. Phosphorus oxychloride was added over a period of 10 min 
and the mixture was heated at reflux for a further 30 min. The solution was 
decanted from the solid residue and concentrated in vacuo. Chloroform (2 0  ml) 
was added and the organic layer was washed with 1 0 % sodium bicarbonate 
(3x20 ml) and then water (3x20 ml). The organic layer was dried (MgSCU), 
filtered and concentrated under reduced pressure to leave after recrystallisation 
from chloroform, the title compound as a white solid, 78 mg (10% yield); mp 
129-130 C (lit.76 128-131 C); Umax 2 1 2 0 , 1570 and 1450 cm -1 8 h (2 0 0  MHz)
(CDCI3) 8.0 (2 H, d, J  7.7 Hz, 3- and 5 -H) and 8 .1  (1 H, dd, J 7.4 and 8.4 Hz, 4-
H); 8c  (50 MHz) (CDCI3 ) 115.5 (C-1 and -7), 131.3 (C-3 and -5), 135.1 (C-2
Pvridine-2.6-dinitrile (43) 76
4
7
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and -6 ) and 139.1 (C-4); m/z 129 (M+, 100%) and 103 (found M+, 129.0325. 
C7 H3 N3 requires M+, 129.0327).
Pvridine-2 .6 -ditetrazole (41176
N
N
A mixture of pyridine-2,6 -dinitrile (1.0 g, 7.7 mmol), sodium azide (1.16 g, 17.8 
mmol) and ammonium chloride (0.82 g, 17.8 mmol) in dimethylformamide under 
a nitrogen atmosphere was heated at 70 C for 24 h. The solution was cooled 
and added to diethyl ether (50 ml). The precipitate was filtered off, washed with 
ether (30 ml), and dried to give the title compound as a white solid, 1.5 g (90% 
yield); mp >300 C (lit. 76 >300 C); Umax 3000, 2500 and 1699 cm '1, §h (2 0 0  
MHz) (D2 0) 8.30 (3H, s, 3-, 4- and 5-H); 5c (50 MHz) (D2 0) 122.6 (C-3 and 
-5), 139.6 (C-4), 1482 (C-2  and -6 ) and 162.5 (C-1 and -7); m/z215 (M+, 24%) 
and 187 (100%) (found M+, 215.0672. C7 H5 N9 requires M+, 215.0669).
Dry hydrogen chloride gas was bubbled through a solution of pyridine-2,6 - 
dinitrile (500 mg, 3.9 mmol) in anhydrous methanol (10 ml) at 0 C. The white 
crystalline material produced was filtered off and dried. Recrystallisation from 
water gave dimethylpyridine-2 ,6 -diimidate, 1 0 0  mg (1 0 % yield); mp >300 C 
(lit. 76 >300 C); umax 2960, 1660, 1590, 1310 and 1100 cm-1; 5h (200 MHz) 
(D2 0) 7.34 (3H, m, 3-, 4- and 5-H); 5c (50 MHz) (D20) 54.2 (C-8  and -9), 129.6 
(C-4), 140.8 (C-3 and -5), 147.8 (C-2  and -6 ) and 166.5 (C-1 and -7); m/z 196 
(M+ , 4%), 165, 136 and 80 (100%).
Dimethyl pvridine-2.6-diimidate (42176
Dimethyl 2.6-dibromopimelate (255)208
MeOoC C 0 2Me
To a solution of pimelic acid (1.0 g, 5.7 mmol) in toluene (20 ml) was added 
thionyl chloride (1 ml, 12.4 mmol). The solution was heated at reflux for 2 h 
with stirring. To the solution at reflux was added bromine (0.7 ml) dropwise 
over 20 min. The solution was heated at reflux for a further 10 h. The solution 
was concentrated in vacuo to leave a residue which was poured carefully inrto 
methanol (1 0  ml) at 0 C, with stirring. The solution was concentrated and the 
product isolated as an orange oil, 1.7 g (87% yield); 5h (2 0 0  MHz) (CDCI3) 1 .2 -
1.7 (2 H, m, 5-H2), 2.0 -2 .2  (4H, m, 4- and 6 -H2), 3.8 (6 H, s, 1- and 9 -H3) and 4.3 
(2 H, t, J  7.7 Hz, 3- and 7-H); 5q (50 MHz) (CDCI3 ) 25.0 (C-5), 33.8 (C-4 and
-6 ), 45.0 (C-3 and -7), 53.0 (C-1 and -9) and 169.8 (C-2  and -8 ); m/z 318 (M+- 
C2 H6, 0 .8 %), 316 (M+-C2 H6, 9.6%), 314 (M+-C2 H6 2 0 .1%), 235, 153 (1 0 0 %), 
125, 79 and 81 (found M+-C2 H6 (2 x81Br), 317.8752. C7 H80 4 Br2 requires M+- 
C2 H6, 317.8747).
Methyl thiinane-2.6-dicarboxvlate f2561
MeO 2C ‘ 
1 2
C 0 2Me 
8 9
To a solution of compound (255) (4.0 g, 11.5 mmol) in dimethylformamide (15 
ml) was added sodium sulfide (0.9 g, 1 equiv.). Water (3 ml) was added to 
dissolve the sulfide. The reaction was stirred for 3 h before the solution was 
concentrated in vacuo. The residue was partitioned between water (15 ml) and 
ethyl acetate (15 ml). The organic layer was further washed with brine (2x10 
ml), dried (MgS0 4 ), filtered and concentrated under reduced pressure to leave 
the title compound as an oil, 1.2 g (48% yield); §h (200 MHz) (CDCI3 ) 1.3-2.0
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((6 H, m, 4-, 5- and 6 -H2), 3.50 and 3.51 (6 H, 2xs, 1 - and 9 -H3 ) and 4.0 (2H, t, J
7.7 Hz, 3- and 7-H); SC (50 MHz) (CDCI3 ) 24.6 (C-5), 29.4, 33.7 (C-4 and -6 ),
44.9 (C-3 and -7), 52.4, 52.8 (C-1 and -9) and 169.7 (C-2  and -8 ); m/z218 (M+,
1.7 %), 159, 104, and 73 (100%) (found M+ , 218.0619. C 9 H 14O4 S requires 
M+, 218.0609).
Attempted preparation of dimethyl 1.6-dibromohexan-4-one-1.6-dicarboxvlate
1257)203
O
Me02C‘ Br Br' ‘CC^Me
4-Oxopimelic acid (1 .0  g, 5.7 mmol) was brominated under the same conditions 
used for the preparation of compound (255). The resulting brown oil, 1.5 g 
(72.5% yield) was purified by silica gel chromatography to leave a yellow oil 1.2 
g (58% yield) which by 1H and 13C NMR spectrometry was found to be not 
consistent with the desired structure.
f-Butvldimethvlsilvl serine methvl ester (2591
10
To a flame dried flask under a dry nitrogen atmosphere was added serine 
methyl ester (5 g, 32.1 mmol), imidazole (5.5 g, 2.5 equiv.) and anhydrous THF 
(50 ml). The mixture was stirred and cooled to 0 C. fe/t-Butyldimethylsilyi 
chloride (4.8 g, 1.0 equiv.) was dissolved in anhydrous THF (5 ml) and added 
dropwise to the reaction mixture. Stirring was continued for 1 h and imidazole 
hydrochloride was filtered off. The filtrate was washed with 10% citric acid 
solution (2 0  ml) and brine (2 0  ml) before being dried (Na2S0 4 ), filtered and
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\concentrated in vacuo to leave the title compound as an oil, 6 .5  g (98.5% yield); 
vmax 2915 and 1745 cm'1; 8 h (2 0 0  MHz) (CDCI3) -0.3 and -0.1 (6 H, s, 4- and
5 -H3 ), 0.85 (9H, s, 7-, 8 - and 9-H3), 3.5 (1 H, ABX, Jax+BX 8.2 Hz, 2-H), 3.7 
(3H, s, IO-H3 ) and 3.7-4.0  (2 H, ABX. Jab 9-7 Hz, Jax 4.4 Hz and Jbx 3 .8  Hz, 3 - 
H2 ); 5c (50 MHz) (CDCI3 ) -5.7 and -5.6 (C-4 and -5), 18.0 (C-6 ), 25.6 (C-7 , -8
and -9), 51.8 (C-2 ), 56.3 (C-1 0 ), 65.2 (C-3) and 174.4 (C-1 ); m/z 233 (M+ , 
0.1%), 218, 176, 116 (100%), 102, 89, 75 and 73 (found: M+ , 233.1447. 
CioH23N0 3 Si requires M+, 233.1441).
A/-(Hydroxyethvn-f-butyldimethylsilvl serine methyl ester (260^
To a solution of compound (259) (3.0 g, 12.7 mmol) in water (25 ml) and 
ethanol (3 ml) at 0 C was added ethylene oxide (3 ml, 4.0 equiv.). The 
reaction was stoppered and stirred for 1 h at 0 C. The solution was left to 
stand overnight at room temperature. Solvents were removed under reduced 
pressure to leave a clear oil, 2.99 g (85% yield). The product proved to be a 
mixture of compounds which were separated by silica gel chromatography; 
compound (260) was isolated from the column in 65% yield; t>max 3385, 2910 
and 1748 cm '1; 5h (200 MHz) (CDCI3) 0.00 (6 H, s, 4- and 5-H3), 0.82 (9H, s, 7-
, 8 - and 9-H3), 2.6-2.9 (4H, m, 11- and 12-H2), 3.45 (1H, t, J4 .6  Hz, NH), 3.61 
(1H, ABX, J 5.1 and 5.3 Hz, 2-H), 3.63 (3 H, s, IO-H3 ) and 3.7-3.9 (2H, ABX, 3- 
H2); 8 q  (50 MHz) (CDCI3 ) -5.7 and -5.6 (C-5 and -5), 18.1 (C-6 ), 25.6 (C-7, -8 ,
-9), 49.5 (C-12), 51.7 (C-10), 61.0 (C-11), 62.7 (C-2), 64.4 (C-3) and 173.6 (C-
1); m/z 262 (M+-CH3, 2 .1%), 246, 2 2 0 , 218, 188, 160, 132, 117 and 75 (100%) 
(found M+-CH3, 262.1471. C n H 24N0 4Si requires M+-CH3, 262.1468).
Two other compounds (263) (19% yield) and (264) (approximately 1% yield) 
were identified from the above reaction and are shown below:
lactone (263): 5h (200 MHz) (CDCI3 ) 0.00 (6 H, s, 4- and 5 -H3 ), 0.81 (9H, s, 7-,
8 - and 9 -H3), 2.41 (1H, brs, OH), 2.60-2.77 (2H, m, 3-H2), 3.05-3.11 (1 H, m,
12-H2), 3.33-3.98 (7H, m, 10-, 1 1 -, 1 2 - and 13-H2), 4.03-4.37 (1 H, m, 2 -H); 5q
(50 MHz) (CDCI3 ) -5.6 and -5.5 (C-4 and -5), 18.2 (C-6 ), 25.7 (C-7, -8  and -9),
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46.8 (C-3), 56.2 and 58.5 (C-10 and -12), 63.7 and 67.9 (C-11  and -13), 6 6 .8  
(C-2 ) and 169.4 (C-1); m/z 288 (M+-H, 0 .2 %), 246, 230, 2 0 2 , 101  and 7 5  
(1 0 0 %) (found M+-H, 288.1629. C i3H26N0 4Si requires M+-H, 288.1625).
Di-alkylated compound (264) was observed by mass spectrometry of a crude 
sample from the reaction mixture, m/z 306 (M+-CH3 ., 0.1%), 288, 246, 230, 
202, 101 and 75 (100%) (found M+-CH3, 306.1730. C i3 H28N05Si requires 
M+-CH3, 306.1729).
Attempted preparation of A/O-di-p-toluenesulfonvl A/-(hvdroxvethvlVf- 
butvldimethvlsilvl serine methyl ester (261)
A solution of (260) (100 mg, 0.38 mmol) in dichloromethane (10 ml) was stirred 
at room temperature. To this was added tosyl chloride (0.15 g, 2.1 equiv.), 30% 
sodium hydroxide solution (1 0  ml) and benzyltriethylammonium chloride (1 0  
mg). Vigorous stirring was continued for 4 h before the reaction mixture was 
poured into water (10 ml). The organic layer was separated and washed with 
water (3x10 ml). The organic layer was dried (NaaSCU), filtered and 
concentrated under reduced pressure to leave an oil, 50 mg (24% yield). NMR 
analysis showed that the products isolated were not of the structure expected 
for the product.
MeO ?C
10 i
14
MeO 2 C
Ts
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4-Hydroxytetrahydropyran-c/s-2.6-dicarboxvlic acid and tetrahvdroDvran-c/s- 
2.6-dicarboxvlic acid (262) and (263V
OH
Method 1
To an oven dried flask under nitrogen was added chelidonic acid (1.0 g, 5.4 
mmol). To this was added glacial acetic acid (10 ml) and platinum oxide (50 
mg, 0.05 equiv.). The flask was evacuated briefly to remove any nitrogen gas 
and the vacum was replaced with hydrogen gas from a balloon on the flask. 
The reaction mixture was stirred for 2 d under the hydrogen atmosphere before 
the spent platimun oxide was removed by filitration through a celite pad. The 
pad was washed with methanol (3x10 ml) and the filtrate was concentrated 
under reduced pressure to leave a sticky white solid, 450 mg (50% yield).
Method 2
To a flame dried flask under a nitrogen atmosphere was added chelidonic acid 
(1.0 g, 5.4 mmol), 10% palladium on carbon (approx. 20 mg), formic acid (1.0 g, 
4 equiv.) and anhydrous methanol (7 ml). The suspension was stirred at room 
temperature for 12 h. The spent palladium on carbon was removed by filtration 
through a celite pad. The celite pad was washed with methanol (2x10 ml) and 
removal of the solvent in vacuo left a white solid which turned sticky 
immediately on exposure to air, 400 mg (44% yield).
Data for compound (262) and (263): compounds were inseparable at this point. 
Both reactions gave the same products with only the ratio of hydroxy to 
deshydroxy varying slightly; 5h (200 MHz) (CDCI3 ) ; for compound (263) 5q (50
MHz) (CDCI3 ) 23.2 (C-4), 28.3 (C-3), 76.2 (C-2 ) and 174.8 (C-1) and for 
compound (262) 37.3 (C-3), 6 6 .8  (C-4), 74.4 (C-2 ) and 174.7 (C-1 ); m/z 129
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(M+-(0 H )C 0 2 H, 66.3%), 112, 101, 83 and 73 (100%) (found M+ -(O H )C 0 2 H, 
129.0551. C 6 H9 0 3  requires M +-(0 H )C 0 2 H, 129.0549).
Dimethyl 4-hvdroxytetrahvdropvran-c/s-2.6-dicarboxvlate (265) and dimethyl 
tetrahvdropvran-c/s-2.6-dicarboxvlate (264).
OH
' 0 ^ ^ ^ C 0 2Me 
1 5
Compounds (262) and (263) (500 mg, 2.63 mmol) were dissolved in anhydrous 
methanol (15 ml) with stirring. The solution was cooled to 0 C and thionyl 
chloride (1.25 g, 4 equiv.) was added dropwise over a period of 1 0  min. The 
solution was stirred for a further 30 min at 0  C before being left to stand for 2  
h. The solvent was removed in vacuo and the residue was partitioned between 
ethyl acetate (20 ml) and brine (15 ml). The organic layer was separated and 
washed with brine (2x15 ml), dried (Na2 S0 4 ), filtered and concentrated under 
reduced pressure to leave a clear oil, 350 mg (61% yield). Purification by silica 
gel chromatography gave the two compounds as their dimethyl esters; 
compound (264) (45% yield): Umax 1739 and 1165 cm '1; 5h (200 MHz)
(CDCI3) 1.40-2.05 (6 H, m, 3- and 4-H2), 3.71 (6 H, s, 5-H3) and 4.0-4.12 (2 H, m, 
2 -H); 6 c  (50 MHz) (CDCI3 ) 22.7 (C-4), 27.8 (C-3), 52.4 (C-5), 76.4 (C-2) and
170.7 (C-1); m/z 202 (M+ ,6.4%), 187 (100%), 172, 143, 128 and 84 (found M + 
202.0833. C 9 H 1 4O5 requires M + 202.0837). Compound (265) (16% yield): 
Umax 3450, 1742 and 1162 cm '1; 5h  (200 MHz) (CDCI3 ) 1.42-2.05 (4H, m, 3-
H), 2.22-2.30 (1H, m, 4-H), 3.71 (6 H, s, 5-H 3) and 4.00-4.08 (2 H, m, 2-H); 5c  
(50 MHz) (CDCI3 ) 36.9 (C-3), 52.3 (C-5), 66.5 (C-4), 74.5 (C-2 ) and 170.1 (C-
I); m/z 218 (M+ , 1.7%), 203 (100%), 188, 144 and 100 (found M+ 218.0790. 
C 9 H 1 4 O6  requires M + 218.0786).
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